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Abstract 
 
This thesis describes efforts made towards the synthesis of a biologically stable, luminescent 
molecular probe, which could be used to investigate in vivo the processing of sugars by β-
galactosidases.  To this end, a lactose-based probe was designed, featuring a Lanthanide 
held within a chelate and appended to the glucosyl unit, and a proximal naphthyl moiety, 
attached to the galactose unit, which would function as a sensitiser for luminescence.   
 
A β-galactosidase enzyme from B. circulans was chosen to carry out the investigation.  A 
number of novel methyl glucosides, functionalised with a naphthyl moiety at C6 of the sugar, 
were prepared.  These were then used as glycosyl acceptors to make disaccharides (lactose 
analogues), with the enzyme (functioning in reverse) catalysing the glycosylation.  The 
enzymatic reaction was optimised by varying the amount of enzyme, the reaction pH, the 
ratio of glycosyl acceptor to donor, the reaction temperature, concentration and solvent 
mixture.  The optimal conditions were found to be a 0.4 M reaction solution at pH 7.0 with 
20% acetonitrile, a 7:1 ratio of glycosyl acceptor to donor, 19.6 U of enzyme per mmol of 
acceptor, and a reaction temperature of 30 oC.  The resulting disaccharide products exhibited 
unusual regioselectivity for the β-galactosidase from B. circulans, with unexpected β(1→3) 
and β(1→2) glycosidic linkages being formed.   
 
In an effort to increase the efficiency of the process of identifying suitable substrates for the 
enzyme, a dynamic combinatorial chemistry approach was also explored.  This used 
disulfide bonds to attach the naphthyl moiety to the methyl glucoside using linkers of different 
lengths.  From this library, the enzyme successfully processed the novel disulfide GlcOMe-S-
S-CH2Np as a glycosyl acceptor with p-nitrophenyl galactose as the glycosyl donor.  This 
resulted in a novel disaccharide featuring a naphthyl group attached via a disulfide bond to 
the glucosidic residue. 
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Chapter 1         Introduction 
1. Introduction 
1.1 The Biological Importance of Sugars 
 
Sugars are essential for life, they are ubiquitous in Nature and have roles throughout nearly 
all biological processes.   They are referred to variously as carbohydrates, saccharides, 
oligosaccharides and starches. Ultimately, the monosaccharide glucose is the source of 
energy for our cells and without it, life would cease to be. 
 
Carbohydrates are one of the major classes of biological polymers in biology, they can be 
highly branched and the monosaccharide units can be be connected together using a 
number of different linkages.  Proteins and nuceic acids are almost always linear and contain 
a single type of linkage; amide bonds for proteins and 3’-5’ phospho diester bonds for nuceic 
acids.  The scope for structural complexity in carbohydrates is almost limitless.  Whilst 
carbohydrates can be found without being attached to anything else, the majority of 
carbohydrates in cells and attached to proteins and lipids, referred to as glycoproteins and 
glycolipids, and the carbohydrate that is attached to the protein or lipid is often referred to as 
an  oligosaccharide.1   Glycoproteins are key to a number of biological processes, including 
but  not limited to: 
• fertilisation; 
• viral replication; 
• parasitic infection; 
• cell growth; 
• cell-cell adhesion; 
• degradation of blood clots and 
• inflammation. 
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Glycoproteins and glycolipids are abundant in the outer surface of mammalian cells.  And 
because of this, it has long been thought that oligosaccharides are critical to cell-cell 
interactions.  The best documented roles of oligosaccharides in cell-cell recognition are that 
of the selectin family of receptor proteins.  These mediate adhesion of white blood cells to 
endothelial cells (L-selectin), the recognition of white blood cells by stimulation of wounded 
endothelium (E-selectin) and the interactions of platelets or endothelium with white blood 
cells (P-selectin).  In each case the carbohydrate ligands involved in these recognition events 
are sialylated fucosylated  sugar chains like sialyl Lewisx (sometimes referred to as sialyl 
Lex, Figure 1.1a) 
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O
OH
HO
HO
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O
HO
HO
HO
OH
HO
AcNH
O
C2O
-
Sialyl Lewisx  
Figure 1.1a:  The structure of sialyl Lewis
x
 
 
Other biological recognition may depend on the presentation of multiple copies of such 
oilgosaccharides in a specialised fashion, for example in a sequence on a linear polypeptide 
chain or in the requisite three-dimensional form. In other words, single-molecule sugar-
protein interactions are weak,  so it is this oligosaccharide recognition that is a key feature for 
molecular recognition.2   Alternatively , specific modifications of oligosaccharides – sulfation 
for example – might be creating specific binding sites for recognition.3  Given the complexity 
of oligosaccharide structure and function it is perhaps obvious that mis-processing of an 
oligosaccharide structure by enzymes could lead to incorrect or absent cell-cell recognition.  
Alterations to the cell surface oligosaccharides are associated with various illnesses but the 
one that always causes the most worry is the malignant change within cells – cancer and 
consequent tumour metastatis.    
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Lectins are carbohydrate binding proteins other than enzymes and antibodies and are 
present in most living organisms.  They are involved in numerous biological processes 
including the adhesion of infectious agents to host cells (viral and bacterial infection), the 
recruitment of white blood cells to inflammatory sites (the over-recruitment of which are the 
cause for diseases such as rheumatoid arthritis and lupus, amongst other autoimmune 
diseases) and cell interactions in malignancy and metastatis.  The ubiquitous nature of 
lectins  means that they have great potential for uses in medical science,4 concanavalin A is 
amongst the most studied of such Lectins and is used extensively in histochemcial staining.5  
 
Given the extensive roles that carbohydrates play within biology it is not surprising that they 
play important roles in a number of illnesses and diseases, the most obvious of which is 
diabetes.  However, the problem in such illnesses does not always lie with the carbohydrate 
itself, but more often the countless enzymes present in nature that process carbohydrates 
and on which a vast number of life processes rely.  The subjects of this thesis are the 
glycosidases, ubiquitous enzymes on which various biological processes depend. 
 
 
 
1.2 Glycosidases and Glycosyl Transferases 
 
Enzymes are proteins which catalyse most biological reactions.  They are therefore 
extremely important and a great deal of time and effort has been devoted to their study.  
Some enzymes are also able to catalyse reactions involving both natural and unnatural 
substances in vitro as well as performing their usual task in vivo. As biological catalysts they 
have the following characteristics: 
 
• they operate under mild conditions; 
• accelerate the rate of reactions; 
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• they are highly substrate-specific; 
• they demonstrate high chemo-, regio- and stereo-selectivity; 
• they are chiral and can show high enantiodifferentiation; 
• their stability is highly dependent on the environment in which they are used (causes 
of instability can be, for example, changes in temperature or pH and also solvent 
environment); 
• they may be subject to regulation in that their catalytic activity may be influenced by 
the concentration of substrates, products etc.6 
 
Amongst the myriad enzymes that exist, there are classes of enzyme which deal solely with 
the processing of carbohydrates.  As discussed in Section 1.1 sugars are incredibly 
important molecules and many life processes hinge on the proper function of so-called 
“Carbohydrate-Active Enzymes” (CAZymes) in an organism. 
 
The most comprehensive database of structural information on CAZymes is the CAZy 
database.  The developers of this database have created a dedicated family classification 
system with which to correlate the structure and mechanism of CAZymes.  The CAZy 
database classifies glycosidases in families based on amino acid sequence and thus the 
folding similarities of the enzymes in each family. The enzymes are grouped into families 
which have a similar mode of action and structural features.  The families can also be 
grouped into ‘clans’ which are groups of families wherein the members have related 
sequences or structures.7 
 
Glycosidases (or ‘GH’, Glycosyl Hydrolases) are a large group of CAZymes that hydrolyse 
the glycosidic bond between two or more carbohydrates or between a carbohydrate and a 
non-carbohydrate moiety in vivo.7  They are ubiquitous in Nature and play an essential role in 
the biochemical processing of carbohydrates. 
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Glycosyltransferases (GTs) are CAZymes that catalyse the formation of the glycosidic 
linkage to form a glycoside.  They use ‘activated’ sugar phosphates as glycosyl donors and 
catalyse glycosyl group transfer to a nucleophilic group (usually an alcohol) on the acceptor.  
The product of glycosyl transfer can be an O-, N-, S- or C-glycoside which may be part of a 
monosaccharide glycoside, oligosaccharide or polysaccharide.   
 
In 1982 Whitesides successfully synthesised N-acetyllactosamine using the β-1,4-galactosyl 
transferase (E.C.2.4.1.22).  This landmark synthesis was significant because Whitesides 
included additional enzymes in the reaction mixture to regenerate the co-factors (uridine 5’-
diphosphate glucose and  uridine 5’-diphosphate galactose) in situ.8  This was a big step 
forward as the use of GTs had previously been limited by specific and costly co-factors 
needed in order to perform the desired glycosylation.  Figure 1.2a shows the complexity of 
the cycle needed to use the GT enzyme efficiently.  A large number of different enzymes 
were used, and also a wide variety of substrates were needed for the whole cycle to work. 
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Abbreviations: UDP, uridine 5’-disphosphate; UTP uridine 5’-triphosphate; UDPGE, UDP-galactose 4’-epimerase; UDPGP, 
UDP-glucose pyrophosphorylasse; PGM, phosphogluco-mutase; PK, pyruvate kinase. 
 
Figure 1.2a:  Whitesides’ synthesis of N-acetyllactosamine using b-1,4-galactosyl transferases 
was important as it worked as a system to both perform the transglycosylation and regenerate 
the co-factors needed for the enzymatic reaction 
 
 
In contrast to glycosyl transferases, glycosidases are acknowledged to be much ‘easier to 
handle’ and are also significantly cheaper to employ.  Although these enzymes have 
apparently opposite functions, they do share some similarities.  Both types of enzymes have 
been under extensive investigation for oligosaccharide synthesis.   It is possible to make 
glycosidic bonds using a glycosidase by forcing the enzyme to work ‘in reverse’.  
Glycosidases have many potential advantages over glycosyl transferases in these synthetic 
applications (see Section 1.3.3).   
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Like many enzymes in the body, a lack, deficiency or surfeit of an enzyme can lead to illness 
and disease; this is no less the case with GHs and GTs.  The study of how these enzymes 
work in the body is crucial to understanding and working towards treatments and cures for a 
number of diseases (see Section 1.2.1 for diseases associated with glycosidase deficiency).  
By designing inhibitors for these enzymes, research groups hope to develop such cures. 
 
 
1.2.1   Glycosidase Inhibition for the Treatment of Illness 
 
Glycosidase inhibitors have two main uses; they are tools through which the understanding 
of the glycosidase catalysed processes can be understood and they are also excellent 
candidates for diagnosis and treatement of many illnesses. 
 
Understanding the biological processes mediated by glycosidases can lead to the 
deveopment of treatments for various illnesses.  Most glycosidase inhibitors share two 
common structural features, i) a basic nitrogen which at physiological pH mimics the positive 
charge formed during the hydrolysis of the glycosidic bond (see Section 1.2.3.1 for 
mechanistic details) and ii) an array of hydroxyl groups in a motif which fits selectively into 
the enzyme active site.9   
 
Inhibition of glycosidases (in particular α-glycosidases) in the body can have a large effect on 
the structure of the glycan in question and, because of this, affects the maturation, transport, 
secretion and function of glycoproteins.  This could therefore alter various recognition 
processes in the organism.  This in turn can lead to specialised, directed treatment for 
various illnesses and diseases whose pathology is bound with the action of glycosidases in 
the body.  For example; Tamiflu is a neuroaminidase inhibitor for the treatment of influenza 
and the α-glucosidase inhibitor ‘Glyset’ has been used in the treatment of non-insulin-
dependant diabetes.  The list continues to the treatment of various serious human diseases 
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such as cancers and various viruses; AIDS, hepatitis B, hepatitis C and Dengue. There has 
been recent development of five-membered iminocyclitol derivatives  for use as antiviral 
agents and for the treatment of osteoarthritis.10 
 
Cancer is one of the most feared illnesses in the present time.  Everybody has had contact 
with the disease, whether directly or indirectly and it significantly alters lives.  Glycosidase 
inhibition is a developing area of cancer treatment.  Abnormal cell growth and metastatis can, 
in some cases, be blocked by use of a glycosidase inhibitor.  Tumour and normal cells have 
different rates of cell growth, so if an inhibitor can be used to block the assembly of a 
carbohydrate structures relevant to cell growth, it could lead to a therapeutic treatment for 
cancer by reducing the rate of cell growth (slowing down the pace of cancer growth) or by 
blocking metastatis.11 
 
Investigations into the role and inhibition of glycosidases are therefore crucial to the 
advancement of medical sciences. 
 
 
1.2.2  β-Galactosidases 
 
The enzyme that we have chosen to study is a β-galactosidase from Bacillus circulans.  We 
are interested in studying β-galactosidases as they are responsible for a variety of essential 
life processes where any hindrance or lack of the enzyme can have very serious health 
consequences.   
 
Mammalian β-galactosidases have been studied extensively and there are four reasonably 
well defined biological functions in which they are active.  There are two lysosomal or acid 
enzymes, a neutral β-galactosidase and an intestinal, membrane-bound enzyme.  A 
hereditary deficiency of one lysosomal β-galactosidase results in GM1 gangliosidosis; 
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hereditary deficiency of the other leads to Krabbe’s disease.  Both of these acid β-
galactosidases are genetically distinct.12 
 
1.2.2.1 GM1 Gangliosidosis and Krabbe’s Disease 
 
GM1 gangliosidosis is an inherited lysosomal storage disease due to a deficiency of GM1-β-
galactosidase.  There are various clinical variants which are different in terms of the onset of 
symptoms, which include neurodegeneration, seizures, enlargement of the liver and spleen, 
coarsening of facial features, distended abdomen and skeletal problems, joint stiffness and  
muscle weakness which causes problems with mobility.13 
 
Krabbe’s Disease is a similarly devastating degenerative neurological disorder.  The onset of 
the disease occurs between three and six months of age and initial symptoms are spasticity, 
irritability, abnormal posture, partial or complete blindness, hypertonic fits and loss of tendon 
reflexes. Sadly, death usually occurs before two years of age.  The cause is the deficiency of 
galactocerebrosidase, and the subsequent build up of unmetabolised glycolipids affects the 
myelin sheath surrounding nerves which causes hypersensitivity to external stimuli (light, 
touch etc.,) nerve demyelination (which can lead to hyperallodynia, a severe and chronic 
pain condition caused by abnormal neurological response to touch and movement) and a 
severe degeneration of motor skills.14 
 
Two very serious diseases, both with devastating effects but thankfully quite rare.  
 
1.2.2.2 Lactose intolerance 
 
A more mundane and much more common illness associated with a β-galactosidase 
deficiency is lactose intolerance.   
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The mammalian intestinal, membrane-bound β-galactosidase (often referred to as lactase) is 
responsible for the hydrolysis of lactose into glucose and galactose, both of which can be 
transported across the cell membrane.   All mammals experience a dramatic decrease in 
intestinal lactase after weaning; humans lose 90-95% of birth lactase levels by early 
childhood and this continues to decline throughout the course of a lifetime.   Malabsorbtion of 
lactose occurs in three main types, the most common being primary adult hypolactasia.  
Secondary or acquired hypolactasia can follow any gastrointestinal illness which damages 
the wall of the gut or increases transit time of stomach contents through the digestive 
system.  The third type of lactose malabsorbtion is congenital alactasia, which is very rare 
and describes a life-long, complete absence of this β-galactosidase.  Up to 15% of persons 
of northern European descent, up to 80% of those of African and South American descent, 
and up to 100% of Native Americans and those of Asian origin exhibit a deficiency of this 
enzyme.15   Yoghurts with live cultures (sometimes called ‘friendly bacteria’ and also pre- and 
pro-biotics) often contain bacterially derived lactase which aids the processing of lactose, at 
least in the short term, though various yoghurt manufacturers advertise their products as 
‘cures’ for intestinal tract issues.  It is claimed that the bacteria in these cultures help to 
repopulate the gut with flora, thus aiding digestion. 
 
Diagnosis of lactose intolerance can be difficult.  Patients typically present with loose stool, 
cramps, excessive gas and bloating, all of which can also be due to a number of other 
disorders.  Irritable Bowel Syndrome (IBS) is another extremely common but complex 
intestinal disorder and often presents with very similar symptoms to lactose intolerance.  
Establishing a positive diagnosis for either condition through dietary restriction is often 
difficult, and there is considerable overlap between patients with IBS and lactose intolerance.    
There are two formal diagnostic tests for lactose intolerance.  The first is to administer an 
oral dose of lactose (1-1.5 g/Kg of body weight) and take serial blood samples to monitor 
blood glucose levels; however 20% of test results are subject to false-negative or false-
positive due to the influence of variable gastric emptying and glucose metabolism.  A test 
which measures breath hydrogen after the ingestion of 25 – 50 g of lactose is more sensitive 
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and specific.  It is based on the principle that the breakdown of carbohydrate in the gut is 
detectable in exhalation gases – specifically hydrogen.  A rise of more than 20 ppm in breath 
hydrogen from the baseline after lactose ingestion suggests lactose intolerance.  Whilst this 
test is deemed to be more accurate, the results can still be affected by varying levels of 
bacterial flora in the gut as well as smoking. 
 
A particular goal of the dairy industry, and one that has been successful in recent years to 
the extent that lactose-free milk is now available in supermarkets in the UK, is the ‘removal’ 
of lactose from milk.  This would obviously allow people with a lactose intolerance to drink 
milk from cows rather than having to rely on soya or rice milk.  In the early 1990s Bakken et 
al.16 carried out research into the immobilisation of lactases on a solid support for industrial 
use in hydrolysing the lactose contained in skimmed milk (milk containing less than 0.1 % 
fat).  One such system featured the β-galactosidase from B. circulans. 
 
1.2.3 Enzyme-Mediated Carbohydrate Synthesis in the Laboratory 
 
The synthesis and modification of carbohydrates by enzymes is one of the most intensely 
investigated areas of enzyme applications.  Glycosylation is extremely important for the 
structural modification of compounds of biological interest.  The addition of a sugar on to a 
lipophilic substrate will increase its hydrophilicity and it can change pharmacodynamic 
properties and lead to novel prodrugs.  Importantly, using an enzyme to mediate a 
glycosylation event in the synthesis of biologically active substances is invaluable if 
traditional synthetic methods, using synthetic catalysts, are inappropriate for the end 
application in the medicine and food industries.17  
 
The complexities of oligosaccharide synthesis by conventional procedures has led to great 
interest in using naturally occurring enzymes to form glycosidic linkages because of the 
potential simplicity of the technique.  When using enzymes to make oligosaccharides there is 
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ordinarily no need for a protection/deprotection strategy to ensure that the glycosylation 
event occurs with the desired regioselectivity – unlike conventional chemical oligosaccharide 
synthesis.  Glycosylation also takes place with complete control of stereochemistry: either α- 
or β-linked oligosaccharides are produced depending on the specificity of the enzyme 
chosen for the synthesis.  It is this potential for building complex carbohydrates without multi-
step protection/deprotection strategies and with control of the stereochemistry at the 
glycosidic linkage that is one of the most crucial developments in the field of oligosaccharide 
synthesis.   
 
Glycosyl transferases offer regio- and stereoselective transfer and high glycosylation yields, 
but they require expensive commercial nucleotide donors, or donors that must be created in 
situ using additional enzymatic techniques.  In addition to this, GTs are highly selective with 
respect to the glycosyl acceptors so the glycosylation event is unlikely to occur on a modified 
substrate; although there are examples of this through the diligence and enthusiasm of a 
number of research groups.18,19 
 
In this study, the focus is on glycosidases rather then glycosyl transferases.  Glycosidases 
are much easier to work with than glycosyl transferases, and they are also significantly 
cheaper.   They can accept simple sugars (rather than sugar-nucleotides) and are often 
promiscuous, accepting a wide variety of modified sugars.20,21   Glycosidases are abundant 
in Nature, being produced by animals, plants and bacteria; they are robust and easy to 
handle in the context of a chemistry laboratory, and crucially, they have the ability to function 
in reverse.  Using certain reaction conditions, a glycosidase can be used to carry out 
transglycosylation reactions.22,23 
 
Glycosidases exhibit extremely high stereoselectivity in transglycosylation reactions; for 
example use, of a retaining β-glycosidase will always result in the formation of a β-linkage,  
although the regioselectivity of the glycosylation can be more variable.  However, thanks to 
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the active research in this area there is now a wealth of information on many glycosidases 
investigating the different regioselectivity of enzymes from different sources and how to 
optimise the regioselectivity using different reaction conditions and substrates.   As a 
consequence, they are a phenomenally useful synthetic tool for any synthetic chemist.22,24 
 
The specific examples pertaining to this investigation are discussed in Chapter 3, but I will 
give some general information about the use of glycosidases in carbohydrate synthesis here.   
 
The use of CAZymes to synthesise oligosaccharides using sugars, and also organic 
alcohols, dates back into the 1960s and there is now a plethora of literature on the subject.  
The refinement of these initial forays over time has led to a deep understanding of the 
conditions required to facilitate glycosyl transfer in good yield.  I will focus on the more recent 
use of these enzymes, primarily by Crout, Vic and Thiem, although there are others who 
have made significant contributions to the field. First though, an explanation of the 
mechanism of action and terminology for describing the mode of glycosidase-mediated 
oligosaccharide synthesis. 
 
1.2.3.1 Mechanism of action of the β-galactosidase from B. circulans 
 
As yet the crystal structure of the β-galactosidase from B. circulans has not been determined, 
but there is structural information to be gleaned from comparisons with other enzymes and 
through experimental deduction (Section 1.3.4).  For example, in the CAZy database the 
glycosidases are grouped into families which have similar structural characteristics.  This is 
often deduced by comparison of the amino acid sequence of enzymes with an unknown 
structure to the sequence of one which has a known structure.  So it is possible to find out 
structural information about an enzyme you wish to use but that has not been crystallised.  
This can give the researcher a good idea of structural characteristics and potentially the 
active site as well.  
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The active site of a glycosidase has two recognition centres, one for the glycosyl donor and 
another for the glycosyl acceptor (Figure 1.2.3.1a).  The glycosyl donor is the non-reducing 
end of the sugar, which must be a galactoside for a galactosidase.  Since the β-
galactosidase from B. circulans hydrolyses lactose in Nature, the glycosyl acceptor site 
would be occupied by glucose.  However, extensive studies have shown that many different 
glycosyl acceptors can be used with the β-galactosidase from B. circulans (noted throughout 
Chapters 1 and 3). 
 
Figure 1.2.3.1a: Illustration of a glycosidase active site with two areas, one for the glycosyl 
donor and the other for the glycosyl acceptor. 
 
The β-galactosidase from B. circulans catalyses the hydrolysis of terminal, non-reducing β-D-
galactose residues in β-D-galactosides (including lactose) and does so with retention of 
stereochemistry at the anomeric centre.  The general mechanism of action for a retaining 
glycosidase, also called as an exo-glycosidase, was proposed by Koshland in 1953 and still 
stands more than fifty years later.  This mechanism is shown in Figure 1.2.3.1b.25  
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Figure 1.2.3.1b:  The general mechanism for a retaining b-galatosidase, proposed by Koshland 
in 1953, demonstrates the ‘double displacement’ action of a retaining glycosidase. 
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The mechanism of a retaining glycosidase is believed to function through a ‘double 
displacement’ mechanism.  In this, a covalent glycosyl enzyme intermediate is formed and 
hydrolysed via oxocarbenium ion-like transition states.  The nucleophile and the acid/base 
catalysts, which will work in concert, have been identified as the carboxylic side chains of 
glutamic and aspartic acid residues.  However, it is difficult to assign these side chains to 
specific amino acids without access to crystal structures of the enzyme with bound 
substrates. 
 
1.2.3.2 Transglycosylation and reverse hydrolysis 
 
Most glycosidases used in synthesis are exo-glycosidases (retaining).   Research using 
endo- (inverting) glycosidases for glycosyl transfer is more limited.23 
 
For a glycosidase to be used to form a glycosidic bond between a glycosyl donor and a 
glycosyl acceptor, the enzyme must be discouraged from performing its natural hydrolysis 
function.   
 
In terms of mechanism, incubation of a glycosyl donor with an exo-glycosidase results in a 
glycosyl-enzyme intermediate which can then be intercepted either by water (hydrolysis) or 
by a specific glycosyl acceptor, ROH, which can be an organic alcohol, another glycoside or 
a different nucleophile altogether (Fig 1.2.3.2a).23  In the mechanism for a retaining β-
glycosidase, the first step is the formation of the glycosyl-enzyme intermediate which occurs 
with inversion of stereochemistry via an SN2 mechanism.  In the second step the glycosyl-
enzyme intermediate undergoes another SN2 mechanism when it is intercepted by the 
glycosyl acceptor, again proceeding with inversion of stereochemistry.  Overall, the reaction 
occurs with retention of stereochemistry through this double-displacement mechanism. 
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Figure 1.2.3.2a: The above schematics show  the competing hydrolysis and transglycosylation 
pathways for a retaining b-glycosidase (top) and a-glycosidase (bottom). 
 
Forcing the enzyme to make a glycosidic bond in preference to hydrolysing the glycosyl 
donor can be done in two ways, both of which are outlined in Figure 1.2.3.2b.26  
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Figure 1.2.3.2b: Schematic comparing conditions for reverse hydrolysis and 
transglycosylation.  In reverse hydrolysis a low water concentration disfavours hydrolysis, in 
transglycosylation, a good leaving group is used to move the kinetic equilibrium towards 
glycosyl transfer. 
 
17 
 
Synthesis by reverse hydrolysis 
In reverse hydrolysis the approach is equilibrium-controlled where the equilibrium is shifted 
towards synthesis. Reverse hydrolysis is usually brought about by using a high concentration 
of organic solvent such as t-BuOH, which forces the enzyme to use ROH as the acceptor 
instead of H2O (see Figure 1.2.3.2b). The organic solvent is more abundant than water, 
decreasing the local concentration of water around the active site.  This alters the equilibrium 
so that production of the desired glycoside is favoured over hydrolysis.27  This method of 
enzymatic synthesis dates back to the 1960s,28,29 but has been refined over the years. 
 
Vic and Crout first reported the use of almond β-glucosidase to prepare a variety of β-D-
glucosides.30  In this work the approach was that of reverse hydrolysis as  hydrolysis was 
discouraged by using a high concentration (80 to 90% (v:v)) of the organic solvent, t-BuOH in 
this case (Figure 1.2.3.2c).  Yields for glucosides 1a, 1b and 1c were 22%, 7% and 17%, 
respectively, and it was noteworthy that the enzyme remained active and stable at this high 
concentration of t-BuOH.   
 
O
HO
HO
HO
OH
OH
O
HO
HO
HO
OH
XR
+ RXH
0.2 M
0.8 M
β-D-glucosidase
(almond)
t-BuOH:H2O
90:10 (v:v)
XR = 
1a
1b
1c
O
OH
O
NHCOCF3
S SH
 
Figure 1.2.3.2c:  The use of almond b-galactosidase to synthesise glucosides using the reverse 
hydrolysis method. 
 
 
Following this, two other approaches were tried in order to increase the yield.  The first was 
to decrease the water concentration, the second to increase the substrate concentration.  
The water concentration was decreased to 1% by using t-butyl methyl ether as the co-
solvent.  For glucose to be soluble in this solvent mixture it was derivatised as its phenyl 
boronate derivative (Figure 1.2.3.1d).  Whilst glycosides 1a (yield 7%) and 1c (yield 10%) 
were both made successfully using this method, yields were lower than those employing the 
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conditions in Figure 1.2.3.1c.    Since there was such a high level of organic solvent present 
it suggests that there is a limit to the amount of organic solvent that a given enzyme can 
tolerate before it is deactivated. 
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Figure 1.2.3.1d: An attempt to increase the yield of the reactions with a 1% water concentration 
required the use of the phenyl-boronate-derivative of glucose. 
 
To investigate the effect of substrate concentration, the reaction was carried out directly in 
1,6-hexane diol with 10% v:v H2O.  After five days, glucoside 1a was obtained in 61% yield.  
By increasing the amount of water to 20% the reaction was faster but the yield was lower, at 
43%.  This method is only viable for use with other alcohols that are liquid at <50 oC, do not 
inhibit the enzyme and can solubilise 10 - 20% (v:v) of water.  
 
Synthesis by transglycosylation 
The transglycosylation method is a kinetically controlled glycoside synthesis in which the 
enzyme catalyses the transfer of a glycosyl residue from a glycosyl donor to a glycosyl 
acceptor.  The aim is to increase the yield of the desired product by reducing the extent of 
competing hydrolysis.27  Transglycosylation can provide greater versatility as the glycosyl 
acceptor can be another glycoside, thus leading to oligosaccharide synthesis. 
 
Enzymatic transglycosylation between saccharides was first attempted by Tanaka in the 
early 1980s using crude enzyme preparations that were commercially available or used for 
food manufacturing on an industrial scale.31 This glycosylation method is somewhat different 
to that employing reverse hydrolysis.  In transglycosylation the reaction is not expected to 
reach equilibrium so a high concentration of the glycosyl acceptor is not required if the 
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starting glycoside is chosen appropriately.20   Figure 1.2.3.2e shows this early work on 
transglycosylation when using β-phenyl glucoside as the glycosyl acceptor. 
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22 a) 
C6H10- 13 0.3 CH3(CH2)7- 13 a) 
HOCH2CH2- 36 1.0 (CH3(CH2)3)2CH- 5 a) 
(CH3)2C(OH)(CH2)3- 13 0.76    
1. Two phase (water/nitrobenzene) system used due to hydrophobicity of ROH, carried out at 50 
o
C 
Figure 1.2.3.2e: Conditions and substrates used for the investigations into transglycosylation 
reactions catalysed by the β-glucosidase from K. lactis 
 
This study showed that for this particular disaccharide both primary and secondary alcohols 
can be used for transglucosylation, and that using a primary alcohol will generally result in a 
higher yield than a secondary alcohol.  This is probably on steric grounds as the hydrolysis 
reaction proceed through an SN2 mechanism which will occur most readily with an 
unhindered primary alcohol.  As with reverse hydrolysis, a higher concentration of alcohol will 
result in a higher yield, but in each case there is a point where adding more ROH inhibits the 
enzyme in terms of hydrolysis and transglycosylation. 
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1.2.4 Investigations into the β-galactosidase (B. circulans) active site 
 
As already mentioned, there is no precise structural information about the active sites of the 
β-galactosidase from B. circulans; however there is a good deal of work demonstrating the 
variety of substrates that can be processed by this enzyme.  This gives a very useful insight 
for designing synthetic targets that are likely to be accepted by the enzyme. 
 
In 2001, Usui et al. reported on the enzymatic synthesis of sulfated disaccharides using the 
β-galactosidase from B. circulans and Escherichia coli.    Firstly they looked at the hydrolysis 
of a functionalised galactoside donor, and found that both enzymes hydrolysed 6-O-sulfated 
sugars but not 3-O-sulfated sugars.  The enzyme from B. circulans was used to catalyse the 
trans-galactosylation between 4-methylumbelliferyl 6-O-sulfo-β-D-galactopyranoside and N-
acetyl-glucosamine as detailed in the Scheme below (Figure 1.2.4a).  
 
 
 
Figure 1.2.4a: Usui’s investigation into the glcosyl transfer of N-acteyl-glucosamine onto 6-O-
sulfo-β-D-galactospyranoside suggests that the glycosyl donor site of the β-galactosidase from 
B. circulans can tolerate some functionalised galactosyl donors 
 
The reaction was successful, giving a 49% overall yield of disaccharide product in a ratio of 
1:4 of 2a β(1→4):2b β(1→6),  linked disaccharides and demonstrated that the enzyme would 
tolerate the presence of a relatively bulky, negatively charged substituent at C6.  This 
example gives clear evidence that the donor active site is able to tolerate an unnatural sugar 
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(the natural substrate being lactose).  It also gives insight into the glycosyl acceptor active 
site, which seems capable of handling a large aromatic group, suggesting that a degree of 
freedom is possible in choosing the glycosyl acceptor.21 
 
Work later followed from Thiem and Weingarten who investigated the formation of LacNAc 
mimetics using novel glycosyl donors and catalysis by the β-galactosidase from B. circulans 
(Figure 1.2.4b).   
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CH3 76 66 
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CHO 66 19 
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* after acetylation 
 
Figure 1.2.4b: Investigation into LacNAc mimetics featuring a modified C6 substituent on the 
glycosyl donor 
 
 
The R substituent on the GlcNAc acceptor is remote from the donor active site, and the 
contrast that can be seen in yields seems to indicate that the α-O-allyl functionalised 
acceptor is a slightly better substrate than GlcNAc - the natural substrate.  The most 
significant differences are between the modifications made at C6 of the galactoside donor.  
Complete removal of the C6 group from the donor significantly reduces the reaction yield, as 
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does replacing the alcohol with an amine.  An amine would likely exist as a positively 
charged ammonium ion in vivo, so a decreased reaction yield would perhaps indicate binding 
negatively charged residues in the active site, or an unfavourable electrostatic interaction.  
This may affect the position that the sugar adopts in the active site in such a way that 
glycosyl transfer is inhibited.  However, the enzyme will still process the other three 
permutations, in high yield for the simple methyl substituent, then lower yields for the 
aldehyde and olefin derivatives.  This, perhaps, indicates that it is a carbon atom at C6 itself 
which is important for acceptance into the active site, with modification of the substituent on 
C6 then affecting binding efficacy.32 
 
The conclusion from these two examples is that the primary (C6) alcohol group in a 
galactoside does not seem to be crucial for recognition in the donor site of the β-
galactosidase from B. circulans.   A report by Wong et al.33 seems to confirm this as they 
used a 6-oxo-D-galactoside (in which the 1o alcohol has been oxidised to an aldehyde) as a 
glycosyl donor in β-galactosidase (B. circulans) catalysed transglycosylation reaction. 
 
The galactoside can be modified quite significantly and the enzyme may still accept it as a 
donor; however there are not yet any clear rules governing what types and sizes of 
modification can be tolerated. 
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1.3      Lanthanide Luminescent Probes  
 
The chemistry of the lanthanide series is dominated by the +3 oxidation state and the 
lanthanide contraction whereby the radii of both lanthanide metal atoms and Ln(III) ions 
decrease with increasing atomic number.  This arises from the f-electrons being poorly able 
to shield the other valence electrons from the nuclear charge.  Consequently the effective 
nuclear charge felt by the valence electrons increases slightly on progressing from left to 
right along the series which leads to this decrease in atom/ion radii.34 
 
The spectroscopic properties of lanthanides are based on f-f- transitions which are weak as 
they are forbidden by Laporte selection rules.  Both ground and excited states have the same 
fn electronic configuration so the transitions are parity forbidden so the molar absorptivity of 
the compound is weak.  This means that direct excitation of lanthanide ions is difficult and 
must be accomplished indirectly via an ‘antenna’ or ‘sensitiser’ molecule which is ordinarily 
an organic chromophore. 
 
Ln(III) ions are able to luminesce when excited states are occupied following energy transfer 
from the sensitiser.  The choice of the sensitiser used as an antenna molecule for lanthanide 
luminescence depends upon the lanthanide ion in use.  The chromophore is chosen for a 
strong UV absorption and a long-lived triplet excited state which is closely matched to (but 
slightly higher than) that of the lanthanide ion which leads to energy transfer.  The energy 
transfer can occur through-bond or through-space, in the latter case, the orientation to the 
chromophore to the lanthanide ion can have a large impact on the efficiency of the energy 
transfer.35,36  A simple scheme to demonstrate this is shown in Figure 1.4a.  
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ISC – inter-system crossing 
Figure 1.3a: A simple scheme showing the process of transfer of energy from the excited stae 
of an organic chromophore to the excited state of a Ln(III) ion, resulting in luminescence 
 
Absorption of UV light by the antenna chromophore promotes a ligand-based electron from 
the singlet ground state of the ligand into one of the vibrational levels of the excited singlet 
state of the ligand.  Subsequently, non-radiative Inter system Crossing (ISC) occurs to a 
vibrational level of the excited triplet state which lies lower in energy than the excited singlet 
state.  After relaxation to the ground vibrational level of the excited triplet state, ISC can 
again take place to a nearby excited level of the Ln3+ ion.  Light at a different wavelength is 
then emitted during relaxation down to the ground state.37  The consequence of these 
forbidden transitions is that the decay time (lifetime) on any luminescence caused by the 
transitions is long, typically in the milli-second range.  Europium, terbium, samarium and 
dysprosium are the only four trivalent lanthanide ions which emit visible light, and of these 
europium and terbium give the strongest emission and have the longest luminescent 
lifetimes. 
 
In addition to meeting the energy-level requirements of the lanthanide with respect to the 
sensitiser, the lanthanide chelate and the sensitiser must be in close proximity in order for 
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the energy transfer to take place efficiently.   For example, quinoline can be used to sensitise 
both europium and terbium luminescence.  Quinoline has a triplet excited state energy of 
around 22 000 cm-1, the 5D0 emissive state of europium(III) is 17 200 cm
-1, and similarly the 
5D4 emissive state of terbium(III) at 20 500 cm
-1.  The energy gap between these states is 
ideal for such sensitisation processes.38,39 
 
There has been enormous interest in the development of lanthanide-based luminescent 
sensors within the last two decades.  A lanthanide-based probe exhibits various properties 
which offer advantages over organic chromaphores. These factors all lead to a high 
sensitivity of detection which is of great importance in clinical analysis. 
 
 
Light emission 
 
Lanthanide complexes emit light at long wavelengths, 500 – 700 nm.  This light emission 
occurs in the visible and near IR regions of the electromagnetic spectrum unlike an organic 
chromophore which will typically fluoresce in the UV region.  Thus the measured signal from 
a lanthanide probe is at a different wavelength to that of an organic chromophore and 
importantly the background fluorescence found in biological systems (typically 300 – 420 
nm). 
 
Lanthanide luminescence occurs via excitation of an external organic chromophore requiring 
UV radiation which results in emission of light from the lanthanide in the visible and near IR 
region of the spectrum.  This difference in wavelength of absorbed and emitted light leads to 
a large Stoke’s shift.37  Maximising the wavelength split between excitation and the detection 
of emission wavelengths also reduces scattering and Raman scattering effects. 
Lanthanide spectra exhibit sharp emission lines, with each lanthanide exhibiting a 
characteristic pattern of emission resulting from the different excited state energy levels 
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populated during the energy transfer process.  The emission is observed as multiplets due to 
several electronic transitions and as sharp bands because of the shielding of the f orbitals. 
 
Lanthanide emission has a long fluorescence lifetime, typically greater than 20 ns.  Since the 
background fluorescence of serum has lifetimes of less than 10 ns this difference in 
fluorescence lifetime enables interference-free measurements using time-resolved 
fluorescence.   
 
 
1.3.1 The Design and use of Lanthanide Luminescent Probes for Biological 
Events 
 
Luminescent lanthanide probes must meet a number of requirements in order to be efficient.  
They must: 
• be water soluble; 
• be thermodynamically stable at biological pH and in the presence of biological fluids; 
• be kinetically inert; 
• have an absorption above 330 nm to minimise destruction of live biological material; 
• have efficient sensitisation of the metal luminescence; 
• have the Ln(III) ion encapsulated into a rigid, multi-dentate ligand to prevent damping 
of emitted signal by water; 
• have a long excited state lifetime; 
• be photostable; 
• be non-toxic; 
• have the ability to interact specifically with the biological target without interfering with 
the biological event that it is monitoring; 
• be excreted safely and ideally in the span of 12-24 hours. 
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The lanthanide ion must be encapsulated within an organic chelating agent containing 
several hard nucleophilic groups which interact with the lanthanide non-covalently.  
Lanthanide ions can typically accept between eight and nine electron donors, and in the 
capacity of the sensor as many donor sites as possible must be occupied in order to exclude 
water molecules which can quench lanthanide luminescence by energy transfer from the 
lanthanide(III) excited state to the O-H stretching vibrations leading to radiationless 
transitions.  Small ligands, such as water or carboxylic acids, undergo rapid exchange 
around a lanthanide(III) ion.  All f-element complexes with small ligands are very labile, so 
the ligand sphere cannot exclude water as the small ligands undergo exchange, and so such 
ligands are not useful for luminescent sensors.  There are a variety of multi-dentate ligands 
suitable for coordinating lanthanide(III) ions.  These include polyazacarboxylic acid 
macrocycles, terpyridines and bipyridines, crown ethers, cryptands and porphyrins.  Large 
multi-dentate macrocycles form the most stable complexes with lanthanide(III) ions, since the 
chelate effect ensures the formation of a highly thermodynamically stable complex of the 
lanthanide ion with such a macrocycle.40   
 
Large macrocycles such as cyclen (1,4,6,10-tetraazadodecane), have been employed 
extensively as chelates for lanthanide ions in luminescence signalling studies.  The central 
tetraazadodecane ring can form the basis of the sensor and be functionalised with pendant 
arms carrying sensitiser chromophores.  A typical example of such a sensor is shown in 
Figure 1.4.1a.  The macrocycle is eight-coordinate around the lanthanide(III) ion, blocking 
most of the coordination sphere and effectively encapsulating the lanthanide ion.  
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Figure 1.3.1a: Europium(III) 1,4,6,10-tetrakis[N-(2-methyl-4-quiinolylcarbamoylmethyl)]-1,4,7,10-
tetraazacyclododecane 
 
This particular example by Parker et. al.38 is designed to demonstrate the use of such 
systems for the signalling of ions and molecules through ‘off-on’ luminescent sensing.  The 
tetraamide complex Eu2 (Figure 1.3.2a) detects H+ present in solution by protonation of the 
quinoline aryl nitrogen moiety.  Simply put, the sensor can be ‘off’ under neutral/basic 
conditions and ‘on’ under acidic conditions. 
 
 Another widely used chelate for the lanthanide ions is the octa-dentate ligand DTPA-
bisamide (diethylene triamine pentaacetic acid, Figure 1.4.1b).  The five negatively charged 
oxygen donor atoms bind strongly to the lanthanide ion in solution.  The neutral N bridging 
atoms and the amide carbonyl groups have been determined to also bind within the 
lanthanide sphere, leaving the amide NH free for functionalisation.  Since the heavily 
shielded f-orbitals do not interact to any great degree with their environment, complex 
formation is dominated by electrostatic effects.  This ionic type of bonding leads to a lack of 
directionality in the lanthanide-ligand interactions.  The stereochemistry of association is thus 
determined by the ionic radius of the lanthanide, ligand characteristics and solvation effects.  
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Since lanthanide complexes are ionic in nature, the kinetics of complexation are normally 
rapid for simple ligands, and the binding constant of these derivatives with lanthanide(III) ions 
is high. 
 
N
N
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COOH
HOOC
HOOC
COOH
COOH
DTPA  
Figure 1.3.1b: Diethylene triamine pentaacetic acid 
 
 
DTPA formed the framework for a novel heterometallic luminescent lanthanide probe for 
DNA interacalative recognition developed by Pikramenou et. al. (Figure 1.3.1c).41 
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Figure 1.3.1c: The hairpin-shaped heterometallic lanthanide probe [Ln-Pt2]
2+
 for DNA 
intercalative recognition is based on the DTAP framework 
 
 
The thio aryl-functionalised DTPA ligand was designed such that the backbone of DTPA 
featuring eight hard electron donors would coordinate to a lanthanide (III) ion.  The pendant 
aryl-thiol arms are soft binding sites for other metals, in this case Pt(II) which is bound within 
a terpyridine ligand.  This probe has a ‘hairpin’ shape allowing the Pt(II) intercalating units to 
interact with the DNA backbone but leaving the lanthanide luminescent unit remote from that 
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the DNA backbone.  Keeping the signalling unit (the lanthanide chelate) at a distance from 
the biological recognition event means that the bulky sensor should not inhibit any biological 
action but is still in a position to report the biological event that it is monitoring. 
 
1.3.1.1 The use of lanthanide luminescent probes for the determination of enzyme 
activity 
 
Using fluorescent probes to determine enzyme activity has attracted a lot of attention in 
scientific fields such as in vivo imaging and pharmaceutical screening.  Luminescent 
methods to determining the activity of enzyme activity can be classified into four categories: 
 
a. fluorogenic enzyme substrates; 
b. substrate bearing a Fluorescence Resonance Energy Transfer (FRET) 
donor/acceptor system; 
c. Immunological assays; 
d. specific probes for enzyme substrates or reaction products. 
 
Substrates with a FRET donor/acceptor couple can be used for determining the activity of 
enzymes including proteases, lipases and esterases.  Enzymatic cleavage of each of the 
substrates leads to disruption of the resonance energy transfer leading to a significant 
increase of the donor fluorescence, thereby signalling the enzymatic event.42   
 
In terms of our project, we are interested in fluorescent probes that are used to monitor the 
consumption of substrates, in our case this would be a disaccharide.  To the best of our 
knowledge, a luminescent lanthanide probe for monitoring glycosidase activity has not yet 
been developed.   
A number of europium(III) complexes have been reported to respond to phosphate or 
adenosine triphosphate (ATP) produced during the course of a phosphatase reaction.  A 
europium oxytetracycline complex has been used to determine the concentration of ATP  in a 
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buffered solution.  It was postulated that the enhancement in fluorescence occurred because 
of intermolecular energy transfer in the ternary complexes.  Indeed a number of publications 
relating to europium complexes as luminescent probes for detecting different analytes 
exemplifies their significant versatility.  Conversely, the large versatility points to a lack of 
selectivity, and due to high sensitivity towards interference in biological conditions it is 
unlikely that europium probes would be able to be used to quantify the concentration of ATP 
or another analyte in a complex biological sample. The utility of the probe would then be 
limited to, for example, pharmaceutical high throughput screening.   
 
In order to investigate the process of a protein kinase with increased specificity, the 
monitoring of different nucleoside phosphates associated with enzymatic phosphorylation 
reactions could be the answer.  The conversion of ATP to adenosine diphosphate (ADP) is a 
key step in all kinase-catalysed reactions, in fact a number of molecules are formed from 
ATP.  A  europium oxytetracycline complex was used in a direct fluorometric method to 
monitor the conversion of ATP to its enzymatic reaction product ADP,  adenosine-3’,5’-cyclic 
monophosphate (cAMP), and pyrophosphoric acid (PP).  It was also used to monitor 
guanosine phosphate (GTP) conversions.  The technique is based on the strong quenching 
effect of ATP (and GTP) on the luminescence of the europium tetracycline complex.  This 
method offers advantages over existing assays of ATP as it is affordable and straightforward, 
requires no additional enzymes, requires no fluorescently labelled antibodies and could 
replace radioactively labelled substrates in such assays.43 
 
There is very wide scope for using lanthanide luminescent probes in biological systems.  Our 
intention is to build a lanthanide luminescent probe capable of directly interacting with a β-
galactosidase and in so doing giving a direct and measurable response. 
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1.4 Design of a Luminescent Lanthanide Probe for Monitoring  β-
Galactosidase Activity 
  
Our aim is to develop a biologically stable, luminescent probe in order to investigate the 
activity and specificity of β-galactosidases in vivo.  We intend that our work will shed light on 
the function of glyclosidases in higher mammals – such as humans – so it must be a non-
toxic probe which does not inhibit the enzyme and so could potentially be used in vivo rather 
than be restricted to in vitro assays.    
 
The probe will feature an intramolecular through-space energy transfer from the antenna 
molecule to the lanthanide chelate (fig 1.4.a) as described in the examples in Section 1.4.   
 
The mechanism by which the probe works is as follows: 
 
• The disaccharide (lactose) modified with a sensitiser at C6 of the glycosyl donor and 
a lanthanide chelate at C6 of the glycosyl acceptor should be ‘switched on’ by intra-
molecular energy transfer prior to enzyme processing.  The sensor will be emitting a 
measurable, visible light signal. 
• Upon hydrolysis of the modified disaccharide by the enzyme the sensitiser and 
lanthanide chelate will no longer be in close enough proximity for energy transfer to 
take place as the two parts of the probe will be separated.  The signal will then be 
‘switched off’ 
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Figure 1.4a: This schematic shows the idea behind the design of our probe.  It will be a ‘switch 
off’ system where a decrease in signal intensity from the probe will indicate glycosidase 
activity 
 
 
The decrease in light emission during the assay can be measured and quantified by 
comparison with the amount of luminesence prior to the addition of the enzyme.  
 
Placing the relatively small, planar antenna on the glycosyl donor, which has to fit into the 
more specific active site, and using a tether to make it more remote from the sugar we 
postulate that the enzyme will accept the modified disaccharide.  The much larger lanthanide 
chelate will be attached to the glycosyl acceptor as we know the acceptor active site to be 
more promiscuous than the donor site in glycosidases.  We expect that a tethered lanthanide 
will allow the modified glycosyl donor to fit into its active site as well.  This is discussed in the 
next Section (2.1) which details the building of the probe and the chemical synthesis of the 
various components. 
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Chapter 2       Results and Discussion 
2. Design and Synthesis of First-Generation Probes for 
Assessing β-Galactosidase Activity 
 
2.1 Initial Design of the Probe 
 
As discussed in the Introduction (Section 1.5) our proposed probe for interrogating β-
galactosidase activity is based upon lactose, which is a natural substrate of many β-
galactosidases.    
 
In the first instance we need to determine whether the β-galactosidase from B. circulans will 
accept a sugar that has been functionalised with a bulky aromatic sensitiser.  We began work 
on a synthesis to install the sensitiser at C6 of the galactose moiety (glycosyl donor) in 
lactose; however, however, it quickly became apparent that this would be a long, linear 
synthesis that could potentially take a long time to complete. 
 
Instead, knowing that the β-galactosidase from B. circulans had been successfully employed 
in the synthesis of oligosaccharides, we thought that a much more elegant solution would be 
to take advantage of the transglycosylation function of the enzyme and make a disaccharide 
containing the sensitiser.  In this way we would be able to determine if the enzyme could 
process the modified sugar and use it to make a disaccharide.  Owing to the principle of 
microscopic reversibility, if the enzyme can make a disaccharide containing a modified sugar 
then it must be able to carry out the reverse reaction and cleave a disaccharide containing 
that same modification (Figure 2.1a).  In this way, we will be able to test whether the enzyme 
will accept modifications at an earlier stage of the project. 
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n.b.: conditions for the transglycosylation would differ from those for hydrolysis see Chapter for further 
information. 
 
Figure 2.1a: This schematic shows the first step of the development of our probe.  We will 
install a chromophore at C6 of the glycosyl acceptor using a number of different linking 
moieties.  We will then use a transglycosylation reaction to discover if the modified sugar is a 
substrate for the enzyme 
 
Conformational flexibility, along with changes in the length of the linker, may be needed to 
allow the modified sugar to fold in such a way that it can enter the active site of the enzyme.  
We therefore chose to attach the sensitiser, through a range of linkers, to C6-OH of the 
glycosyl acceptor – glucose – as this is the more flexible part of the sugar and, being the only 
primary alcohol, most readily derivatised.  We were also aware that the acceptor part of the a 
glycosidase active site is generally more promiscuous than the donor part,44 so as a first 
study we would find out if the enzyme will accept the modified glycosyl acceptor and 
subsequently start work on a modified glycosyl donor.  Ultimately though, we would plan to 
append the smaller sensitiser to the glycosyl donor (as the donor part of the active site is 
more specific in its substrate choice than the acceptor part) and the bulkier lanthanide 
complex to the glycosyl acceptor. 
 
The two glycosyl donors we chose to use in these investigations are lactose – the ‘natural’ 
substrate for β-galactosidase hydrolysis and p-nitrophenyl galactose (GalOpNP) which is 
chemically more reactive than lactose in these circumstances as the cleavage of a glycosidic 
bond is not always the rate determining step for glycosidase catalysis.45 
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As discussed in the Introduction (Section 1.3.4) the C6 atom itself seems to be important for 
the recognition of the glycosyl donor in the active site of the β-galactosidase from B. 
circulans, so we must keep the sensitiser quite remote from that carbon atom so that it can 
be recognised by the enzyme.  It is normal practice when attaching sensitising or fluorescent 
markers to probes for biomolecules to use a ‘spacer’ or ‘linker’ to keep the modification 
somewhat remote from the substrate to which it is attached.  This is so that the substrate is 
able to interact with the biomolecule in its usual fashion (or as close to that as possible).  The 
probe will not be as effective in reporting changes in activity if the biomolecule is unable to 
process it ‘naturally’.  
 
The β-galactosidase from B. circulans has a much remarked on preference for forming 
β(1→4) glycosidic linkages,46  but will also make β(1→6) linkages.47-49  By functionalising the 
glycosyl acceptor at C6 the enzyme will not be able to make β(1→6) linkages as this site will 
be blocked.  We postulated that this may give us a single β(1→4) linked disaccharide, just 
like lactose, rather than a mixture of regioisomers.   
 
A summary of the proposed development route for making luminescent probes for monitoring 
β-galactosidase activity is shown in Figure 2.1b.  
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Figure 2.1b:  Summary of the proposed route for the development of a luminescent probe for 
monitoring β-galactosidase activity 
 
 
We first needed to select a sensitiser that would sensitise the lanthanide luminescence, the 
types and lengths of linker that might be suitable and the method for attaching the linker and 
sensitiser to the glucoside. 
 
 
 
Synthesise glucosyl acceptors functionalised with a sensitiser for lanthanide 
luminescence at C6 
Use the β-galactosidase (B. circulans) to make disaccharides containing these modified 
glucosides 
Synthesise galactosyl donors functionalised with the same sensitiser at C6 
Use the β-galactosidase (B. circulans) to make disaccharides containing these modified 
galactosides 
Synthesise glucosyl acceptors with a lanthanide chelate attached via various spacer 
molecules 
Use the β-galactosidase (B. circulans) to make disaccharides containing the lanthanide-
functionalised glucosyl acceptors 
Use the β-galactosidase (B. circulans) to make disaccharides containing the most 
successful lanthanide-functionalised glucosyl acceptor and the most successful 
sensitiser-functionalised galactosyl donor  
This will then form the blueprint for the final disaccharide-based probe 
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2.2 Choice of Sensitiser and Spacer 
A number of organic chromophores are capable of sensitising lanthanide luminescence but, 
mindful that our probe must be able to fit into the active site of the enzyme, we needed to 
consider the size of the sensitiser carefully.  Both quinoline and naphthalene are suitable for 
sensitising luminescence in europium and terbium complexes.  These are the smallest 
sensitisers suitable for use in our probe.  Deciding which of the two to choose will depend 
upon the ease of synthesis of the chromophore-modified sugar.   
 
We also needed to consider the length of the linker molecule which would be used to attach 
the sensitiser to the sugar, and the chemical nature of that linker.  Amide bonds are used 
quite frequently as part of the ligands for lanthanides.  Whilst the enzyme we are using will 
not hydrolyse an amide bond, amide linkers may not be suitable to use in vivo where other 
enzymes (e.g. proteases) could potentially hydrolyse them.  Simple alkyl chains will not be 
hydrolysed in biological conditions, but may cause solubility issues in an aqueous solution.  A 
commonly used linker in biological probes is one based upon poly-ethylene glycols.  Ether 
chains are not hydrolysed under biological conditions, and various ethylene glycols of 
different length are readily and cheaply available and they can be functionalised in a number 
of different ways. 
 
Based on these considerations, we chose to first consider the use of quinaldine-
functionalised methyl glucosides and if necessary, examine naphthyl-functionalised methyl 
glucosides.  We selected methyl glucoside (as opposed to glucose) as the glycosyl acceptor 
as the methyl group positioned at the anomeric carbon would lock the anomeric position 
facilitating characterisation, and also block any possible glycosylation at that point since we 
did not expect our enzyme (a β-galactosidase) would be able to process a glucoside. 
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2.2.1 Investigations into Quinaldine-Functionalised Methyl Glucosides 
Quinoline has been used extensively as a sensitiser for lanthanide luminescence.38  2-Methyl 
quinoline (quinaldine) has similar photo-physical properties, and has also been used to 
sensitise lanthanide luminescence and is much cheaper to buy than the quinoline analogues 
of the compounds we would need.   
 
Sensitisation of Eu3+ and Tb3+ luminescence by a cyclen-based chelate with a quinaldine 
antenna was reported by Gunnlaugsson.38   This quinaldine chromophore has a high 
extinction co-efficient and its T1 energy is E = 21 980 cm
-1 (protonated form in glacial 
enthanol).  This T1 energy is close to those of the Eu 
5D0 and Tb 
5D4 emissive states, hence it 
is suitable for sensitisation of these two ions.   
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Figure 2.2.1a: Cyclen based lanthanide complex with quinoline pendant arm to sensitise 
lanthanide luminescence 
 
The complex [Eu1] was investigated as a pH sensor; in alkaline solution the luminescence 
intensity was said to be ‘switched off’ as the emission was of low intensity.  When the pH of 
the solution was lowered there was a significant increase in the luminescence intensity, 
signalling that protonation of the antenna was occurring.  Complex [Tb1] also showed a pH 
dependence similar to that of the [Eu1] complex.  
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Design of quinaldine-functionalised methyl glucosides 
Although as already alluded to, amide linkers are not necessarily the best choice for in vivo 
studies, for their potential ease of preparation, we elected for two initial target compounds 3 
and 4 (Figure 2.2.1.b), which have different lengths of amide linker chain, and both could be 
made using 4-aminoquinaldine.  
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Figure 2.2.1b: Quinaldine-functionalised methyl glucoside target molecules 
 
The longer chain would be accessed via a succinic anhydride ring opening by 6-(deoxy 
amino)-methyl glucoside.  Quinaldine would then be introduced in a peptide-type coupling 
reaction between the carboxylic acid and 4-aminoquinaldine. We would take a linear 
approach to the synthesis, adding the sensitiser in the final step so that it might give us the 
option to optimise the system by including modified sensors in the final step, should this 
prove necessary. 
   
The retrosyntheses of the first target compound 3 is shown in Figure 2.2.1c. 
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Figure 2.2.1c: Retrosynthesis for compound 6 
 
 
Attempted synthesis of quinaldine functionalised glucoside 3 
The synthesis of compound 3 began with the synthesis of compound 10 – methyl glucose.  
This was prepared in quantitative yield from D-glucose by heating a solution of the sugar in 
MeOH with DOWEX 50W8-400 resin according to a method first published in 1952 by 
Cadotte et.al.50  In this paper, the use of the method above resulted in the production of α-
methyl glucoside.  In our hands, the method resulted in a mixture of both of the α- and β- 
anomers in a ratio of 1.0:0.8 respectively.  Following this first step, the next steps in our 
synthesis of 6 are shown in Figure 2.2.1d below. 
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Figure 2.2.1d: Proposed synthetic route to compound 6 
 
Methyl 6-O-tosyl-D-glucopyranoside 9 was prepared from the methyl glucoside 10 according 
to a method by Wang51.  The procedure chosen used a methyl α-D-mannoside rather than a 
glucoside and reported yields for that compound were 74%.  In our hands, yields employing 
our substrate were much lower, ranging between 30% and 44%.  Some of the discrepancy in 
mass recovery was due to di-tosylated material of which a small amount (~5%) was 
produced in each reaction.  Starting material accounted for the remaining mass balance.  We 
believe that the yields were lower than expected due to the quality of anhydrous pyridine 
used.  Later on in the project when we attempted a similar conversion with TrCl, the use of 
purchased anhydrous pyridine (as opposed to lab-prepared and stored anhydrous pyridine) 
improved the yield of that reaction.   
 
Azide 8 was produced following another procedure by Wang52 by treating tosylate 9 with 
NaN3 in DMF.  Then, in a departure from the published procedure, this was immediately 
followed by acetylation of the alcohols in the resultant 6-azido sugar under standard 
conditions53 to provide the desired acetyl-protected azido glucoside 8 in 70% yield over the 
two steps.  It was necessary to protect the free secondary alcohols as acetates at this stage 
to facilitate handling and characterisation of the sugars.  The hydrogenation52 reaction to 
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install the amine at C6 of the sugar proceeded well in 97% yield and without the need for 
further purification.  The final step in this sequence was the succinic anhydride ring-opening 
to form sugar 6 bearing a pendant carboxylic acid arm, primed for further functionalisation.  
Following a method by Murphy,54 the reaction of amine 7 with succinic anhydride proceeded 
efficiently providing the desired acid in a 91% yield with no need for further purification.   
 
With the synthesis of sugar 6 complete, the next stage was to attach the quinaldine sensitiser 
to the sugar. We first chose a procedure to form an acid chloride on 6 and then use this to 
couple with the amine functionality in 4-aminoquinaldine (Figure 2.2.1e). 
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Figure 2.2.1e: Attempted synthesis of target compound 5 from the succinamic glucoside 6 
 
Following methods from Domagala55 and Bernauser,56 the reaction shown in the scheme 
above was attempted.  Formation of the acid chloride using oxalyl chloride appeared to 
proceed correctly.  Effervescence was observed when adding the substoichiometric amount 
of DMF and the reaction solution turned green.  After two hours, the solvent was removed 
under reduced pressure and the second stage initiated.  The solution of acid chloride in 
CH2Cl2 (1 M) was slowly added via cannula into a cooled solution of the amine.  The reaction 
was followed by TLC, and a new spot that streaked was observed.  We had expected this to 
indicate the coupling of 4-aminoquinaldine onto the sugar.  However after an acid/base work 
up, and purification of the residue by column chromatography, NMR analysis of the isolated 
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fractions showed no sign of the desired product.  The reaction was repeated, this time 
leaving the amine coupling step overnight to see if this had an effect on the yield of the 
desired product.  After work up, mass spectrometric analysis of the crude organic residue 
revealed a peak at m/z = 560 corresponding to the desired product, which was confirmed by 
HRMS.  However, none of this was recovered after column chromatography. 
 
After considering the reaction conditions, we concluded that the acidic reaction conditions 
were affecting the quinaldine moiety.  HCl is produced in the formation of the acid chloride 
and is not removed prior to the addition of 4-aminoquinaldine, and we concluded that 
protonation of our nucleophile was occurring when 3-aminoquinaldine was added in the 
second stage (Figure 2.2.1e).57  We also tried the reaction using SOCl2 instead of oxalyl 
chloride but still no product formed.  Thus we concluded that the reaction was not working 
and would be unlikely to under these conditions. 
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Figure 2.2.1f:  Protonation of 2-methyl-4-aminoquinoline 
 
We next attempted a DCC coupling between 8 and 4-aminoquinaldine (Figure 2.2.1g). 
Following a method reported by Stoddart,58 the DCC coupling was attempted, but proved 
unsuccessful.  It was repeated three times but in each case the reaction none of the desired 
product was isolated, only dicyclohexylurea (DCU) was obtained. 
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Figure 2.2.1g: Attempted DCC coupling of 4-aminoquinaldine to succinamic glucoside 6 
 
An attempt was made to perform the earlier anhydride opening using 4-aminoquinaldine 
(Figure 2.2.1h) and then perform a DCC coupling onto 7, but this also proved unsuccessful 
as the quinalidine was insoluble under the reaction conditions.     
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Figure 2.2.1h: The envisioned alternate route to target compound 3 via a succinic anhydride 
ring-opening by 4-aminoquinaldine was attempted but unsuccessful 
 
The formation of compound 3 was proving very difficult, so we chose to leave it and 
investigate the synthesis of our second target, compound 4.  The retrosynthesis is 
summarised in Figure 2.2.1i. 
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Figure 2.2.1i: Retrosynthesis of target compound 4 
 
The first stage in the synthesis of 4 was to acylate 4-amino quinaldine and make the known 
compound chloro-N-(2-methyl-4-quinolyl)-ethanamide (14a) and novel bromo-N-(2-methyl-4-
quinolyl)-ethanamide (14b).  Both compounds were made following a method by 
Gunnlaugsson (Figure 2.2.1j).38  Both reactions resulted in the successful synthesis of the 
targets although the yields were low.  14a was produced in only 42% yield (published value 
60%) and 14b in an even lower 20% yield, but this was sufficient for our purposes at the 
time. 
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Figure 2.2.1j: Synthesis of chloro-N-(2-methyl-4-quinolyl)ethanamide and bromo-N-(2-methyl-4-
quinolyl)ethanamide 
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An orthogonal protecting group strategy is necessary to produce a methyl glucoside which 
has a free OH at C6.  There are myriad ways of achieving this with the wealth of information 
available about protecting group strategies, particularly on carbohydrates.   
 
The generally accepted approach to making a glycoside with a free OH at C6 is to first install 
a bulky protecting group at that position.  This alcohol is easily differentiated from the 
secondary alcohols when using a stoichiometric amount of the sterically demanding group 
under the requisite conditions.  Commonly used groups are TIPS, TBDPS, TBDMS and trityl 
ethers and tosylates which, due to their steric bulk, all react preferentially at the less sterically 
hindered C6 position.  Then, the remaining secondary alcohols are protected with groups 
introduced using conditions that will not cleave the bulky group at C6 and that will be stable 
to conditions required to remove this bulky group at a later stage (Fig 2.2.1k). 
 
 
Figure 2.2.1k: Strategy to reach the selectively deprotected target molecule 
 
So, in order to install the sensitiser at C6 of the sugar, we used a selective 
protection/deprotection strategy as shown in Figure 2.2.1k. The 6-hydroxy sugar 11 was 
made following a procedure by Vasques by selectively protecting C6 of the sugar with 
TBDPS.  Following a method by Vásquez,59  the TBDPS ether was similarly introduced onto 
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C6 of our methyl glucoside using imidazole in a concentrated solution of DMF and achieved 
an 81% yield for the mixture of anomers.  TBDPS was chosen as it has more steric bulk than 
TIPS and TBDMS whilst also being significantly cheaper than TIPS, which is the next largest 
in terms of bulk.  In its first reported use, by Hanessian and Lavallee,60 TBDPS was noted to 
silylate primary alcohols in preference to secondary alcohols and was installed by them using 
imidazole in DMF, a method previously reported by Corey and co-workers61 with respect to 
the protection of hydroxyl groups as TBDMS derivatives.  Following the same method by 
Vásquez59 the secondary alcohols were benzylated using a Williamson ether synthesis in 
71% yield.  The TBDPS group was then removed using TBAF in THF62 in a 90% yield 
(Figure 2.2.1l). 
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Figure 2.2.1l: Proposed synthetic strategy to reach quinaldine functionalised glucoside 4 
 
Using another Williamson ether reaction, 15 was made from 11 using 14b, and so we had 
successfully made a methyl glucoside with a quinaldine sensitiser attached.  However, our 
synthesis faltered in the final step as we were unable to remove the benzyl groups.  There 
are a number of ways to do this,63 we chose to start  with hydrogenolysis (Pd/C, H2)
53 which 
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we attempted first, but which resulted in the recovery of only mono-debenzylated material.  
We thought that this might be due to the quinaldine poisoning the catalyst we attempted 
debenzylation using FeCl3;
59 however this did not work either.  We then tried the 
hydrogenolysis using the Degussa-type catalyst Pd(OH)2/C, but this was also unsuccessful 
and we only recovered starting material from the reaction.  Finally we tried Raney Ni64 but 
again only recovered starting material 
 
It was very clear at this point that the quinaldine was hampering the syntheses, sometimes in 
ways that we could rationalise and explain, other times it seemed that it was just a capricious 
compound to work with.  We chose not to waste any more time on installing this sensitiser 
and instead turned to naphthalene, which is also capable of sensitising lanthanide 
luminescence.  Naphthalene should be inert to acidic and basic conditions compared to 
quinaldine, and many derivatives are available commercially.  Overall we thought that this 
would have a much better chance of success. 
 
 
2.2.1.1 Investigations into Naphthalene-Functionalised Methyl Glucosides 
 
Naphthalene is capable of sensitising Ln luminescence but unlike quinoline and quinaldine, it 
is not a heterocycle.  We might expect that synthetic handling of naphthalene would be less 
problematic than our experience of quinaldine. 
 
Naphthalene typically sensitises luminescence of Eu3+.  In study by Viswanathan65 
complexes of Eu3+ with 1-naphthoic acid and 2,6-naphthalenedicarboxylic acid, the use of 
these two compounds as ligands was found to sensitise and enhance Eu3+ fluorescence in 
aqueous solutions.   
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In another report by Quici66 a detailed study of the luminescence properties of Eu3+ and Tb3+ 
complexes it was found that the naphthalene chromophore sensitised the luminescence of 
the lanthanides and it was confirmed to be through ISC between the excited triplet state of 
the chromophore and the excited state of the Ln(III) ion.  It was also stated in this report that 
quinoline had a similar effect on the sensitisation of luminescence. 
 
Six new target sugars were originally envisaged, three using amine and amide linker chains 
based on the amino methyl glucosides we had already synthesised (Figure 2.2.1.1a), and 
three using ether and ester linker chains (Figure 2.2.1.1b). 
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Figure 2.2.1.1a: Suggested retrosynthesis of amide- and amine-linked naphthyl glucosides 
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Figure 2.2.1.1b: Suggested retrosynthesis of ether- and ester-linked naphthyl glucosides 
 
However, the synthetic pathways to all of these sugars were different.  We had spent a great 
deal of time trying to make quinaldine-functionalised sugars by two different methods, and it 
had proved very inefficient.  We were reluctant to embark upon another synthetic strategy 
that involved six different sets of reactions to optimise.   
 
We therefore considered the types of linkers that are commonly used in biological probes 
and those based on poly-ethylene glycols (PEGs) were both abundant and successful.  By 
concentrating solely on making ether linkages we could make our synthesis less complicated 
and more efficient.  After all, the major part of the project was to screen potential substrates 
using the β-galactosidase from B. circulans, and as yet we had no substrates with which to 
begin the study.  The next Section of this work discusses the synthesis of a family of ether-
linked naphthalene functionalised glucosides. 
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2.3 Synthesis of a Family of Ether-Linked Naphthalene-
Functionalised Glucosides 
 
Having investigated various options for installing a naphthalene moiety at C6 of a methyl 
glucoside, it was decided that we proceed with a design based upon ether linkages (see 
Figure 2.3e).  These were more analogous to each other, thus more comparable, and they 
have also been widely used in studies on biological systems as they exhibit good 
biocompatibility. 
 
Polyethylene glycol (PEG) linkers have been used for many years in biological applications 
as they are non-toxic, non-biodegradable, non-immunogenic and as such have been widely 
studied in protein and small molecule modification.67  They have been used in cell 
aggregation68 and also as drug delivery aids due to their enhanced cell permeability and 
water solubility.69  PEG has also found frequent employment as a spacer or linker in various 
sensors and inhibitors.  For example, Wong and co-workers investigated the effect of spacer 
length in the inhibition of E-Selectin using bivalent sLex derivatives containing oligoethylene 
glycols of different lengths (Fig 2.3a).70   
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Figure 2.3a: PEG bridging units used in a E-Selectin inhibitor 
 
Visintin et al. used PEG spacers, including a variable length spacer, in the synthesis of 
biotin-labelled membrane receptor probes (Fig 2.3b).71   
 
 
 
Figure 2.3b: PEG spacers of varying lengths were used in a membrane receptor probe 
 
An example from Blais and co-workers describes the attachment of meso-tetraphenyl 
porphyrins to a number of glycosides via a diethylene glycol linker (Fig 2.3c).72  The aim of 
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this work was to study the photoefficiency of these probes for potential Photodynamic 
Therapy treatment of retinoblastinomas. 
 
Figure 2.3c: diethylene glycol spacers were used in this probe for the potential treatment of 
retinoblastomas 
 
An example using PEG as a linker attached to a naphthyl group is described in a 2005 paper 
by Nishimura and co-workers concerning the design and synthesis of novel inhibitors for a 
human β−1,4-galactosyltransferase.73  Two inhibitors were synthesised using ethylene glycol 
spacers (Fig 2.3d), with one inhibitor carrying amide and ester bonds to attach the sugar and 
naphthyl moiety to the chain (16a, 16b), and the other having simple ether linkages (16c).  
This report is of particular interest to us as it involves a glycosyl transferase which performs 
the opposite function to glycosidases in the body, though with a similar mechanism of action.  
The inhibitors have similar features to our planned probes, though our intention is not to 
inhibit the β-galactosidase. 
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Figure 2.3d: Use of a PEG spacer in an inhibitor for human β-1,4-galactosyltransferase 
 
Our design would use the simplest PEGs, ethylene- and diethylene glycols, as linkers 
between methyl glucoside and the naphthyl sensitiser, and to install these tether molecules 
using a Williamson etherification.  This new synthetic route also meant that a convergent 
strategy could be used in the synthesis, making the operation more efficient than our 
previous ideas as each probe would be made from common precursors, the p-
methoxybenzyl protected sugar 17.  As shown in Figure 2.3e, the simplest probe would be 
made by installation of the naphthyl group at C6 of the methyl glucoside by a Williamson 
ether reaction between the sugar and 2-bromomethylnaphthalene.  This is a common 
procedure as the naphthyl group can be used as an orthogonal alcohol protecting group to 
PMB ethers, which can then be selectively removed.  Using hydrogenolysis to remove the 
PMB groups would actually preferentially remove the naphthyl group.  Using CAN removes 
the PMB ethers, leaving the naphthyl group intact.74   
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Figure 2.3e:  Retrosynthesis of our three target methyl glucosides featuring ether linkages of 
different lengths 
 
 
The other two glucoside-based probes featuring the longer EG and DEG linkers would be 
made using the components shown in Figure 2.3e (synthesis of these naphthyl linkers is 
described later).  In keeping with the synthesis of the simplest probe we would functionalise 
our EG and DEG naphthyl tethers as bromides and use a Williamson etherification to attach 
these to an appropriate methyl glucoside.  There is a potential side reaction when using the 
longer tether molecules which is due to E2 elimination, as shown in Figure 2.3f. 
 
Figure 2.3.f: Potential elimination side reaction when using the two naphthyl linkers 18 and 19 
 
Examining work from Nishimura and co-workers (Figure 2.3g),73 who had installed a PEG 
naphthyl tether onto C6 of UDP galactose from a chloride-functionalised tether molecule we 
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had confidence that this side reaction could be minimised.  We proceeded with the reaction, 
knowing that optimising the reaction conditions with the help of literature precedent would 
hopefully minimise this potential side reaction. 
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Figure 2.3g: Synthetic method for the attachment of a halo polyethylene glycol naphthyl group 
on C6 of a galactoside 
 
 
2.3.1 Synthesis of Methyl-(2,3,4-O-p-methoxylbenzyl)-D-Glucopyranoside 
2.3.1.1 Use of the trityl group to protect C6 of methyl glucoside 
 
At this point we could have gone back to our earlier work on TBDPS protected methyl 
glucose (Section 2.2.1), but we decided to try a selective trityl protection instead.  TrCl is 
significantly cheaper than the TBDPSCl used to make the compounds in Figure 2.2.1l and 
does not require handling under an inert atmosphere. Trityl ethers are commonly used as 
bulky protecting groups in carbohydrate synthesis displaying the expected preference for 
primary alcohols.75, 76  The preference of trityl ethers for C6 of α-methyl glucosides was first 
noted in 1926 by Helferich in a report published in Annalen.77 This protecting group also 
works well as an orthogonal protecting group to PMB ethers despite the acidic conditions that 
are used to remove the trityl group.  Generally a strong acid, such as HBr in acetic acid is 
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required to deprotect benzylic ethers, but trityl ethers are known to be labile to dilute acetic 
acid.78  Thus, the PMB ethers should survive the mildly acidic conditions required for removal 
of the trityl group.   
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Figure 2.3.1.1a: Trityl ether approach to a selectively C6 deprotected PMB ether 17 
 
The reaction scheme shown in Figure 2.3.1.1a was based upon similar work on α-methyl 
mannoside by Fairbanks and coworkers79 which details the entire process of a selective 
protection/deprotection strategy to access a free OH at C6 of the sugar.   
 
Trityl protection of 10 using a classical method as detailed in Fairbanks’ paper proceeded 
reasonably well in yields ranged between 63% and 86% which was comparable to the 75% 
yield for this reaction on an α-methyl mannoside.  The trityl-protected methyl glucoside was 
isolated as a mixture of two anomers (1.0:0.8 mixture of α:β anomers) which were 
inseparable by column chromatography at this stage.   Initial attempts at the installation of 
the PMB ethers as described in Section 2.3.1 afforded compound 21 in a range of yields 
from 39% – 58%, which were unsatisfactory.  At this point we invested in a bottle of ‘extra-
dry’ DMF, the use of which raised yields to a maximum of 74%.  Even though separation was 
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possible by careful column chromatography 21 was isolated as a mixture of anomers, except 
for characterisation purposes.   Compound 21 was therefore carried through to the de-
tritylation as a mixture of anomers as it turned out to be more practical to separate the 
anomers after the trityl group had been removed.  
  
The Tr group was removed by heating the trityl ether 21 overnight in a 1:1 mixture of AcOH 
and EtOH.  After the reaction was complete (very obvious by TLC stained with ammonium 
molybdate dip, as the characteristic yellow colour of the Tr group had been removed from the 
intense blue/violet of the PMB protected sugar).  Work up furnished the desired alcohols 17a 
and 17b as a mixture of anomers in a very satisfying 92% yield.  This was followed by a very 
careful column to separate the two anomers for characterisation and use in subsequent 
experiments. 
 
Summary 
With an effective and reliable route to our target compounds 17 in hand, work progressed on 
to installing the naphthyl group at C6 of the methyl glucoside.  The next stage was to 
synthesise the naphthyl linker compounds and then attach them to 6-hydroxy sugar 17 in a 
Williamson ether process.   
 
2.3.1.2 Synthesis of naphthyl tethers using ethylene- and diethylene glycol 
As discussed at the beginning of Section 2.3 we planned to make a small family of naphthyl-
functionalised methyl glucosides, which were related by using ether linkages of different 
lengths as the linkers (Figure 2.3.1.2a) 
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Figure 2.3.1.2a: Naphthyl linker target compounds 
 
Ordinarily the purpose of the tether in fluorescent probes is to separate the chromophore 
from the point of recognition, such that it does not interfere with the molecular recognition 
event.  So, too short a tether may inhibit the action of the enzyme, rendering the probe 
ineffectual, but in our case, the tether should not be too long as that may make the 
chromophore too remote to sensitise lanthanide luminescence (see Sections 1.4 and 1.5).  
For our initial studies we chose to investigate three different tether lengths of a similar type in 
order to determine if the enzyme was capable of processing the labelled methyl glucosides. 
Enzymes function in an aqueous environment.  Substrates, whether natural or not, must be 
water-soluble to a good degree in order for the enzyme to work upon them.  The methyl 
glucoside probes we have designed have three free OH groups which will aid water 
solubility, but they also have a naphthyl group which is hydrophobic.  By using an ether chain 
for the tether, rather than a simple alkyl chain, we should enhance the water-solubility of the 
probe so that it can be used under biological or near-biological conditions for the enzyme 
experiments. 
 
Synthesis of naphthyl tethers 
The shortest naphthyl tether used in the project is the commercially available 2-
bromomethylnaphthalene (2BMN) and this same compound also forms the basis of our route 
to the other two naphthyl tethers.  Whilst it is commercially available it is also rather 
expensive and somewhat prone to decomposition when exposed to light, heat and air.  It was 
felt that synthesis of 2BMN from the much less costly 2-methylnaphthalene in a radical 
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bromination with NBS would be prudent.  There is ample literature for this reaction, the 
overwhelming majority of which use CCl4 as the solvent, which is expensive and highly 
carcinogenic.  We decided to go ahead with the radical bromination using a method 
described by Burke80 (Figure 2.3.1.2b), which is a rare example of the use of CH2Cl2 as the 
solvent, whereby the desired target is obtained in 78% yield.   
 
 
 
Figure 2.3.1.2b: This bromination of an aryl methyl group defies convention as it is carried out 
in CH2Cl2 rather than CCl4 
 
The work up described by Burke was to cool the reaction and remove the volatiles by rotary 
evaporation prior to purification by column chromatography.  However, we referred to 
another paper81 on the radical bromination of 2-methyl naphthalene (using CCl4 rather than 
CH2Cl2) which gave more efficient work up and purification process.  By cooling the reaction 
mixture to 0 oC, the succinimide crystallised out, was filtered off and a basic work up 
performed prior to removal of solvent under reduced pressure.  The residue was then 
recrystallised from EtOH to furnish 2BMN in 90% yield.  
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Figure 2.3.1.2c: Synthesis of 2-bromomethyl naphthalene 
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With access to pure and relatively inexpensive 2BMN (22), it was now possible to work on 
the synthesis of the remaining 2 naphthyl tethers.  The retrosynthesis for our targets is 
shown in Figure 2.3.1.2d. 
 
Figure 2.3.1.2d: Retrosynthetic analysis of the ethylene glycol-based naphthyl linkers 
 
In the forward synthesis (Figure 2.3.1.2e), a silver(I)-mediated alkylation would be used to 
install ethylene- and di-ethylene glycol onto 2BMN.  This could have been done via yet 
another Williamson etherification, but may well have led to di-functionalised glycol even when 
using stoichiometric amounts of base and bromide.  A paper by Sauvé82 deals with highly 
selective silver(I) oxide-mediated monoprotection of symmetrical diols, which is exactly what 
we wanted to do.  In this paper, yields for selective mono protection of ethylene glycol with 
benzyl bromide were 70%.  Yields in our hands varied according to substrate but were 
generally satisfactory, even up to 96% when using diethylene glycol.  Bromination of the 
remaining alcohol was achieved in a typical fashion using PPh3 and CBr4
83 and normally 
proceeded in near quantitative yield. 
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Figure 2.3.1.2e: Successful synthesis of the target naphthyl-linker bromides 
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2.3.1.3 Synthesis of naphthyl-labelled methyl glucosides 
 
As discussed at the beginning of this Section, the naphthyl linkers would be attached to the 
methyl glucosides 18 using a Williamson etherification (Figure 2.3.1.3a). 
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Figure 2.3.1.3a:  Attachment of the naphthyl linkers onto the selectively deprotected methyl 
glucosides 
 
In order to optimise yield and avoid side-reactions, the bromide was added 30 minutes after 
the addition of NaH to the solution of the sugar, this is to achieve maximum formation of the 
alkoxide and minimise reaction of hydride with the bromide when it is added later on. 
There is a significant disparity in the yields when attaching 2-bromomethylnaphthalene to the 
sugar compared to the longer naphthyl linkers.  The attachment of the ethylene- and 
diethylene glycol naphthyl linkers to glucosides 17a (α) and 17b (β) gave yields of just over 
50%, compared to 92% for the simple 2-bromomethyl naphthalene.  This can be rationalised 
due to the difference in reactivity of the benzylic CH2 on 2-bromomethylnaphthalene 
compared to the Br-CH2 through which the longer naphthyl linkers react.  In 2-
bromomethylnaphthalene, the halide is subject to the benzylic effect84 as the halide is 
adjacent to a π-bond and thus has increased reactivity towards SN2 substitution.  In the case 
of the longer linkers, the CH2 through which the reaction proceeds is not adjacent to a π-
bond and is in fact more susceptible towards elimination by the alkoxide anion which leads to 
the lower yield of target material. 
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For ease of characterisation and storage, we chose to remove the PMB groups and re-
protect the secondary alcohols as acetates.  Removal of the PMB groups was done 
oxidatively using CAN as this does not remove the naphthyl group.74  Acetylation of the 
crude, deprotected sugar was carried out according to our general method (Exptl. Section 
Method A) using pyridine and acetic anhydride and stirring overnight.  Final purification was 
carried out by column chromatography and yields over these two steps were quite good, 
ranging from 51-64% (Figure 2.3.1.3b). 
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Figure 2.3.1.3b: Acetylation of the target naphthyl-functionalised methyl glucosides prior to 
characterisation. 
 
Full characterisation was carried out and assignment using 2D NMR spectroscopy confirmed 
the structures, supported by mass spectrometry and elemental analysis.  COSY and HSQC 
were used to assign the resonances in the 1H- and 13C-NMR spectra.  The protons on the 
glucose ring were assigned using COSY starting from the anomeric proton – a 1H doublet.  
COSY also allowed us to single out the resonance due to the benzylic CH2 AB system and 
from that facilitated assignment of the protons in the ethyl chains in compounds 29 and 30.  
Subsequent examination of HSQC spectra then allowed us to assign the 13C- NMR spectra. 
 
Having fully characterised the three sugars protected as acetates, these protecting groups 
must be removed before embarking on the enzyme studies, which was achieved as shown in 
Figure 2.3.1.3c (Exptl Section Method B). Yields were high, as expected, and the sugars 
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needed no further purification after work up.  Characterisation of the three compounds was 
carried out, NMR data was recorded in d4-methanol but a full assignment was not possible 
due to the close proximity of the sugar C-H peaks in the spectra.  The complete assignment 
of the acetates described above had previously confirmed the location of the naphthyl group 
on C6 of the methyl glucosides and so such detailed characterisation was deemed 
unnecessary for the deprotected sugars. 
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Figure 2.3.1.3c: The final stage – deacetylation of our naphthyl-functionalised methyl 
glucosides in preparation for the enzyme experiments. 
 
2.4 Summary 
 
We have investigated a number of approaches to installing a chromophore at C6 of methyl 
glucose and decided that the most appropriate linking moiety to use was an ether linkage as 
they have proven biocompatibility. They were also the most efficient to make synthetically, 
compared to the initial work on amides etc., as the reaction sets to our target molecules (32, 
33, 34) followed the same synthetic procedures.  
 
The optimal way to attach a naphthalene chromophore onto the sugar via an ether linkage 
was to bring together the sugar and the naphthyl-functionalised linkers as the final step. To 
make the naphthyl-functionalised linker, we used a silver (I) mediated coupling reaction 
between 2-bromo methyl naphthalene and ethylene- or diethylene glycol, which proved an 
effective method to prepare the longer naphthyl linkers.  The resultant alcohols were then 
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converted to bromides and attached to the selectively protected methyl glucoside 17 using 
the Williamson etherification.  Characterisation of the acetyl protected sugars confirmed their 
structures and they were then de-acetylated in preparation for the enzyme experiments, 
which is the focus of the next chapter 
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Chapter 3       Results and Discussion 
3. Investigation into Transglycosylation using Novel Naphthyl-
Functionalised Methyl Glucosides with the β-Galactosidase 
from B. circulans 
 
Whilst our focus is on a probe for  β-galactosidase activity (hydrolysis), in order to investigate 
suitable labelled substrates for the enzyme more rapidly we decided to take advantage of the 
glycosyl transfer activity common to glycosidases.  A substrate that can be made by a 
glycosidase will also be a substrate for the enzyme when it is working in its normal sense.  
So, if we can make naphthyl-functionalised disaccharides using the enzyme they will also be 
substrates for hydrolysis. 
 
We chose to probe the B. circulans enzyme with the three naphthyl-labelled methyl 
glucosides (32, 33 and 34) discussed in Chapter 2 (Figure 3a) and use either GalOpNP
§ or lactose as the glycosyl donor.  The glycosidase active site should behave the same way 
towards acceptable substrates whether operating as a glycosyl hydrolase or as a catalyst for 
transglycosylation.  So, by using the enzyme to make a disaccharide containing our labelled 
methyl glucoside we can probe which, if any, of these molecules is the best candidate for the 
final probe. 
                                                           
§ Synthesis of known compound GalOpNP is described in the Experimental Section compounds 54 - 
57 
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Figure 3a: General scheme showing the basis of our enzyme experiments; the novel 
glucosides will each be used in a transglycosylation reaction with the enzyme to test if it will 
accept them as substrates 
 
To develop a suitable method for this β-galactosidase-catalysed transglycosylation reaction, 
we scoured the literature on transgalactosylations carried out using the enzyme from B. 
circulans.  We found a wide variety of literature about the enzyme but we were most 
interested in those papers describing the use of the enzyme in the synthesis of glycosides as 
the first step on the way to our probe would be to use the enzyme to make disaccharides 
containing our naphthyl-functionalised sugars. 
 
 
3.1 Glycoside Synthesis Using the β-Galactosidase from B. 
circulans 
 
The enzyme-catalysed approach to the synthesis of glycosides provides a very elegant and 
efficient route to complex biomolecules for further study and biological evaluation as potential 
disease therapies.  It is a potentially cost-effective procedure, simple to perform and also 
32 
33 
34 
69 
 
very attractive for industrial scale preparation as a lot of the enzymes under investigation are 
important in the food industry so can be produced on large scale.  Crucial for use in industry 
is the immobilisation of the enzymes on a solid support, which stabilises the enzyme, 
allowing the catalyst to be reused thereby streamlining the industrial process.16,85    
There are numerous examples of the use of glycosidases to make oligosaccharides, some of 
which are discussed in Section 1.3.3.1. Here I will concentrate on the use of the B. circulans 
enzyme to make glycosides.  Using the examples in the literature and following a few key 
rules that seem to apply throughout the sphere of β-galactosidase-catalysed carbohydrate 
synthesis  furnished us with a technique for working with our novel substrates and the β-
galactosidase from B. circulans. 
 
The decision to use the β−galactosidase from B. circulans was heavily influenced by the 
volume of research that has been carried out on this enzyme.  It has been investigated 
extensively for its regioselectivity during trans-glycosylation.  Our probe is based upon 
lactose which is a β(1→4) linked disaccharide.  The B. circulans enzyme displays good 
β(1→4) regioselectivity when used to synthesise oligosaccharides using a galactosyl donor 
and a glucosyl acceptor, but the effect can be enhanced by using particular acceptors and 
reaction conditions (Section 3.2).  This enzyme is also widely reported to be able to accept a 
variety of substrates, particularly in the glycosyl acceptor area of the active site, which we 
hoped would work to our advantage as our substrates are sugars functionalised with bulky 
naphthyl groups (see Section 2.1). 
 
The scope of this research does not extend to the synthesis of long-chain oligosaccharides 
or the development of glycosidase inhibitors for medical purposes.  We are simply taking 
advantage of the reverse hydrolysis facility of the β-galactosidase from B. circulans in order 
to begin development of a future probe for galactosidase activity.   
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As discussed in Chapter 2, our probe will feature a disaccharide which is functionalised at C6 
of both of the monosaccharide units.  This is a hitherto unexplored area of labelling and 
monitoring to use with glycosidases.  To our knowledge, the ability of the β-galactosidase 
from B. circulans to accept sugars modified at C6 with a large organic group has not been 
investigated.  Our work on this for the development of our luminescent probe is discussed in 
this section. 
 
Crout et al. first used the β-galactosidase from B. circulans to synthesise the core 
trisaccharide of ovarian cyst fluid mucosin, β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)-D-GalNAc 
(Figure 3.1.a).49  
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Figure 3.1a: Synthesis of β-D-Gal-(1→4)-β-d-GlcNAc-(1→6)-D-GalNAc using the β-galactosidase 
from B. circulans 
 
Disaccharide EG1 was made using the β-N-acetyhexosaminidase from Aspergillus oryzae.  
EG1 was then used to make the target trisaccharide EG2, which contains a β(1→4) link, 
using the β-galactosidase from B. circulans in 48% yield.  A side product from this reaction 
was tetrasaccharide EG3, which had an added galactose moiety attached via a β(1→4) link.  
The ‘remarkable’ selectivity of the enzyme is commented on with respect to the formation this 
tetrasaccharide.  The galactose moiety which has been added onto EG1 to form EG2 has a 
sterically unencumbered 6-OH group.  However, the  β-galactosidase from B. circulans 
asserts specificity to cause a glycosyl transfer to the 4-OH group of the galactose moiety.  
The 4-OH group is thought to be one of the least reactive positions in glycosyl acceptors.  
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The procedure was then assessed for generality by carrying out a transfer between 
GalOpNP and lactose to yield β-D-Gal-(1→4)-β-D-Gal-(1→4)-D-Glc in 52% yield.  The 
conditions for this reaction were a 6:1 ratio of acceptor to donor, in pH 5.0 NaOAc buffer at 
30 oC for 3.5 h.   
 
Thiem et al. carried out a comprehensive investigation of the conditions needed to promote 
β(1→4) transglycosylations shown in Figure 3.1b.86  His intention was to synthesise 
galactose-containing disaccharides using the β-galactosidase from B. circulans.  In this case, 
the glycosyl donor is GalOpNP and the glycosyl acceptors are GlcNAcαOAll, GlcNAcβOAll, 
GalαOAll, GalβOAll and GalβSPh.  The group looked at the effect of the donor-acceptor 
ratio, buffer pH, reaction time and temperature. The optimised conditions were found to be 
1:7.5 donor/acceptor mixture incubated in a 1:1 mixture of sodium phosphate buffer/MeCN.  
0.7 – 1.0 U of the enzyme were required with heating at 30 oC for 72 h.  The reaction was 
stopped by heating for 10 minutes at 90 oC which denatures the enzyme.   
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Figure 3.1b: Thiem’s work on optimised conditions for β(1→4) transglycosylations 
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The β(1→4) linked disaccharides were produced regioselectively in yields ranging from 30 – 
60%.  These are high yields when one considers that a ‘chemical’ synthesis of such 
compounds would take a number of steps in order to gain the β(1→4) glycosidic linkage.  It 
would also take much longer than 72 hours to do the entire synthesis due to the extensive 
protection-deprotection strategy involved.   
 
A point to note is that the enzyme catalyses the reaction between our intended glycosyl 
donor GalOpNP, to form di- and tri-saccharides (final scheme in Figure 3.1b). This must be 
borne in mind for our synthesis as a competing reaction.  
 
Later work by Thiem involved the regioselective synthesis of galactosylated tri- and tetra-
saccharides using the β-galactosidase from B. circulans (Figure 3.1c).47  This report contains 
a method for the transglycosylation between methyl-α-D-glucose and GalOpNP or lactose. 
This is more analogous to our planned reaction than the previous paper as the glycosyl 
acceptor is methyl glucose. 
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Figure 3.1c: Synthesis of β(1→4) and β(1→6) disaccharides using the β-galactosidase from B. 
circulans 
 
The procedure for these reactions used a ratio of 10:1 glycosyl acceptor to glycosyl donor, 
pH 5.0, 50 mM NaOAc buffer and 1.2U/mmol acceptor of the enzyme.  The reaction mixture 
was incubated at 55 oC for 2 hours and then the reaction terminated by heating at 90 oC for 
10 minutes.  The yield of disaccharides starting from GalOpNP as the glycosyl donor was 
57% and from lactose was 38% with a 10:1 ratio of β(1→4) : β(1→6) glycosidic linkages. 
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In this case, the glycosidic linkages produced were β(1→4) and β(1→6), though the former 
was the major product from the reaction.  This result is in contrast with the previous work 
where only β(1→4)  glycosidic bonds were made.  Since our glycosyl acceptor has a 
naphthyl group attached at C-6 we might expect a β(1→4) linked disaccharide from our 
synthesis due to the proven regioselectivity of the enzyme.  However, the possibility of 
β(1→2) and β(1→3) linkages cannot be ruled out as the bulky naphthyl substituent on our 
novel glucoside acceptors may change the way in which the acceptor sits in the active site of 
the enzyme.  We began development of our own procedure for β-galactosidase-catalysed 
transglycosylation based upon these three reports.   
 
 
3.2 Simple Trans-Glycosylation Experiments 
 
Before starting our investigations into how the enzyme will treat our novel naphthyl-
functionalised sugars it was important to gain experience of handling the enzyme.  β-
Galactosidases are used quite routinely by a number of research groups in oligosaccharide 
synthesis (as explained in Sections 1.3.3.1 and 3.1) so there is a good amount of 
experimental literature to start from.    Our intention was also to use the enzyme in reverse, 
to synthesise a disaccharide thus proving that the enzyme will accept the modified 
monosaccharides, giving us evidence to suggest that the enzyme would accept a 
disaccharide probe with the same structural modifications.   
 
Our initial aims were: 
• To determine the activity of the enzyme we had been supplied with; 
• To use the enzyme in some simple trans-glycosylation experiments with 
commonly used substrates (methyl glucose, p-nitrophenyl galactose, lactose); 
• To determine the best conditions for transgalactosylation reactions involving our 
napththyl-functionalised methyl glucopyranosides. 
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3.2.1 Determining the Activity of the Enzyme 
 
The ‘activity’ of the enzyme must be determined before starting the enzyme experiments.  
One unit of activity for a β-galactosidase is defined as “the amount of enzyme needed to 
release 1 µmol min-1 of p-nitrophenol from p-nitrophenyl galactose”.86 
 
Determining the activity of the enzyme was done according to the method outlined by 
Thiem86 by adding an aqueous solution of the β-galactosidase from B. circulans to a solution 
of synthesised p-nitrophenol β-D-galactose (GalOpNP) in 2.0 M sodium acetate buffer at pH 
6.0 (see Experimental Section 5.3).   When incubated 37 oC, the enzyme hydrolyses the 
glycosidic bond, thus releasing free p-nitrophenyl into solution (Figure 3.2.1a).   
 
 
 
 
 
 
 
Figure 3.1.1a: Hydrolysis of GalOpNP using the β-galactosidase from B. circulans 
 
The solution of GalOpNP and enzyme was incubated for 15 minutes at 37 oC and 10 µL 
aliquots were taken at 1, 2, 4, 6, 8, 10 and 15 minutes to monitor the progress of the 
reaction.  Each aliquot was diluted with 1 mL of 0.1 M NaOH solution, ensuring that enzyme 
was denatured immediately, stopping the hydrolysis reaction and enabling us to investigate 
the UV-vis spectrum of the released free p-nitrophenol.  Since the λmax of free p-nitrophenol 
and that of GalOpNP are the same (302 nm), it is impossible to tell whether there is any free 
p-nitrophenol in solution until base is added, which deprotonates the phenol and shifts the 
λmax to 400 nm (Figure 3.2.1b).  In practice, 15 minutes was an unnecessarily long time for 
running the experiment, as all of the GalOpNP was hydrolysed in one minute, so the figure 
below shows results up to 6 minutes only. 
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Figure 3.2.1b: UV plot showing the hydrolysis of GalOpNP over time 
 
From the above graph it can be seen that at 0 minutes, prior to adding the enzyme, all of the 
UV signal is due to the yellow GalOpNP at 302 nm.  Once the enzyme is added all of the 
GalOpNP is hydrolysed within one minute, as shown by the green line which has no 
absorbance at  302 nm but plenty at 400 nm – corresponding to the p-nitrophenolate ion 
hydrolysis product. 
 
At this early stage of the proceedings the task of taking accurate 10 µL aliquots from the 
small reaction volume in use was rather difficult with the 200 µL pipettor we used at the time, 
hence the large difference in absorbance seen in Figure 3.2.1b. However, it is still clear that 
no GalOpNP was present in any aliquot taken after one minute.  Since all of the GalOpNP in 
the reaction was hydrolysed within one minute, it was only necessary to determine how many 
moles were put into the reaction in the first place (rather than using the Beer-Lambert Law). 
 
One unit of activity for our enzyme is thus defined as 3 mg as this is the amount of enzyme 
needed to hydrolyse 1 µmol of GalOpNP in 1 minute.   
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3.2.2 Making Disaccharides Using α-Methyl Glucose, p-Nitrophenol-β-D-
Galactose and Lactose 
 
The next stage would be to familiarise ourselves with the methods for the enzyme-catalysed 
transglycosylations.  We elected to try two different procedures published by Thiem and 
Crout and compare the results.  From this information we would then begin developing our 
own method.   In the experiments, the glycosyl acceptor would be α-methyl glucose, and the 
glycosyl donors to be evaluated were to be pNP-galactose and lactose (Figure 3.2.2a). 
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Figure 3.2.2.1b: Schematic for the initial enzyme experiments 
 
The conditions of the two methods chosen for investigation are shown in Table 3.2.2b below. 
 Crout Thiem 
Acceptor/Donor ratio 10:1 6:1 
Buffer 50mM NaOAc pH 5.0 
Reaction conc wrt acceptor 1.7 M 0.2 M 
U β-galactosidase 1.2 30 
Temp/oC 55 30 
Reaction time/h 2 3.5 
 
Table 3.2.2b: Table showing the differences in the two methods that we would test in the trial 
transglycosylation reactions 
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3.2.2.1 Testing Thiem’s method 
 
The first test reaction carried out was according to Thiem’s method (see Exp Section 5.3 
ENZ 1).47 Upon addition of the enzyme to the stirring solution of GlcOMe and GalOpNP in pH 
5.0 buffer at 55 oC, the solution turned bright yellow, signalling hydrolysis of GalOpNP.   
 
HPLC analysis of aliquots removed from the reaction mixture at regular intervals showed the 
appearance of new peaks from the aliquot taken at 5 minutes (see Table 3.2.2.1a) and 
accompanying graph Figure 3.2.2.1b). α-GlcOMe has a retention time of 1.6 minutes, 
GalOpNP of 6.2 minutes. 
 
 
Rel. Area % 
Reaction 
time/min 
tr = 1.6 
(α-GlcOMe) 
tr = 6.2 
(GalOpNP) 
tr = 7.0 
prod. 1 
tr = 12.2 
prod. 2 
0 92.59 7.41 0.00 0.00 
5 75.40 3.10 1.95 19.55 
10 79.84 1.67 3.13 15.36 
20 82.83 0.92 5.02 11.23 
40 84.77 0.77 5.60 8.86 
80 82.91 0.94 6.39 9.76 
120 85.61 0.92 6.02 7.46 
 
Table 3.2.2.1a: ENZ 1 tabulated HPLC data 
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Figure 3.2.2.1b: ENZ1 – graph showing the changes in the relative area % ofpeaks found by 
HPLC over 2 hours 
 
The graph above shows that the peak at tr = 6.2 minutes corresponding to GalOpNP 
diminishes quickly, within 20 minutes of the enzyme being added.  The peak at tr = 1.6 
minutes initially dropped within the first 5 minutes and then began to increase again. A 
plateau of the peak is seen from 20 minutes onwards.  Meanwhile, two new peaks appeared 
at tr 7.00 and 12.2 = minutes.  The former seemed to plateau at 20 minutes, while that at 12.2 
minutes showed a sharp increase between tr = 0 and 5 minutes and then decreased in 
intensity. 
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Figure 3.2.2.1c:  ENZ 1 HPLC trace; reaction time = 2 hours 
 
Analytical HPLC separation of the final reaction mixture at 2 hours was carried out to isolate 
the peaks and determine what each one contained.  Due to problems with the solvent pump 
which we experienced using the ECD-HPLC, the retention time of the peaks were often not 
consistent between experiments although they were consistent within experiments.  Because 
of this, it was better to look at the order in which the compounds eluted during HPLC rather 
than compare retention times between different experiments.  Comparison of Figures 
3.2.2.1c and 3.2.2.1d shows the difference in retention times between one day and the next. 
 
80 
 
 
 
Figure 3.2.2.1d: ENZ 1 HPLC trace prior to analytical separation 
 
 
The samples obtained from the analytical separation and collection of the peaks found in the 
HPLC trace (Figure 3.2.2.1d) were submitted for analysis by mass spectrometry.  The results 
are shown in Table 3.2.2.1e below.  
 
 
 
 
 
 
 
 
Peak 1 
Peak 2 
Peak 3 
Peak 4 
Peak 5 
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tr/min Comment on HPLC appearance m/z found Compound 
1.5 
Expansion of HPLC shows two 
peaks overlapping 
217 [M + 23]+ GlcOMe 
379 [M + 23] + 
Gal-GlcOMe 
disaccharide 
4.3  324[M + 23] + 
GalOpNP 
(unhydrolysed) 
5.0  203 [M + 23] + 
Gal 
(hydrolysed GalOpNP) 
7.4 
(prod. 1) 
 365 [M + 23] + Gal-Gal disaccharide 
12.5 
(prod. 2) 
 486 [M + 23] + 
Gal-GalOpNP 
disaccharide 
 
Table 3.2.2.1e:  Assignment of peaks collected from HPLC separation 
 
The peak at tr = 2.0 minutes (corresponding to the peak at tr = 1.6 minutes in the experiment) 
was found to be two peaks overlapping when that area of the spectrum was expanded.    
This first peak is due initially to the starting material GlcOMe and, as the reaction progressed, 
our target disaccharide Gal-GlcOMe appears at the same retention time.  We also observed 
the formation of two more disaccharides, Gal-Gal and Gal-GalOpNP.  These results were 
excellent encouragement as it showed that we had successfully used the enzyme to 
synthesise three different disaccharides. 
 
 
3.2.2.2 Testing Crout’s method 
 
The second test reaction was carried out according to the method by Crout (see Exp Section 
5.3 ENZ 2).49  A solution of GlcOMe and GalOpNP in pH 5.0 buffer were stirred at 30 oC with 
the enzyme and aliquots were taken at regular intervals throughout the course of the 
reaction.   In contrast to the previous experiment the bright yellow colour due to the 
enzymatic hydrolysis of GalOpNP evolved quite slowly over the course of 10 minutes.   
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HPLC analysis of aliquots removed from the reaction mixture at regular intervals showed the 
appearance of only one new peak at tr = 4.6 minutes (see Table 3.2.2.2a and Figure 
3.2.2.2b).   From the previous experiment, we expected the Gal-GlcOMe target to appear at 
tr = 1.6 minutes.   
 
 
Rel. Area % 
Reaction 
time/min 
tr = 1.6 
(GlcOMe) 
tr = 4.6 
(prod. 3) 
tr = 5.4 
(GalOpNP) 
0 64.31 0.00 35.69 
2 66.92 0.20 32.87 
4 69.25 0.28 30.47 
6 71.73 0.69 27.58 
8 76.53 1.01 22.46 
10 80.78 1.52 17.71 
15 63.13 5.63 31.24 
20 84.00 4.70 11.29 
30 84.46 8.41 7.13 
45 82.61 14.00 3.39 
60 79.48 18.94 1.58 
90 72.48 26.83 0.69 
120 65.93 33.35 0.72 
180 62.15 31.13 0.71 
240 58.40 41.02 0.58 
 
Table 3.2.2.2a: ENZ 2 tablulated HPLC data 
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Figure 3.2.2.2b: ENZ 2 – graph showing the changes in the relative area % of peaks found by 
HPLC over 2 hours.  (N.B. An anomalous result at 15 minutes due to a sampling error has been 
removed) 
 
 
Figure 3.2.2.2c:  ENZ 2 HPLC trace, reaction time = 2 hours 
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Since only one new peak was evolved (see Figure 3.2.2.2c), we analysed the reaction 
mixture by mass spectrometry without isolating the peaks.  A major peak at 379.0 m/z was 
found, corresponding to the desired Gal-GlcOMe disaccharide. 
 
An HPLC trace of the co-injection of samples from ENZ 1 and ENZ 2 is shown in Figure 
3.2.2.2d.  This was done to be able to compare peaks in both experiments as the solvent 
pump problems had meant that the different compounds eluted at different times in each 
experiment. 
 
 
Figure 3.2.2.2d: ENZ1 and ENZ 2 co-injection 
 
The HPLC spectrum shown above has five peaks due to the combined components of 
BCEXP1 and BCEXP2.  When compared with the HPLC trace from BCEXP1 and 2 (Figures 
3.2.2.1c and 3.2.2.2c) the difference in retention time of the peaks is modest but obvious. 
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Peaks in 
BCEXP1 
Peaks in 
BCEXP2 
Proposed peak in 
combined HPLC 
Assignment 
tr = 2.0 tr = 1.6 tr = 1.6 GlcOMe + GalGlcOMe 
tr = 4.8 tr = 4.6 tr = 4.33 Gal   
tr = 5.5  tr = 5.4 tr = 4.8 GalOpNP 
tr = 7.8  tr = 5.3 Gal-Gal disaccharide 
tr = 11.8  tr = 6.9 Gal-GalOpNP disaccharide 
 
Figure 3.2.2.2e: ENZ 1 and ENZ 2 peak correlation from the co-injection 
 
Figure 3.2.2.2e shows the correlation between the peaks in the co-injection and the HPLC 
spectra from the two experiments.   In this co-injection the Gal-Gal and Gal-GalOpNP peaks 
which appeared at tr =7.8 and 11.8 respectively were moved to tr =5.3 and 6.9 – a very stark 
contrast. 
 
In summary, we had successfully made a Gal-GlcOMe disaccharide in both experiments.  By 
following Thiem’s method we also generated Gal-Gal and Gal-GalOpNP disaccharides. 
However, the differences in retention times due to HPLC problems between the experiments 
made them difficult to compare and evaluate.   
 
We decided to begin our optimisation studies using Thiem’s method as it was faster than the 
Crout experiment and had produced more types of disaccharides.  
 
3.2.2.3 Investigating the effect of temperature on the reaction using Thiem’s method 
 
We next compared the effect of carrying out the reaction using Thiem’s method at 55 and 30 
oC.  This is important to investigate as Thiem performs his tranglycosylations at 55 oC and 
Crout at 30 oC.  The β-galactosidase from B. circulans is not a thermophilic enzyme, so one 
would assume that its activity would be best at the more typical biological temperatures 
86 
 
around 37 oC.  We chose to investigate the effect of using a lower temperature (used by 
Crout) with Thiem’s method to see if it had any impact on the efficacy of the enzyme. 
 
In this comparison, we chose to take aliquots at more regular intervals so that the hydrolysis 
of GalOpNP could be monitored by UV-vis spectroscopy and the evolution of new peaks in 
the HPLC could be monitored more closely. 
 
The two experiments were carried out according the method ENZ1 (Section 5.3); ENZ 3a at 
55 oC and ENZ 3b at 30 oC.  Since the previous experiment at 55 oC appeared to have 
ceased at around 20 minutes (no further changes in HLPC), this repeat (ENZ 3a) was run for 
30 minutes.  The 30 oC experiment (ENZ 3b) was run for 60 minutes as we did not know how 
long the reaction would take. 
 
The hydrolysis of GalOpNP was monitored by UV-vis spectroscopy in 0.1 M NaOH solution 
(Figures 3.2.2.3a and Figure 3.2.2.3b).  The significant outcome of these results is that 
GalOpNP was hydrolysed within 8 minutes when the reaction was run at 30 oC and 30 
minutes when the reaction was run at 55 oC.  This can be rationalised as the enzyme is not 
thermophilic (as previously stated), so we might expect it to perform hydrolysis optimally at a 
lower temperature.  Running the reaction at 55 oC appears to slow the rate of hydrolysis  of 
GalOpNP by the enzyme.  This could be because the enzyme is less active at the higher 
temperature or even that some of the enzyme added was denatured. 
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Figure 3.2.2.3a:  Hydrolysis of GalOpNP at 55 
o
C 
 
 
Figure 3.2.2.3a:  Hydrolysis of GalOpNP at 30 
o
C 
 
The HPLC results are tabulated below (ENZ 3a Table 3.2.2.3c and ENZ 3b Table 3.2.2.3d). 
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Rel. Area % 
  
Reaction 
time/min 
tr ~ 1.6 
(GlcOMe) 
tr = 4.7 
(prod.4) 
tr = 5.3 
(GalOpNP) 
tr = 7.8 
(prod. 5) 
tr = 15.7 
(negl.) 
tr = 18.7 
(prod. 6) 
0 43.88 0.00 56.12 0.00 0.00 0.00 
2 33.80 0.00 34.51 31.68 0.39 0.45 
4 35.96 0.00 30.92 31.46 0.78 0.89 
6 37.73 0.00 28.39 31.95 0.79 1.14 
8 39.89 0.00 26.07 31.70 0.94 1.47 
10 41.76 0.00 24.27 31.57 0.91 1.50 
15 36.99 0.31 26.29 32.98 1.02 2.42 
30 45.50 0.29 20.54 31.32 0.68 1.67 
 
Table 3.2.2.3c: Tabulated HPLC results ENZ 3a 
 
 
 
 
Rel. Area % 
  
Reaction 
time/min 
tr ~ 1.6 
(GlcOMe) 
tr = 4.7 
(prod.4) 
tr = 5.3 
(GalOpNP) 
tr = 7.8 
(prod. 5) 
tr = 15.7 
(negl.) 
tr = 18.7 
(prod. 6) 
0 42.85 0.00 57.15 0.00 0.00 0.00 
2 39.92 0.26 27.69 29.88 0.98 1.27 
4 47.62 0.68 23.96 26.58 0.00 1.15 
6 50.93 1.13 23.18 23.81 0.00 0.95 
8 51.97 2.08 24.54 20.69 0.00 0.73 
10 54.72 2.07 24.04 18.48 0.00 0.69 
15 55.30 2.78 25.24 16.21 0.00 0.46 
30 54.52 3.03 27.10 14.94 0.00 0.41 
60 53.33 3.48 28.56 14.25 0.00 0.37 
 
Table 3.2.2.3c: Tabulated HPLC results ENZ 3b 
 
Five peaks were separated and collected by HPLC and the samples submitted for analysis 
by mass spectrometry (Table 3.2.2.3e). The peak at tr = 15.7 minutes was not collected for 
analysis as it was in such a negligible amount in both experiments. 
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tr/min  m/z found Compound 
1.6 
 
217 [M + 23]+ GlcOMe 
 
379 [M + 23] + Gal-GlcOMe disaccharide 
4.7 Prod. 4 324[M + 23] + Gal  (hydrolysed GalOpNP)  
5.3  203 [M + 23] + GalOpNP 
7.8 
Prod. 5 
365 [M + 23] + Gal-Gal disaccharide 
18.7 Prod. 6 486 [M + 23] + Gal-GalOpNP disaccharide 
 
Table 3.2.2.3e:  Combined ENZ3a and 3b mass spectrometry results 
 
Again we had successfully made three different disaccharides using Thiem’s method.  At this 
point we had not investigated the regioselectivity of the disaccharide formation.  As per our 
initial aims, we first wanted to be able to make the disaccharides reliably.  The 
regioselectivity of the transglycosylation reaction would be investigated with the naphthyl-
functionalised sugars. 
 
 
3.2.2.4 Control experiments  
 
Before progressing onto the experiments using our naphthyl-functionalised methyl glucosides 
we decided to carry out a number of control experiments to check the functionality of the 
enzyme (Figure 3.2.2.3f).  Specifically we wanted to answer the following questions: 
1. Will the enzyme hydrolyse α-methyl glucose? 
2. Will the enzyme transfer the pNP group onto Gal? 
3. Will the enzyme transfer GalOpNP onto GalOpNP in the absence of other acceptors? 
4. Will the enzyme use lactose as the glycosyl donor, and if so is lactose a better 
glycosyl donor than GalOpNP? 
 
Each of these four control experiments were carried out using method ENZ 1 
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Control Experiment 1 – will the enzyme hydrolyse α-methyl glucose? 
 
The enzyme we are using is a β-galactosidase, so it should not hydrolyse the glycosyl 
acceptor since it is an α-glucoside.  However, we still wanted to be certain that hydrolysis of 
the acceptor was not going on. 
 
Since we had detected free sugar in our previous experiments we wanted to know whether 
this was glucose (i.e. hydrolysed acceptor), galactose (i.e. hydrolysed donor) or both.    By 
testing if the enzyme would hydrolyse GlcOMe we would be able to determine if any free 
glucose could have been present in our previous enzyme reactions.   
 
The reaction was carried out using method ENZ 1 but in this case without any p-nitrophenol 
galactose as the glycosyl donor (Figure 3.2.2.4a).  The reaction was monitored by HPLC and 
the results are shown in Figure 3.2.2.4b. 
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B. circulans
 
Figure 3.2.2.4a: Control experiment 1 scheme 
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Reaction 
time/min 
Rel. Area % 
tr = 1.6 
(GlcOMe) 
tr = 6.5 
(Glc) tr = 10.9 
0 96.37 3.63 0.00 
2 65.53 9.69 26.78 
5 64.21 21.74 14.05 
15 64.85 33.39 1.76 
30 63.69 36.31 0.00 
60 63.47 36.53 0.00 
 
Figure 3.2.2.4b: Tabulated HPLC results for control experiment 1 
 
Mass spectrometric analysis of the samples taken at 5 minutes and 30 minutes revealed 
peaks corresponding to α-methyl glucose and free glucose as well as two disaccharides Glc-
Glc and Glc-GlcOMe (Figure 3.2.2.4c).  
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O
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Glc-GlcOMe Glc-Glc
 
Figure 3.2.2.4c: Products from control experiment 1 
 
This result is very surprising as we would not expect the β-galactosidase from B. circulans to 
be able to use glucose as a glycosyl donor, much less be able to hydrolyse α-methyl 
glucose.  There was a small amount of free glucose present in the initial reaction sample, but 
the amount of free glucose then increased over the course of the reaction, giving credence to 
the hydrolysis of GlcOMe, but we have not found any precedent for this in the literature.  
Perhaps the most likely answer to this result is that the enzyme has not been purified by us, 
we are using it directly from the manufacturer, as is done in the literature procedures we 
have followed.  It is much more plausible for the hydrolysis of the methyl glucoside in this 
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control experiment to be due to small amounts of other types of glycosidases which may be 
present in the sample of enzyme that we have to work with.   
 
 
Control Experiment 2: Will the enzyme transfer the pNP group onto Gal? 
 
This control reaction was carried out using method ENZ 1, substituting D-galactose as the 
glycosyl donor and p-nitrophenol as the glycosyl acceptor (Figure 3.2.2.4d).  The reaction 
was run for 1 hour, aliquots were taken at regular intervals and analysed by HPLC over the 
course of the reaction. 
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X
 
 
Figure 3.2.2.4d: Scheme for control experiment 2 
 
No p-nitrophenol galactose was made during the reaction, only Gal-Gal disaccharides were 
seen in the HPLC and mass spectrometric analysis. 
 
Control Experiment 3: Will the enzyme transfer GalOpNP onto GalOpNP in the 
absence of acceptors? 
 
In experiments ENZ 1, ENZ 3a and ENZ 3b, Gal-GalOpNP disaccharides were made.  We 
checked whether these would be made if no other sugars were available as glycosyl 
acceptors (Figure 3.2.2.4e). 
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Figure 3.2.2.4e: Scheme for control experiment 3 
 
Reaction 
time/min 
 
Rel. Area % 
 
tr =4.7 tr = 5.3 tr = 5.9 tr = 8.0 – 9.0 tr= 17.0 – 20.0 
0 0.00 0.00 100.0 0.00 0.00 
2 0.00 0.00 51.78 48.22 0.00 
5 0.00 0.00 50.07 49.93 0.00 
10 0.26 0.13 44.90 54.72 0.00 
15 0.26 0.25 40.32 55.36 3.81 
30 0.59 0.83 38.84 54.96 4.79 
60 0.70 1.66 37.22 55.46 4.97 
 
Table 3.2.2.4f: Tabulated HPLC results for control experiment 3 
 
The HPLC results shown in Table 3.2.2.4f show the evolution of a number of peaks.  
Analysis by mass spectrometry showed only three peaks corresponding to three sugars, 
GalOpNP, Gal-Gal and Gal-GalOpNP as shown in Figure 3.2.2.4e. The number of 
compounds found in the HPLC exceeds this, suggesting a number of different glycosidic 
linkages between the two sugars of the disaccharides. 
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Control Experiment 4: Will the enzyme use lactose as the glycosyl donor, and if so is 
lactose a better glycosyl donor than GalOpNP? 
 
Lactose is often used as the glycosyl donor in transgalactosylation reactions as it is the 
enzyme’s natural substrate.   We evaluated the use of lactose as the glycosyl donor to see if 
it had a comparable performance to GalOpNP (Figure 3.2.2.4g). 
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Figure 3.2.2.4g: Scheme for control experiment 4 
 
The reaction was monitored by HPLC and only three peaks were found (Table 3.2.2.4h), 
unlike ENZ 1,ENZ 3a and ENZ 3b, where the same method was used and more than three 
peaks were detected (Tables 3.2.2.3c and 3.2.2.3e).   
 
Reaction 
time/min 
tr = 1.6 
(GlcOMe) 
tr = 5.5 
(Glc) 
tr = 8.1 
(Lac) 
0 39.35 1.20 59.45 
2 36.49 9.09 54.42 
5 35.01 17.16 47.84 
10 35.29 25.07 39.64 
15 38.27 31.30 30.43 
30 37.33 44.34 17.57 
60 45.17 52.40 1.96 
120 47.13 51.78 1.06 
 
Table 3.2.2.4h: Tabulated HPLC results from control experiment 4 
 
95 
 
 
Figure 3.2.2.4i: Control experiment 4 HPLC dat 
 
The peak at tr = 1.6 minutes is initially due to GlcOMe, but as seen in previous experiments, 
the Gal-GlcOMe disaccharide also resides at this retention time, as evidenced by the dips  
followed by increases in the blue trace on Figure 3.2.2.4i.  Lactose (tr = 8.1 min) is 
hydrolysed over the course of one hour and there is an associated increase in free glucose 
at tr = 5.5 min.   
 
Using lactose as the glycosyl donor may prove more desirable than GalOpNP as it produces 
fewer by products.   
 
3.2.2.5 Evaluating the efficacy of the glycosyl donor 
 
We next chose to evaluate both lactose and p-nitrophenyl galactose as glycosyl donors 
under Thiem’s reaction conditions.  We would then select the better of the two for use in the 
next stages of the experiment. 
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This was done using method ENZ 1 for the transglycosylation reaction.  The experiments 
described below are:  ENZ 4a using GalOpNP as the glycosyl donor and ENZ 4b using 
lactose as the glycosyl donor (Figure 3.2.2.5a). 
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Figure 3.2.2.5a:  Scheme for experiment ENZ 4a and ENZ 4b to evaluate whether GalOpNP or 
lactose are better glycosyl donors 
 
Aliquots of the reaction mixture were taken at 2, 5, 10, 15, 30, 60 and 120 minutes and 
analysed by HPLC (Table 3.2.2.5b). 
 
 ENZ 4a (GalOpNP) ENZ 4b (lactose) 
Reaction 
time/ min 
Tr =1.6 
(GlcOMe/ 
Gal-GlcOMe) 
Tr = 5.7 
(Gal) 
Tr = 6.8 
(GalOpNP) 
Tr = 9.4 
(Gal-Gal) 
Tr =1.6 
(GlcOMe) 
Tr = 5.7 
(Gal) 
Tr = 9.0 
(Lac) 
0 70.85 0.00 29.15 0.00 49.61 0.00 50.39 
2 73.45 0.00 25.36 1.19 50.24 1.11 48.65 
5 75.07 0.69 23.07 1.17 47.95 3.23 48.82 
10 81.71 1.02 16.37 0.91 54.87 6.15 38.98 
15 85.38 0.93 12.48 1.20 53.67 10.81 35.52 
30 91.41 1.20 6.68 0.72 46.29 25.16 28.55 
60 92.96 1.31 4.63 1.11 53.03 38.21 8.76 
120 92.70 1.25 5.18 0.88 54.44 44.45 1.11 
 
Table 3.2.2.5b: Tabulated HPLC data from experiments ENZ 4a and ENZ 4b 
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Peaks at similar retention times were found in both reactions – as expected.  In both cases 
there was an increase in the relative area of the peak at tr =1.6 consistent with the evolution 
of the Gal-GlcOMe disaccharide which has a similar retention time to the starting material 
GlcOMe.  The presence of this Gal-GlcOMe disaccharide target in both reactions was 
confirmed by mass spectrometry as a peak was detected at m/z = 379 which corresponded 
to the Gal-GlcOMe disaccharide ([M + Na]+).  In ENZ 4a there was a decrease in the 
GalOpNP donor, and, as expected, a decrease in lactose in ENZ 4b also (see Figures 
3.2.2.5c and 3.2.2.5d). 
 
 
Figure 3.2.2.5c: ENZ 4a (GalOpNP) HPLC progress graph 
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Figure 3.2.2.5d: ENZ 4b (lactose) HPLC progress graph 
 
 
Given all of the data we had collected, it was still not clear which of the two possible glycosyl 
donors would be the most suitable.  Comparing the evolution of the product in HPLC is not 
conclusive.  The best we could say at this point was that the use of GalOpNP resulted in a 
smoother evolution of product when compared to using lactose as the glycosyl donor.  We 
tentatively suggest this because the blue line in the graph shown in Figure 3.2.2.5e (ENZ 4a) 
steadily increases over the first 30 minutes, whereas the red line (ENZ 4b) dips and peaks 
unsteadily over the same timescale. 
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Figure 3.2.2.5e: Comparison of the peak at tr = 1.6 minutes in ENZ 4a and ENZ 4b 
 
At this point, our preliminary studies were complete.  We had succeeded in using the enzyme 
to make disaccharides, had refined the methods of using the enzyme with the sugars and 
also our reaction monitoring tools.  At this stage we had found the optimum conditions for 
using the enzyme to make disaccharides to be: 
 
Ratio of acceptor:donor 6:1 
Units of enzyme 30 
Reaction concentration 0.2 M 
Reaction pH 5.0 
Reaction temperature 30 oC 
Glycosyl donor GalOpNP or lactose 
 
 
The next task was to develop a method that worked when using our novel naphthyl-
functionalised glucosides as the glycosyl acceptors. 
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3.3 Transglycosylation using Naphthyl-Functionalised Methyl 
Glucosides 
 
At this point in the project we had successfully determined the activity of the enzyme and had 
explored two different methods for transglycosylation reactions.  We now needed to develop 
a suitable method (starting from the previous investigations) for performing transglycosylation 
reactions between the glycosyl donor and our naphthyl-functionalised glucosyl acceptors 
(Figure 3.3a).  The final optimisation of techniques would all be carried out using 
NpCH2GlcOMe (32) as the glycosyl acceptor.  Once optimised, the procedure would then be 
applied to the remaining two glycosyl acceptors EGNpGlcOMe (33) and DEGNpGlcOMe 
(34). 
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Figure 3.3a:  The three naphthyl-functionalised glycosyl acceptor substrates for the 
transglycosylation studies 
 
We chose to optimise the reaction by varying the following parameters: 
• solvent system; 
• pH of buffer; 
• temperature; 
• amount of enzyme needed. 
• reaction concentration 
 
32 33 34 
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3.3.1 Optimising the reaction conditions 
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Figure 3.3.1a: Initial scheme for optimising the reaction conditions using the simplest of the 
three naphthyl sugar candidates 
 
 
In order to carry out a full investigation into the conditions needed for the transglycosylation 
reaction shown in Figure 3.3.1ab, we would need a relatively large quantity of 
NpCH2GlcOMe.  We would be monitoring the screening reactions by HPLC but it would be 
extremely difficult at this early stage to quantify and identify any peaks that developed.  This 
is because at this stage we did not know what glycosides would be made in the reaction.  
Moreover, different reaction conditions could lead to different types of linkages being formed, 
β(1→4) or β(1→3), for example.  We need a quantifiable and easily-repeatable way to 
measure the ability of the enzyme to work under various conditions. 
To investigate the effect of these factors on the transglycosylation we needed to go back to 
the basic function of the enzyme.  We would monitor the hydrolysis of the enzyme’s natural 
substrate: lactose.  By finding conditions in which the enzyme works optimally to hydrolyse 
lactose we can then apply those conditions to the transglycosylation reaction knowing that 
the enzyme will function as well as it possibly can in these unnatural conditions. 
 
Having established an appropriate set of reaction conditions we would again attempt 
transglycosylation using GlcOMe as the glycosyl acceptor to evaluate the conditions with 
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respect to transglycosylation.  Once the conditions had been optimised, we would then try 
the reaction conditions with our novel glycosyl acceptors. 
 
We first chose to investigate the solvent conditions needed for the transglycosylation 
reaction.  None of the glycosyl acceptors are soluble in the aqueous buffer solution so a 
mixed solvent system would be needed to aid the solubility of the glycosyl acceptors. 
However, using an organic co-solvent inhibits the action of the enzyme so a full screening 
experiment would be carried out to find a combination of conditions that enabled the best 
activity. 
 
3.3.1.1 Optimising solvent and temperature conditions 
 
There is a great deal of precedent for employing a mixed solvent system when using 
glycosidases to make glycosides.  Firstly, in the initial work on the synthesis of glycosides 
using glycosidases, the reverse hydrolysis technique required a high concentration of organic 
solvent to water to push the enzyme into transferase activity (see Section 1.3.3.2).28-30 
Various organic solvents are tolerated by the β-galactosidase from B. circulans in various 
concentrations when using the enzyme for transglycosylation.   
In general terms the use of organic solvents with β-galactosidases, and indeed other 
glycosidases, is that the use of organic solvents causes enzyme deactivation.  It is accepted 
that the price for being able to perform your desired transglycosylation under these 
conditions is a reduction in yield and a longer reaction time.  However, by optimising 
conditions through experimentation it is possible to get acceptable results which allow 
researchers to take advantage of the desired regio- and stereoselectivity of these enzymes.27 
 
A report by Beau87 records the use of 75% MeCN with the β-galactosidases from A. oryzae 
to perform a number of glycosylations.  This procedure uses a relatively high proportion of 
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MeCN in a reverse-hydrolysis-type synthesis using an excess of the alcohol acceptor 
coupled with a low water concentration (Figure 3.3.1.1a).    
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Figure 3.3.1.1a:  An investigation into the effects of s high concentration of MeCN in the 
reaction solution on the transglycosylation efficacy of the β-galactosidase from B. circulans 
 
The yields achieved with the enzyme in the presence of 75% MeCN are relatively high, 
ranging from 14 – 50%, although over the course of 2-5 days.  This shows that although the 
reaction may take longer, acceptable yields are still achievable when using organic co-
solvents. 
 
Thiem has also investigated the use of MeCN in β-galactosidase catalysed synthesis.88  The 
scheme below (Figure 3.3.1.1b) shows the use of the enzymes from A. oryzae and E. coli to 
make Gal-GalOoNP disaccharides from β-o-nitrophenyl galactose.  The yields here appear 
modest, but again, for a 30 minute reaction in 50% MeCN, this is a very acceptable result 
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Figure 3.3.1.1b:  Investigation into the effect of using a 50% MeCN reaction solution to perform 
transglycosylations using the β-galactosidase from A. oryzae and E. coli 
 
In a report by Finch and Yoon27 the activities of a number of β-galactosidases in various 
water-solvent mixtures were investigated.  The synthesis shown in Figure 3.3.1.1c below 
shows the synthesis of two disaccharides using the β-galactosidase from B. circulans in the 
presence of 60% triethyl phosphate.  In this case the β(1→6) glycosidic linkage was the 
major product. 
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Figure 3.3.1.1c:  A transglycosylation reaction mediated by the β-galactosidase from B. 
circulans in the presence of an organic solvent 
 
In this report the only organic solvent tried with the β-galactosidase from B. circulans was 
triethyl phosphate.  However, given this evidence we might expect it to tolerate other organic 
solvents as well. 
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The literature mentioned above suggests that MeCN is a suitable organic solvent to use with 
β-galactosidases, so we chose to use this in our screening experiment as we will be 
monitoring the reaction by HPLC and mass spectrometry and MeCN is also a suitable 
solvent for those applications.  Since the pH and temperature of the reaction can also affect 
the activity of the enzyme we decided to also screen two pH and temperature values that 
have been reported regularly in the literature for related transglycosylation reactions.49,86 
 
In this first screening experiment we followed a modified method (ENZ 5), which was based 
on the procedure developed by Thiem, and varied the pH, temperature and amount of MeCN 
used.  Table 3.3.1.1d shows the combinations of conditions for each separate test reaction. 
 
 pH 5.0  (NaOAc) pH 7.0 (Na2HPO4/NaH2PO4) 
% MeCN 50 40 30 20 50 40 30 20 
30 oC A B C D E F G H 
55 oC I J K L M N O P 
 
Table 3.3.1.1d: Conditions for experiment ENZ 5 
  
The reactions were carried out by suspending lactose in the mixed solvent system and 
stirring it at the given temperature with the β-galactosidase from B. circulans.  Aliquots were 
taken at regular intervals for HPLC analysis. 
 
The first observation upon beginning the reactions was that lactose was not completely 
dissolved in some of the reactions.  Lactose was completely dissolved only in reactions A 
and H at 30 oC, but was completely dissolved in all of the reactions at 55 oC. 
 
Following the reactions by HPLC it became apparent that several combinations of conditions 
were not conducive to the hydrolysis of lactose.  Table 3.3.1.1e shows the amount of lactose 
remaining in each reaction at the end of the 48 hour reaction period.  The majority of the 
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reactions showed very little processing of lactose at all, indicating that the enzyme was 
inhibited by these reaction conditions. This was not unexpected as the addition of MeCN is 
known to deactivate the enzyme, as discussed at the beginning of this section. 
 
However, in Table 3.3.1.1e the highlighted reaction letters are those where the most enzyme 
processing was seen and it is these sets of conditions that will now be discussed. 
 
 pH 5.0   pH 7.0  
% MeCN 50 40 30 20 50 40 30 20 
30 oC A B C D E F G H 
% Lac remaining at 48h 98.16 97.66 90.60 75.65 94.38 80.89 51.06 35.06 
55 oC I J K L M N O P 
% Lac remaining at 48h 95.59 99.34 99.29 99.63 98.61 97.99 97.35 62.29 
 
Table 3.3.1.1e:  Amount of lactose found by HPLC in each reaction at the end of 48 hours 
 
 
The graph in Figure 3.3.1.1f gives an idea of the rate of hydrolysis of lactose in these five 
reactions.  We can use this indication of the rate of hydrolysis to rank the five sets of 
conditions by the amount of hydrolysis that was observed. The set that led to the greatest 
amount of lactose hydrolysis was H.  This can be seen clearly in both Figure 3.3.1.1f and 
Table 3.3.1.1g.  This is then followed by reaction conditions G, P, D and F.  These five sets 
of reaction conditions would be the starting point of the next stage in the screening procedure 
which was to find out if the enzyme could catalyse transglycosylation reactions under these 
conditions. 
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Figure 3.3.1.1f: Graph to indicate the rate of hydrolysisof lactose in the most promising 
experiments, ENZ 5 D, F, G, H and P 
 
 
 
relative area % lactose in HPLC 
reaction time/min D F G H P 
0 100.00 100.00 100.00 100.00 100.00 
5 100.00 100.00 99.98 98.89 92.82 
10 100.00 100.00 99.87 97.49 87.46 
15 99.93 100.00 100.00 95.76 85.06 
30 99.52 100.00 91.66 91.00 81.87 
60 99.00 100.00 97.81 84.41 72.04 
120 98.08 99.41 96.52 70.81 73.84 
1440 85.69 90.67 70.05 41.73 nr 
2880 75.65 80.89 51.06 35.06 62.29 
nr – not recorded  
Table 3.3.1.1g: Tabulated HPLC results from the most promising experiments, ENZ 5 D, F, G, H 
and P 
 
 
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
0 500 1000 1500 2000 2500 3000
re
la
ti
v
e
 a
re
a
 %
reaction time/min
Comparison of HPLC monitoring of lactose hydrolysis over time in 
experiments D, F, G, H, P 
D
F
G
H
P
108 
 
3.3.1.2 Simple transglycosylation reactions under optimised solvent conditions 
 
The next step was therefore to attempt simple transglycosylations with these five sets of 
conditions.  We decided to use both lactose and GalOpNP as glycosyl donors.  The 
conditions for these reactions were assessed by measuring the hydrolysis of lactose, so 
would be optimal for the use of lactose as the glycosyl donor.  However, since GalOpNP is 
generally acknowledged to be a very good glycosyl donor we chose to try those successful 
sets of reaction conditions with GalOpNP as well, even though they were not optimised for it.   
α-Methyl glucose would be used as the glycosyl acceptor (Figure 3.3.1.2a).   
 
O
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O
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O
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HO
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O
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β-galactosidase
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O
OH
HO
HO
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O
OMe
O
OH)3
ENZ 7
 
Figure 3.3.1.2a: Scheme for experiments ENZ 6 and ENZ 7 
 
Reaction  pH % MeCN Temperature oC 
D 5.0  20 30 
F 7.0  40 30 
G 7.0  30 30 
H 7.0  20 30 
P 7.0  20 55 
 
Table 3.3.1.2b: Reaction conditions for experiments ENZ 6 and ENZ 7 
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The reactions ENZ 6 and ENZ 7 were carried out by suspending the glycosyl donor and 
GlcOMe in the mixed solvent system, at the given pH and temperature, and stirring with the 
enzyme.  Aliquots were taken at regular intervals and analysed by HPLC and mass 
spectrometry. 
 
Monitoring of the experiments by HPLC showed the evolution of new peaks in each of the 
reactions (D, F, G, H, and P).  In contrast to the first transglycosylations that we tried in 
aqueous conditions (Section 3.2), these reactions proceeded very slowly.  This was expected 
however, as the lactose hydrolysis experiments with MeCN were left for 2 days before they 
were stopped and not much hydrolysis was seen until at least one hour had passed. 
 
The Gal-GlcOMe target again appears around tr = 1.6 minutes in HPLC which is roughly the 
same retention time as the glycosyl acceptor, GlcOMe, (see earlier work in Section 3.2.2).  At 
this point monitoring the evolution of the Gal-GlcOMe disaccharide using mass spectrometry 
became more useful than HPLC because this peak overlap obscured the evolution of the 
disaccharide.  In the HPLCs recorded for these experiments, a shoulder can be seen to 
appear on the peak for the starting material GlcOMe, which indicates that the disaccharide is 
forming, but as such its area could not be measured accurately and compared to that of the 
starting material.  
 
 At this point we did not expect to be able to quantify the rate of the reaction or the amount of 
target disaccharide that was produced.   In the mass spectra, the relative peak heights of 
GlcOMe and the Gal-GlcOMe disaccharide can be compared and from this the effectiveness 
of the different conditions can be inferred.   
 
In ENZ 6, in which lactose was used as the glycosyl donor, the presence of the Gal-GlcOMe 
disaccharide was detected from 6 hours onwards in the mass spectra of all of the reactions.  
It is not obvious in the HPLC spectra that the Gal-GlcOMe disaccharide is present for the 
reasons explained above.  In this case the heights of the peaks due to Lac and Gal-GlcOMe 
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in the mass spectra were compared to give an idea of the extent of enzyme processing of the 
various sugars.   
 
Examining the data in Table 3.3.1.2c, which shows the peak-height ratio of lactose to the 
Gal-GlcOMe disaccharide, there is a large difference in the ability of the enzyme to perform 
the transglycosylation under these different conditions.   
 
Reaction Component 6 h 24 h 72 h 
6D Lactose 1.0 1.0 1.0 
 Gal-GlcOMe 0.7 2.3 6.8 
6F Lactose 1.0 1.0 1.0 
 Gal-GlcOMe 0.3 1.1 2.2 
6G Lactose 1.0 1.0 1.0 
 Gal-GlcOMe 0.4 2.2 8.5 
6H Lactose 1.0 1.0 1.0 
 Gal-GlcOMe 3.0 17.9 26.8 
6P Lactose 1.0 1.0 1.0 
 Gal-GlcOMe 0.1 0.0 0.0 
 
Table 3.3.1.2c: Experiment ENZ 6 – table to show the ratio of lactose to Gal-GlcOMe 
disaccharide produced in each set of reaction conditions 
 
Evaluating each set of conditions based on how much of the disaccharide was produced 
relative to the amount of lactose used, the conditions for reaction ENZ 6H clearly produced 
the best result. When the reactions were stopped at 72 hours ENZ 6H had a ratio of 1:27 Lac 
to Gal-GlcOMe.  The results for conditions for ENZ 6G and ENZ 6D were not as good, ENZ 
6D being 1:7 and ENZ 6G 1:9 Lac to Gal-GlcOMe.  Conditions for ENZ 6F and ENZ 6P 
showed very little production of the desired disaccharide. 
 
Overall, however, ENZ 6 was very promising, as we had successfully synthesised our target 
disaccharide in four of the five reactions.   
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In ENZ 7, in which GalOpNP was used as the glycosyl donor, the results were more 
disappointing: in only two cases, ENZ 7H and ENZ 7P, was the Gal-GlcOMe disaccharide 
produced.  This was only detected by mass spectrometry and working out the amount 
relative to the amount of starting material was not possible as GalOpNP was not present in 
the mass spectra.   
 
However, it was possible to conclude that under these reaction conditions, lactose appears 
to be a better glycosyl donor than GalOpNP. 
 
ENZ8 and ENZ 9 – increased reaction concentration 
At this point we also decided to investigate if increasing the reaction concentration would 
have any effect on the efficacy of the transglycosylation reaction.  We therefore repeated the 
reactions ENZ 6 and ENZ 7 (see table 3.3.1.2b for other conditions), but at three times the 
concentration.  This could decrease the solubility of the reagents in the reaction solution, but 
we would expect an increase in the amount of the Gal-GlcOMe disaccharide produced 
should the solubility be adequate. 
 
This reaction was carried out as in the previous two experiments and, as expected, the 
increased reaction concentration led to more of the reaction components being in 
suspension. 
 
ENZ 8 
By comparing the results in Table 3.3.1.2d for ENZ 8 (lactose, 1.2 M) with those in Table 
3.3.1.2c (lactose, 0.4M) it is evident that the production of Gal-GlcOMe was greatly increased 
by increasing the concentration of the reaction solution. 
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Reaction Component 6 h 24 h 72 h 
8D Lactose 1.0 1.0 1.0 
 Gal-GlcOMe 41.7 65.0 58.0 
8F Lactose 1.0 1.0 1.0 
 Gal-GlcOMe 1.3 7.3 40.3 
8G Lactose 1.0 1.0 1.0 
 Gal-GlcOMe 1.9 13.4 53.7 
8H Lactose 1.0 1.0 1.0 
 Gal-GlcOMe 32.2 32.2 32.2 
8P Lactose 1.0 1.0 1.0 
 Gal-GlcOMe 40.3 40.3 40.3 
 
Table 3.3.1.2d: Experiment ENZ 8 – table to show the ratio of lactose to Gal-GlcOMe 
disaccharide produced in each set of reaction conditions 
 
In ENZ 9 (GalOpNP, 1.2M) the enzyme produced Gal-GlcOMe in each case as it appears in 
the mass spectra for all five reactions.  This is unlike ENZ 7 (GalOpNP, 0.4M) where very 
little of the disaccharide was made, and only in two sets of reaction conditions, ENZ 7H and 
ENZ 7P. Again, due to the lack of GalOpNP in the mass spectra and the inability to measure 
the Gal-GlcOMe peak accurately in the HPLC trace we cannot quantify the extent to which 
transglycosylation occurred.  However, we are able to say that increasing the concentration 
of the reaction solution markedly increased the transglycosylation reaction when using 
GalOpNP as the glycosyl donor. 
 
Considering the results from these four investigations, it is apparent that increasing the 
reaction concentration increases the amount of transglycosylation.  However, it is also 
apparent that by adding an organic solvent into the reaction the activity of the enzyme is 
compromised.  It therefore follows that we should determine the activity of the enzyme under 
these various conditions as this would give us quantifiable results on which to base further 
studies into transglycosylation. 
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3.3.2 Determining the activity of the enzyme in the presence of MeCN 
 
ENZ 10 
In this section of the investigation we would determine the activity of the enzyme by 
monitoring the hydrolysis of GalOpNP in the solvent, pH, temperature and concentration 
conditions used in the previous transglycosylation reactions – experiments ENZ 6-9 (Figure 
3.3.2a). 
 
O
OH
HO
HO
OH
OpNP
β-galactosidase
B. circulans O
OH
HO
HO
OH
OH
 
 
Figure 3.3.2a: Scheme for the reaction to determine the activity of the enzyme by hydrolysis of 
GalOpNP 
 
The first investigation would be to determine the activity of the enzyme at the concentration, 
temperature and pH of the transglycosylation reactions without any MeCN present as control 
experiments.  We would then repeat these experiments with MeCN so that we could 
compare the difference in the initial rates of the hydrolysis of GalOpNP both with and without 
MeCN. 
 
Control experiment 1 (ENZ 10C1) – determining the activity of the enzyme in aqueous 
buffer solution 
 
The first control experiment was carried out by monitoring the hydrolysis of GalOpNP by the 
β-galactosidase from B. circulans over the course of ten minutes.  The conditions for each 
control experiment are given in Table 3.3.2b. 
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Reaction number 
 
pH Concentration/M Temperature/oC 
C1a 5.0 0.170 30 
C1b 7.0 0.170 30 
C1c 5.0 0.056 30 
C1d 7.0 0.056 30 
C1e 7.0 0.170 55 
C1f 7.0 0.056 55 
 
Table 3.3.2b: Reaction conditions for ENZ 10C1 
 
An example UV plot showing the hydrolysis of GalOpNP is shown in Figure 3.3.2c (the 
remaining UV plots and the plots for the determination of the molar absorptivity coefficient for 
p-nitrophenolate are in the Appendix Section 3.3.2).  The initial rate of hydrolysis of GalOpNP 
has been calculated for each reaction and is shown in Figure 3.3.2d.   
     
 
Figure 3.3.2c: UV plot showing the hydrolysis of GalOpNP in reaction conditions ENZ 10C1a 
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Figure 3.3.2d: Calculation of the initial rate of hydrolysis of GalOpNP in experiment ENZ10 C1 
 
Examining the initial rate of hydrolysis for each of the six control reactions shown in Figure 
3.3.2d and Table 3.3.2e, the conditions used for C2 (pH 7.0, 0.170 M, 30 oC) give the fastest 
rate of hydrolysis at 5.58 x 10-8 moles of GalOpNP hydrolysed per minute. 
 
Reaction 
 number 
pH 
 
Concn/M 
 
Temp/oC 
 
 
Rate of hydrolysis moles 
GalOpNP min-1 
 
Rate of hydrolysis µmoles 
GalOpNP min-1 
C1a 5.0 0.170 30 2.47 x 10-8 2.47 x 10-2 
C1b 7.0 0.170 30 5.58 x 10-8  5.58 x 10-2 
C1c 5.0 0.056 30 1.43 x 10-8 1.43 x 10-2 
C1d 7.0 0.056 30 1.21 x 10-8 1.21 x 10-2 
C1e 7.0 0.170 55 1.64 x 10-8 1.64 x 10-2 
C1f 7.0 0.056 55 1.12 x 10-8 1.12 x 10-2 
Table 3.3.2e: Tabulated data for the initial rate of hydrolysis of GalOpNP in experiment ENZ 10 
C1 
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One unit of activity for a β-galactosidase is defined as “the amount of enzyme needed to 
release 1 µmol min-1 of p-nitrophenol from p-nitrophenol galactose”.  Since 7 mg of enzyme 
hydrolysed 5.58 x 10-2 µmoles GalOpNP min-1 in C1b, the activity of the enzyme in these 
conditions is 1 ÷ 5.58 x 10-2 x 0.007 = 0.125 g.  In our first calculation of enzyme activity 
(Section 3.2.1) the amount of enzyme needed for this one unit of activity is 0.003 g (pH 6.0 
buffer, 2.0 M, 37 oC).  So, the activity of the enzyme is either not as high under the conditions 
of the control experiment or has diminished during storage.  
 
Now that we had the control results for comparison, we would now carry out enzyme activity 
experiments in the presence of MeCN under similar reaction conditions. 
 
Determining the activity of the enzyme in the presence of MeCN 
 
ENZ 11 
In this investigation the activity of the enzyme was determined in ten reactions corresponding 
to the most successful conditions for the hydrolysis of lactose D, F, G, H and P (see Section 
3.3.1.2).  Because of the presence of MeCN the rate of hydrolysis would be greatly reduced 
compared to the previous experiment, so aliquots were taken for monitoring the reaction at 
greater intervals and over the course of 6 hours. 
 
In order to determine the activity of the enzyme, GalOpNP was dissolved in the mixed 
solvent systems shown in Table 3.2.2f.  This was then stirred at the given temperature with 
the β-galactosidase from B. circulans for a total of 6 hours.  Aliquots were taken at 30 minute 
intervals and the amount of p-nitrophenol released was determined by monitoring the 
absorbance of p-nitrophenolate by UV-vis spectroscopy in NaOH solution. 
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Reaction number pH Concentration/M % MeCN Temperature/oC 
ENZ 
11 
C1 
D 5.0 0.170 20 30 
F 7.0 0.170 40 30 
G 7.0 0.170 30 30 
H 7.0 0.170 20 30 
P 7.0 0.170 20 55 
ENZ 
11 
C2 
D 5.0 0.056 20 30 
F 7.0 0.056 40 30 
G 7.0 0.056 30 30 
H 7.0 0.056 20 30 
P 7.0 0.056 20 55 
 
Table 3.3.2f: Reaction conditiond for experiment ENZ 11 
 
 
The UV plots showing the hydrolysis of GalOpNP are shown in the Appendix Section 3.3.2.  
In order to highlight the very much reduced activity of the enzyme when MeCN is used as a 
co-solvent, examples of a typical UV spectrum for these reaction sets C1 and C2 are shown 
in Figure 3.3.2g.   
 
The initial rate of hydrolysis of GalOpNP has been calculated for each reaction and is shown 
in Figure 3.3.2h.  In this case the initial rate has been calculated over the course of 6 hours 
as the hydrolysis reaction was so slow (which can be seen in the two UV spectra in Figure 
3.2.2g). 
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Figure 3.3.2g: Typical UV spectra for reaction sets ENZ 11C1 and C2 
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NB – anomalous points due to sampling errors have been removed from the calculation of the rate of 
hydrolysis in both graphs  
Figure 3.3.2h: Initial rate calculations for experiments ENZ 11C1 and 11C2 
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Table 3.3.2i below gives the results for the calculations of the rate of hydrolysis of GalOpNP 
by the β-galactosidase from B. circulans in the presence of MeCN co-solvent.  There is one 
set of anomalous results in ENZ 11C2F where a negative rate of hydrolysis is seem.  This is 
most likely due to sampling errors. 
 
Reaction 
number 
 
pH 
 
Conc/M 
 
 
% MeCN Temp/oC 
 
Rate of hydrolysis 
moles GalOpNP 
min-1 
Rate of hydrolysis 
µmoles GalOpNP 
min-1 
ENZ 
11 
C1 
D 
5.0 0.170 20 30 2.87 x 10-11 2.87 x 10-5 
F 
7.0 0.170 40 30 1.03 x 10-11 1.03 x 10-5 
G 
7.0 0.170 30 30 2.45 x 10-11 2.45 x 10-5 
H 
7.0 0.170 20 30 8.00 x 10-11 8.00 x 10-5 
P 
7.0 0.170 20 55 3.91 x 10-12 3.91 x 10-6 
ENZ 
11 
C2 
D 
5.0 0.056 20 30 3.43 x 10-11 3.43 x 10-5 
F 
7.0 0.056 40 30 -1.99 x 10-13 -1.99 x 10-7 
G 
7.0 0.056 30 30 1.52 x 10-12 1.52 x 10-6 
H 
7.0 0.056 20 30 1.13 x 10-11 1.13 x 10-5 
P 
7.0 0.056 20 55 5.75 x 10-13 5.75 x 10-7 
 
Table 3.3.2i:  Tabulated data for the initial rate of hydrolysis of GalOpNP in experiment ENZ 11 
C1 and C2 
 
 
It was clear from these results that the higher reaction concentration (0.170 M), 20% MeCN 
and a temperature of 30 oC worked best, with pH 7.0 (ENZ 11C2H) giving a 2.8 fold increase 
in hydrolysis compared to the pH 5.0 (ENZ 11C2D) reaction. 
 
Set of conditions ENZ 11C2H gives the fastest rate of hydrolysis at 8.00 x 10-5 µmoles 
GalOpNP min-1, although this is still three orders of magnitude lower than when the 
hydrolysis was carried out in the absence of MeCN co-solvent (refer to Table 3.2.2e; fastest 
rate 5.58 x 10-2 µmoles GalOpNP min-1).  Since 7 mg of enzyme hydrolysed 8.00 x 10-5 
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µmoles GalOpNP min-1 in ENZ 11C2H, the activity of the enzyme under these conditions is 1 
÷ 8.00 x 10-5 x 0.007 = 87.5 g µmol-1 GalOpNP.  When compared to the value for the activity 
of BC04 C1b, which was 0.125 g µmol-1 GalOpNP, this is a staggering difference in activity.    
 
87.5 g of enzyme is just not a sensible amount to put into such a small reaction; it is 
completely impractical and inefficient.  However, the presence of MeCN is having a huge 
impact on the efficacy of the enzyme, and we needed to find a sensible way to overcome this 
problem.   The solution lies in using more catalyst. So, more enzyme, but a sensible amount 
of it.   
 
3.3.3 Increasing the rate of hydrolysis of GalOpNP in the presence of MeCN 
by increasing the amount of enzyme used 
 
The next step to optimising the conditions for our transglycosylation reactions would be to 
investigate the effect of increasing the amount of enzyme added, thereby increasing the rate 
hydrolysis of the glycosyl donor, GalOpNP.  In the previous Section, Table 3.3.2i shows the 
rate of hydrolysis by the enzyme under various sets of conditions.  We chose the two best 
sets of conditions (those with the highest rate of hydrolysis) for further investigation. 
 
In the previous experiment, conditions ENZ 11C2D and ENZ 11C2H gave the highest rates 
of hydrolysis, so we would begin our investigation using these two sets of conditions.   The 
conditions that worked best were: 
 
• 20% MeCN 
• 0.170 M wrt donor (1.2 M wrt acceptor) 
• 30 oC 
• pH 5.0 and pH 7.0 
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So, aside from the amount of enzyme being added, the only difference between the two 
reactions is the pH.   
 
Before carrying on with the concentration at 1.2 M with respect to the glycosyl donor, 
GlcOMe, we felt it prudent to carry out a solubility test under these conditions using 
NpCH2GlcOMe (32).  We attempted to dissolve 50 mg of the naphthyl-functionalised sugar 
into a 0.4 M, 80:20 mixture of water and MeCN respectively.  The solution was opaque, so 
the sugar had not fully dissolved.  Given this result we felt that we needed to press on using 
a lower concentration as we were certain that using a more concentrated solution would 
mean that little of the naphthyl-sugar substrate would dissolve in the solution and therefore 
there would not be much available for the enzyme to process.  Although any that does go 
into solution and is processed would shift the equilibrium to allow more acceptor to go into 
solution. 
 
We would therefore carry out eight screening reactions using a 2-, 4-, 8- and 16-fold increase 
in the amount of enzyme added as detailed in Table 3.3.3a below.   
 
ENZ 12 
In order to determine the activity of the enzyme, GalOpNP was dissolved in buffer with 20% 
MeCN co-solvent.  The reaction mixtures were then stirred at 30 oC with different amounts of 
the β-galactosidase from B. circulans (see Table 3.3.3a for details) for a total of 6 hours.  
Aliquots were taken at 30 minute intervals and the amount of p-nitrophenol released was 
determined by monitoring the absorbance of p-nitrophenolate by UV-vis spectroscopy in 
NaOH solution. 
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Reaction 
conditions 
Standard amount of enzyme 
added/g 
Increased amount of enzyme added 
/g 
X2 X4 X8 X16 
 0.007 0.014 0.028 0.056 0.112 
D  pH 
5.0 reaction number 2D 4D 8D 16D 
H  pH 
7.0 reaction number 2H 4H 8H 16H 
 
Table 3.3.3a: Reaction conditions and numbering for experiment ENZ 12 
 
The screening experiment was carried out successfully, the UV-vis spectra for each of the 
eight experiments are in the Appendix.   
 
In all of the reaction solutions there was a proportion of the enzyme that had not dissolved.  
Experiments 16D and 16H were extremely thick with solid compared to experiments 8D and 
8H.  A suspension of the enzyme in the reaction solution is expected, but the extent of the 
solid in experiments 16D and b seemed far too great to be of any benefit to the progress of 
the reaction.  From a practical and efficiency perspective, using 16 times the ‘normal’ amount 
of enzyme did not seem a sensible path to take. 
 
Compared to the UV-vis spectra recorded for the previous experiment (Section 3.3.2), the 
curves in this screening experiment showed a much greater processing of GalOpNP over the 
same time period and at a faster rate – as we had predicted. 
 
Using the results from the UV-vis spectra, initial rate plots have been produced.  The initial 
rate period was taken to be the first 90 minutes.  Plots of the moles of 4-nitrophenolate 
released over the six hours of the reaction period all showed the characteristic sigmoidal 
shape of a rate graph. 
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Figure 3.3.3b: Calculation of initial rate of reaction in ENZ 12D 
 
 
Figure 3.3.3b: Calculation of initial rate of reaction in ENZ 12H 
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Reaction 
 number 
pH 
 
 
Rate of hydrolysis  
moles GalOpNP min-1 
 
Rate of hydrolysis  
µmoles GalOpNP min-1 
 
2D 5.0 
 
5.63 x 10-11 
 
5.63 x 10-5 
4D 5.0 9.53 x 10-11  9.53 x 10-5 
8D 5.0 1.80 x 10-10 1.80 x 10-4 
16D 5.0 2.19 x 10-10 2.19 x 10-4 
 
2H 7.0 
 
4.19 x 10-10 
 
4.19 x 10-4 
4H 7.0 4.61 x 10-10 4.61 x 10-4 
8H 7.0 6.01 x 10-10 6.01 x 10-4 
16H 7.0 5.40 x 10-10 5.40 x 10-4 
 
Table 3.3.3d: Tabulated results of initial rate calculationd for experiment ENZ 12 
 
Examining the results in Table 3.3.3d, the fastest rate of hydrolysis of GalOpNP was with the 
set of conditions 8H.  A rate of 6.01 x 10-4 µmoles GalOpNP min-1 was achieved at pH 7.0 
with 8 times the amount of enzyme used (compared to ENZ 11).  In terms of the activity of 
the enzyme this works out that 1 unit of enzyme is 11.6 g.  This is still unmanageable in 
terms of the experiments we wish to carry out if we were to follow the original procedure. 
However, we did now have an optimum set of conditions on which to base those experiments 
and evidence to show that the enzyme can process GalOpNP at an acceptable rate even in 
the presence of MeCN.  
 
As explained previously, although in the case of 16D using a greater amount of enzyme did 
increase the initial rate of the reaction, the sheer amount of solid that remains un-dissolved in 
solution makes this reaction difficult to work with.  For these reasons and the results from the 
rate calculations, we chose to begin the next phase of the enzyme work based upon the 
following reaction conditions: 
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• pH 5.0/7.0; 
• 8 x 2.45 U enzyme; 
• 0.4M reaction concentration wrt the glycosyl acceptor; 
• 20% MeCN; 
• 30 oC; 
• minimum 6 hour reaction time. 
 
3.3.4 Transglycosylations using the naphthyl-functionalised methyl 
glucosides 
 
The next stage in the project was to use our optimised reaction conditions to make 
disaccharides containing our three naphthyl-functionalised methyl glucosides, 32, 33 and 34.  
We began by checking our optimised reaction using 32 first as this is the most easily 
accessed of the three naphthyl-functionalised glucosides (Figure 3.3.4a) 
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Figure 3.3.4a: Scheme for the initial investigation into the use of our novel naphthyl-
functionalised methyl glucosides as substrates for the β-galactosidase from B. circulans 
 
In this first attempt at the transglycosylation we chose to assess which pH (5.0 or 7.0) and 
which glycosyl donor (Lac or GalOpNP) gave the best results. 
 
 
 
32 
35 
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3.3.4.1 Initial syntheses of napthyl-functionalised Gal-NpCH2GlcOMe disaccharide 35 
 
ENZ 13 & ENZ 14 
In the first instance we carried out four test reactions using naphthyl-functionalised sugar 32 
(NpCH2GlcOMe) as the glycosyl acceptor to determine which of these four sets of conditions 
gave the best result in terms of yield and ability to monitor the reaction.  Following the 
scheme shown in Figure 3.3.4a, the following reaction conditions would be tested (Table 
3.3.4.1a): 
 
Reaction number pH Glycosyl donor 
ENZ 13D 5.0 GalOpNP 
ENZ 13H 7.0 GalOpNP 
ENZ 14D 5.0 Lac 
ENZ 14H 7.0 Lac 
 
Table 3.3.4.1a:  Reaction details for experiments ENZ 13 and ENZ 14 
 
The reactions were carried out by suspending the glycosyl donor (GalOpNP or Lac) and 
naphthyl-functionalised sugar 32 in the mixed solvent system (pH 5.0 or 7.0 buffer/MeCN 
80:20) at 30 oC.  The β-galactosidase from B. circulans was then added and aliquots of the 
reaction solution were taken at regular intervals for analysis by HPLC and mass 
spectrometry.  After 24 hours the reaction was stopped by denaturing the enzyme by 
heating.  The reaction mixture was then freeze-dried and the carbohydrate residues were 
acetylated to facilitate the separation (by column chromatography) and characterisation of 
the products. 
 
HPLC monitoring was done using a UV (224 nm) and an ECD detector simultaneously.  As 
our target disaccharide is UV-active we focused on the appearance of new UV-active peaks 
in the HPLC.   
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ENZ 13: Experiments using GalOpNP as the glycosyl donor 
 
ENZ 13D (pH 5.0) 
The first new UV-active peak seen in the HPLC monitoring appeared at 30 minutes as a 
shoulder on the broad peak at tr = 7.1 min which is the acceptor 32 (Figure 3.3.4.1b). 
 
 
Figure 3.3.4.1b: ENZ 13D HPLC at 30 minutes 
 
The HPLC trace at 1 hour was very similar to this and the shoulder at tr = 9.3 minutes (P1) 
continued to increase until at 24 hours it was large enough to have become a significant part 
of the peak at tr = 7.1 minutes corresponding to naphthyl-functionalised sugar 32 (Figure 
GalOpNP 
32 
New peak (P1) 
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3.3.4.1c).  The peak at tr =11.5 minutes appeared after 5 hours but was a relatively small 
amount of the mixture of compounds.   
 
 
Figure 3.3.4.1c: ENZ 13D HPLC at 24 hours 
 
 
The graph and  in Figure 3.3.4.1d show these changes over the whole 24 hour period of the 
reaction.  The amount of naphthyl-functionalised sugar 32 decreases over the course of the 
reaction, as one would expect, and GalOpNP shows very slow hydrolysis as there is still a 
significant amount remaining at 24 hours.  
 
 
32 + new peak (P1) 
New peak (P2) 
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Relative area % 
Reaction time 
tr = 4.0 - 4.7 min 
(GalOpNP + unknown) 
tr = 7.0 min 
(32) 
tr = 9.3 min 
(P1) 
tr = 11.5 min 
(P2) 
0 min 4.47 95.53 
10 min 3.66 96.34 
30 min 3.25 94.64 2.12 
1 h 3.5 92.08 4.42 
2 h 3.42 90.24 6.35 
3 h 2.38 90.59 7.03 
4 h 2.64 88.27 9.08 
5 h 2.63 85.41 11.55 0.41 
6 h 2.43 83.91 12.99 0.66 
24 h 1.38 95.69 2.93 
 
Tabulated HPLC data from experiment ENZ 13D 
 
 
Figure 3.3.4.1d: Graph to show the overall progress of ENZ 13D over the course of the reaction 
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ENZ 13H (pH 7.0) 
The first new UV-active peak observed in the HPLC monitoring of this reactions appeared 
after 10 minutes as a shoulder on the broad peak at tr = 7.1 min which is naphthyl-
functionalised sugar 32.  Under these reaction conditions (pH 7.0) the consumption of 32 and 
the increase in P1 was much faster than in 13D.   There are also more distinct peaks in the 
HPLC trace, suggesting a number of similar compounds.  This was different from the HPLC 
observed in 13D where an indistinct shoulder formed instead.  The trace recorded at 24 
hours has a broad peak from 7.0 – 9.7 minutes which can be clearly split into four separate 
peaks (Figure 3.3.4.1e).  For ease of comparison I have grouped the peaks due to P1 
together in the table and graph shown in Figure 3.3.4.1f. 
 
 
Figure 3.3.4.1e: ENZ 13H HPLC at 24 hours 
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Relative area % 
Reaction time 
tr = 4.0 - 4.7 min 
(GalOpNP + unknown) 
tr = 7.0 min 
(32) 
tr = 8.5 - 9.7 min 
(P1) 
tr = 13.2-15.6 min 
(P3) 
0 min 4.73 95.27 
10 min 4.05 93.24 2.7 
30 min 2.61 91.04 6.36 
1 h 1.47 82.77 14.2 1.56 
2 h 1.16 75.84 19.47 3.53 
3 h 0.78 69.86 24.77 4.59 
4 h 0.6 67.46 26.43 5.5 
5 h 0.58 66.22 28.08 5.11 
6 h 0.5 63.46 29.74 6.3 
24 h 0.47 43.94 52.27 3.32 
 
Tabulated HPLC data from experiment ENZ 13 H 
 
 
Figure 3.3.4.1f: Graph to show the overall progress of ENZ 13H over the course of the reaction 
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Comparison of Experiments ENZ 13D and ENZ 13H 
Both reactions 13D and 13H showed processing of naphthyl-functionalised sugar 32 in the 
HPLC spectra.  However, in comparing the two experiments it was clear from the graphs in 
Figures 3.3.4.1d and 3.3.4.1f, that 13H (pH 7.0) showed the greatest amount of 32 
processed and the greatest amount of UV-active products formed. 
 
At the end of the 24 hour reaction time the reactions were acetylated. Mass spectrometric 
analysis of the crude material from both reactions revealed the presence of our desired 
disaccharide Gal-NpCH2GlcOMe 36 at m/z 771 (Table 3.3.4.1g). 
 
Reaction MS Peak m/z RMM Assignment 
(acetylated sugars) 
comments 
13D 483 [M + Na]+ 460 XE9b Major peak 
701 [M + Na]+ 678 Gal-Gal  Apparent upon 
expansion of the 
baseline 
771 [M + Na]+ 748 Gal-NpCH2GlcOMe 36 
989 [M + Na]+ 966 Gal-Gal-Gal 
13H 483 [M + Na]+ 460 XE9b Major peak 
701 [M + Na]+ 678 Gal-Gal  ~1/4 height XE9b 
771 [M + Na]+ 748 Gal-NpCH2GlcOMe 36 ~1/5 height XE9b 
989 [M + Na]+ 966 Gal-Gal-Gal baseline 
 
Table 3.3.4.1g: ENZ 13D and ENZ 13H tabulated mass spectra results 
 
TLC analysis of the acetylated material in EtOAc/hexane (1:1) using UV and ammonium 
molybdate to visualise the components showed a set of intense spots at Rf = 0.45 
corresponding to naphthyl-functionalised sugar 32.  The remaining material was seen as UV- 
and ammonium molybdate-active spots on the baseline of the plate.  The column was 
therefore flushed with 5% MeOH in EtOAc once the other spots had eluted (32 could be 
recovered for use in subsequent reactions).  Mass spectra of the material in the flush are 
shown in Figure 3.3.4.1h and the analysis in Table 3.3.4.1i. 
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Figure 3.3.4.1h: mass spectrum form ENZ column flush (top); mass spectrum from ENZ 13H 
column flush (bottom) 
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Reaction MS Peak m/z RMM 
Assignment 
(acetylated sugars) 
comments 
13D 
701 [M + Na]+ 678 Gal-Gal 
Major peaks 771 [M + Na]+ 748 Gal-NpCH2GlcOMe 36 
989 [M + Na]+ 966 Gal-Gal-Gal 
1059 [M + Na]+ 1036 Gal-Gal-NpCH2GlcOMe Minor peak 
13H 
701 [M + Na]+ 678 Gal-Gal ~2/3 peak at 771 
771 [M + Na]+ 748 Gal-NpCH2GlcOMe 36 Major peak 
989 [M + Na]+ 966 Gal-Gal-Gal 
Minor peaks 
1059 [M + Na]+ 1036 Gal-Gal-NpCH2GlcOMe 
 
Table 3.3.4.1i: ENZ 13D and ENZ 13H tabulated mass spectra results for the compounds 
contained in the column flush 
 
The major components in the mass spectra of the flushed material were a Gal-Gal 
disaccharide and our desired  acetylated Gal-NpCH2GlcOMe disaccharide 36.  A minor peak 
in both spectra was a trisaccharide containing NpCH2GlcOMe which can be ‘added’ to the 
yield of the disaccharide as it has been doubly processed by the enzyme. 
 
Although the desired sugars were minor components of the reactions as a whole, it was 
extremely encouraging that the enzyme was able to process the novel sugars and produce 
disaccharides containing them.   
 
In comparing the two reactions qualitatively based on the HPLC and mass spectrometric 
data, the reaction carried out at pH 7.0 produced the greatest amount of our desired 
disaccharide. 
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Experiments using Lac as the glycosyl donor 
 
The results from Experiments ENZ 14D and ENZ 14H were almost identical to their 
counterparts in ENZ 13 in that the pH of the reaction had a much greater impact than the 
glycosyl donor used.  The detailed results from the HPLC and mass spectrometry work from 
Experiment ENZ 14 are shown in the Appendix Section 3.3.4.1.   
 
Summary of results from experiments ENZ 13 and ENZ 14 
 
We carried out four test reactions to evaluate the effect of pH on the transglycosylation 
reaction between a glycosyl donor (GalOpNP and Lac) and the novel glycosyl acceptor 
naphthyl-functionalised sugar 32.  
 
From the data collected, it was clear that a reaction pH of 7.0 gives rise to more enzyme 
activity under these conditions than pH 5.0 as more processing was seen in reactions ENZ 
13H and ENZ 14H than in reactions ENZ 13D and ENZ 14D.  Two graphical representations 
of this are shown in Figure 3.3.4.1s below.  Values for 24 hours are not included as in 
experiments 13D and 14D (pH 5.0) it was not possible to distinguish between the peak for 32 
and that of P1 at 24 hours.  For the purpose of this comparison the trends over the first 6 
hours of the reaction are sufficient.   
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Figure 3.3.4.1s: Comparison of the results of  experiments ENZ 13 and ENZ 14.  The graphs 
give an indication of the extent of glycosyl processing in each reaction 
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The top graph in Figure 3.3.4.1s shows the consumption of 32 over the course of the 
reaction.  The linear trendlines show the consumption of 32 is higher in experiments 13H and 
14H (pH 7.0).  There was a concomitant trend when looking at the increase in the amount of 
P1 (desired Gal-NpCH2GlcOMe disaccharide 35), in that the amount of P1 in experiments 
13H and 14H was almost double that observed in 14D and 14D.   
 
The choice of glycosyl donor had little or no impact on the transglycosylation reaction under 
the reaction conditions used in this case.  There may be a slight advantage in using 
GalOpNP over lactose as the data showed that experiment 13H (GalOpNP) produced slightly 
more P1 over the course of the reaction.  However, the increase is very small and by far the 
biggest factor influencing the efficacy of transglycosylation reactions under the conditions 
used in this experiment is the pH of the buffer solution used.  Using a pH of 7.0 greatly 
increases the amount of processing carried out by the enzyme. 
 
3.3.4.2 Larger scale synthesis of Gal-NpCH2GlcOMe using optimised conditions 
 
In the previous Section we have reported the successful application of the β-galactosidase 
from B. circulans in the synthesis of di- and trisaccharides containing the naphthyl 
functionalised methyl glucoside 32.  The best conditions for this reaction are shown in Figure 
3.3.4.2a. There was no marked advantage to using GalOpNP over lactose as the glycosyl 
donor. 
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Figure 3.3.1.2a: optimised conditions for the tranglycosylation reactions using the β-
galactosidase from B. circulans 
32 
35 
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In these next syntheses we would prepare the disaccharide Gal-NpCH2GlcOMe 35 in 
greater quantity so that the regioselectivity of glycosidic bond formation can be determined. 
 
Two identical reactions were  performed simultaneously using GalOpNP (ENZ 15) and Lac 
(ENZ 16) as the glycosyl donors.  The reactions were carried out in the same manner as 
experiments ENZ 13 and ENZ 14.  Aliquots of the reaction mixture were taken at 30 minute 
intervals and reaction progress monitored by HPLC and mass spectrometry.  
 
Both reactions proceeded smoothly; monitoring by HPLC mirrored the results from 
experiments ENZ 13H and  ENZ 14H.  Following the reaction by mass spectrometry it was 
possible to see the evolution of a baseline peak at m/z = 519 corresponding to Gal-
NpCH2GlcOMe 35 (RMM 496).  The reactions were stopped at six hours by heating at 100 
oC for five minutes to denature the enzyme.  The reaction mixture was then lyophilised and 
the carbohydrate residues acetylated to facilitate separation and characterisation.   Mass 
spectrometric analysis of the crude acetylated material confirmed the presence of the 
acetylated Gal-NpCH2GlcOMe disaccharide 36 at m/z = 771.  The crude reaction mixtures 
were then partially purified by column chromatography.  The starting material 32 was 
recovered in both cases, 210 mg (84%) in experiment ENZ 15 and 203 mg (81%) in 
experiment  ENZ 16.  32 was in a 7-fold excess so recovering this amount of material is not 
an indication of the efficacy of the reaction. 
 
The ‘flushed’ fraction of the columns were then analysed by HPLC so that this mixture of 
disaccharides could be purified further to yield our desired acetylated disaccharide 36 (Figure 
3.3.4.2b). 
 
The HPLC spectra 5.of these crude mixtures were very similar.  Both had a broad peak at tr 
= 12.2 minutes and a broad set of overlapping and adjacent peaks between tr = 33.2 and 
35.7 minutes.  It was within the latter area that we expected to find our target disaccharide. 
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Figure 3.3.4.2b: HPLC analysis of the crude mixtures from experiments ENZ 15 (top) and ENZ 
16 (bottom) 
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The  peaks were successfully separated using HPLC and the resultant samples submitted for 
mass spectrometry.  The results from this are shown in Table 3.3.4.2c. 
 
Peak tr/ min m/z Assignment 
Mass recovered/mg 
ENZ 15 ENZ 16 
12.2 Insufficient material for analysis 
34.1 
483 [M + Na]+ XE9b 
17 7 
757 [M + Na]+ Gal-Gal 
35.0 771 [M + Na]+ Gal-NpCH2GlcOMe 36 15 (12 %) 12 (9.5%) 
35.7 Insufficient material for analysis 
 
Table 3.3.4.2c: Results from HPLC separation of the two crude mixtures obtained from 
experiments ENZ 15 and ENZ 16 and the assignment of peaks from mass spectra 
 
In both cases the peak at tr = 35.0 minutes was found to contain a single major peak at m/z = 
771 ([M + Na]+ Gal-NpCH2GlcOMe 36, RMM = 748). The mass recovery of this product was 
15 mg from ENZ 15 (12% wrt donor) and 12 mg from ENZ 16 (9.5% wrt donor).  This was an 
excellent result and the yields were encouraging.  Yields from enzymatic transglycosylation 
reactions do vary widely, but 12 and 9.5% were good results. 
 
A preliminary  1H NMR spectrum of the  combined, purified Gal-NpCH2GlcOMe 36 from both 
of these experiments showed the presence of a single compound.  This sample was then 
submitted for more detailed 1H, 13C and 2D NMR spectroscopy to determine the 
regiochemistry of the new glycosidic linkage.  The full spectroscopic assignment is in the 
Experimental Section (5.3) 
 
The disaccharide proved to be a β(1→2) linked disaccharide (Figure 3.3.4.2d) after a full 2D 
NMR analysis using HSQC, HMBC and COSY90.   
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Figure 3.3.4.2d: β-D-(-2,3,4,6-tetra-O-acetyl)galactopyranoside-(1→2)-α-D-methyl-((2,3,4-tris-O-
acetyl)-6-O-(2-naphthylmethyl))glucopyranoside 36 
 
Discussion of structural assignment 
The anomeric carbons are clear at 101.9 and 99.0 ppm in the 13C NMR spectrum; by 
examining the HMBC the methoxy group on the glucose ring shows 3J coupling to C1’ at 
99.0 ppm.  C1” is therefore at 101.9 ppm, with HSQC to the corresponding anomeric proton 
H1” at 4.58 ppm; H1’ is at 4.88 ppm.  The glycosidic linkage is, as expected, beta; confirmed 
by the coupling constant 3JH1”-H2” = 8.1 Hz, typical for a β-linked disaccharide. COSY90 allows 
assignment of the protons within the sugar rings which, in turn, identifies the carbons within 
the sugar rings by HSQC (Figure 3.3.4.2e). 
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Figure 3.3.4.2e: confirming the stereoselectivity of the glycosidic bond formation 
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In order to determine the position of glycosylation, examination of the HMBC of H1” on the 
galactose ring shows 3J coupling to C2’ of the glucose ring; confirming C2’ as the point of 
attachment (Figure 3.3.4.2f). 
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Figure 3.3.4.2f: determining the regioselectivity of the glycosidic bond formation 
 
 
Summary 
In this part of the project we have successfully developed and used a method for carrying out 
transglycosylation reactions between a glycosyl donor and a novel methyl glucoside 
functionalised with a naphthyl group at C6 using the β-galactosidase from B. circulans.  This 
is an excellent result, and, the use of the enzyme to make disaccharides containing a bulky 
organic chromophore at C6 of the glycosyl acceptor has not been done before.  It was 
particularly interesting to note the point of glycosidic linkage: β(1→2).  The enzyme we have 
chosen to use has a marked preference for forming β(1→4) and β(1→6) glycosidic bonds.  
Obviously in our case C6 was not available for glycosylation as it was blocked by the 
naphthylmethyl group; however, the formation of a β(1→2) linkage rather than β(1→4) 
linkage was a surprise.  No other naphthyl-functionalised disaccharides were detected in our 
screening and analytical studies of this set of reactions, so we can say that for this 
donor/acceptor set, the β-galactosidase from B. circulans is β(1→2)-selective. 
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We would now use the knowledge and experience gained through Experiments 18-21 to 
make disaccharides using our two other naphthyl-functionalised methyl glucosides, 33 and 
34. 
 
3.3.4.3 Synthesis of disaccharides using novel glucosides 33 and 34 
 
Having successfully made our first naphthyl-functionalised disaccharide we would now use 
the same reaction conditions to attempt the synthesis of two more, shown in Figure 3.3.4.3a. 
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Figure 3.3.4.3a: Scheme for transglycosylation reactions using the two other novel, 
naphthalene functionalised methyl glucosides using the β-galactosidase from B. circulans 
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Experiment ENZ 17 would make the disaccharide using 33 as the glycosyl acceptor, and 
Experiment ENZ 18 would make the disaccharide using 34 as the glycosyl acceptor.  
Lactose would be used as the glycosyl donor as i) it is not UV active and ii) the retention time 
of GalOpNP was very similar to the retention times of 33 and 34 (HPLC traces of this are in 
the Appendix).  So, using lactose as the glycosyl donor makes monitoring the reaction by UV 
detection in HPLC easier. In light of the results with naphthyl acceptor 32, It would be 
interesting to see where the glycosidic bond formed if we succeeded in making both of these 
disaccharides. 
 
ENZ 17 Synthesis of disaccharide Gal-EGNpGlcOMe 37 
 
The transglycosylation reaction between 33 and lactose was carried out as described in 
method ENZ 17 in the Experimental Section (5.3). 
 
HPLC monitoring of the reaction showed the evolution of a new peak at tr = 7.4 minutes after 
30 minutes.  The HPLC results are shown in Table 3.3.4.3b and Figure 3.3.4.3c.  However, a 
peak with m/z = 563 corresponding to a disaccharide of 33 was not seen in the mass spectra 
until 4 hours had passed. 
 
Relative area % 
Reaction time 
tr = 4.5 min 
(29b) 
tr = 7.4 min 
(P1) 
tr = 15.2 min 
(P2) 
0 min 100 
  
30 min 96.78 3.22 
 
1 h 95.02 4.98 
 
2 h 93.62 6.38 
 
4 h 90.8 9.2 
 
6 h 89.6 9.29 1.1 
24 h 81.89 15.25 2.86 
 
Table 3.3.4.3b: ENZ 17 tabulated HPLC results 
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Figure 3.3.4.3c: ENZ 17 graphical representation of HPLC results 
 
 
The graph in figure 3.3.4.3c shows the slow evolution of the peak P1 which we attributed to 
our desired disaccharide 37 as the simultaneous evolution of a peak with the correct m/z was 
seen in the mass spectra. Peak P2 was present in such small amounts in the HPLC trace 
(3%), and thus the reaction mixture, that no new other peaks were seen in the mass spectra.  
 
The reaction was terminated after 24 hours, the reaction mixture was freeze-dried and the 
carbohydrate residues acetylated.  Figure 3.3.4.3d shows the expanded baseline region of 
the mass spectrum of the acetylated reaction mixture.   
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Figure 3.3.4.3d: Expanded baseline of the mass spectrum for ENZ 17 showing the peak at m/z = 
815 corresponding to the acetylated Gal-EGNpGlcOMe 38 
 
Mass spectrometric analysis of the crude acetylated material confirmed the presence of the 
desired acetylated Gal-EGNpGlcOMe disaccharide 38 at m/z = 815.  The crude reaction 
mixture was then partially purified by column chromatography.  Most of the starting material 
33 was recovered (79 mg, 70%) The mass spectrum of the flushed fractions contained four 
peaks, detailed in Table 3.3.4.3e. 
 
MS Peak m/z RMM Assignment 
(acetylated sugars) 
comments 
527[M + Na]+ 504 33 Major peak 
701 [M + Na]+ 678 Gal-Gal  ~3/4 height major peak 
815 [M + Na]+ 792 Gal-EGNpGlcOMe 38 ~1/3 height major peak 
989 [M + Na]+ 966 Gal-Gal-Gal ~1/3 height major peak 
 
Table 3.3.4.3e: ENZ mass spectrometric analysis of the contents of the ‘flush’ fractions 
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HPLC separation of this mixture was then carried out (Figure 3.3.4.3f).  Three peaks were 
isolated and submitted for mass spectrometric analysis.  The second peak at tr = 33.6 
minutes contained the target disaccharide Gal-EGNpGlcOMe 38.  
 
 
Figure 3.3.4.3f: HPLC separation of the acetylated material containg the target compound 38 
 
 
There was very little material from this reaction, so it was repeated on a larger scale and 14 
mg (41% yield wrt lactose) of the desired disaccharide was isolated following the procedure 
described above.  This sample was then submitted for analysis by 1H, 13C and 2D NMR 
spectroscopy to determine the regiochemistry of the glycosidic linkage.  Again, only one 
regioisomer was found, the full spectroscopic assignment is in the Experimental Section 5.3.  
In this instance, the disaccharide proved to be a β(1→3) linked disaccharide (Figure 
3.3.4.3g) after a full 2D NMR analysis using HSQC, HMBC and COSY90.   
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Figure 3.3.4.3g:  "Gal-EGNpGlcOMe”  β-D-(-2,3,4,6-tetra-O-acetyl)-galactopyranoside-(1→3)-β-D-
methyl-((2,3,4-tris-O-acetyl)-6-O-[2-(2-naphthylmethoxy)ethyl]glucopyranoside 38 
 
 
 
Discussion of structural assignment 
 
The anomeric carbons are clear at 101.3 and 101.2 ppm in the 13C NMR spectrum, HSQC 
gives the corresponding protons at 4.28 and 4.54 ppm respectively.  H1’ (glucose) is located 
by HMBC 2J coupling to OCH3 at 4.28 ppm.  COSY90 then allows for assignment of protons 
on each of the sugar rings and subsequent HSQC analysis then determines the 
corresponding carbon atoms.  The disaccharide is beta linked as the coupling constant from 
H1” to H2” is 8.0 Hz, a typical value for  axial-axial coupling in a sugar (Figure 3.3.4.3h). 
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Gal Glc
 
Figure 3.3.4.3h: confirming the stereochemistry of the glycosidic bond formation 
 
The point of glycosidic bond linkage is found by examining the HMBC couplings from H1”.  
H1” shows 2J coupling to C2” and 3J coupling to C3” and C3’, thus showing that the 
disaccharide is 1→3 linked (Figure 3.3.4.3i). 
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Figure 3.3.4.3i: determining the regioselectivity of the glycosidic bond formation 
 
The β(1→3) regioselectivity of glycosidic bond formation observed in this case is different to 
the disaccharide made with 32, which possesses a β(1→2) glycosidic bond.  The point of 
glycosidic linkage is determined by the way in which the glycosyl acceptor sits in the active 
site of the enzyme.  Clearly, 32 and 33 sit quite differently within the active site, thus resulting 
in a different regioselectivity. 
 
ENZ 18 Synthesis of Gal-DEGNpGlcOMe 39 
 
The transglycosylation reaction between naphthyl-functionalised glucoside 34 and lactose 
was carried out as described in method EN18 in the Experimental Section. 
 
HPLC monitoring of the reaction showed the evolution of a new peak at tr = 7.5 min after 1 
hour.  The HPLC results are shown in Table 3.3.4.3j and Figure 3.3.4.3k.  A peak with m/z = 
607 corresponding to a disaccharide of 30b was observed in the mass spectra from 1 hour 
into the reaction. 
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Relative area % 
Reaction time 
tr = 3.1 min 
(XE11b) 
tr = 7.5 min 
(P1) 
0 min 100 
 
30 min 100 
 
1 h 99.53 0.47 
2 h 98.86 1.14 
4 h 97.22 2.78 
6 h 96.29 3.71 
24 h 94.95 5.05 
 
Table 3.3.4.3j: ENZ 18 tabulated HPLC results 
 
 
 
Figure 3.3.4.3k: ENZ 18 graphical representation of HPLC results 
 
 
The reaction mixture was stopped at 24 hours and the carbohydrate residues acetylated.  
Partial purification was carried out as before, with the disaccharides known to be contained in 
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the fraction ‘flushed’ from the silica-gel chromatography column using 5% MeOH in EtOAc 
after other spots had eluted. 
 
The crude mass spectrum of this fraction contained four major peaks (Table 3.3.4.3l) 
 
MS Peak m/z RMM 
Assignment 
(acetylated sugars) 
comments 
571[M + Na]+ 548 30b 
Major peaks 
701 [M + Na]+ 678 Gal-Gal 
859 [M + Na]+ 836 Gal-DEGNpGlcOMe 40 
989 [M + Na]+ 966 Gal-Gal-Gal 
 
Table 3.3.4.3l: ENZ 18 mass spectrometric analysis of the contents of the ‘flush’ fractions 
 
HPLC separation of this mixture was then carried out (Figure 3.3.4.3m). The three peaks 
were isolated and submitted for mass spectrometric analysis.  The second peak at tr = 33.2 
minutes contained the target disaccharide Gal-DEGNpGlcOMe.  4 mg of disaccharide 40 
was isolated and submitted for 1H, 13C and 2D NMR spectroscopy to determine the 
regiochemistry of the the glycosidic linkage.  Only one regioisomer was found, the full 
spectroscopic assignment is in the Experimental Section (5.3).  
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Figure 3.3.4.3m: HPLC separation of the acetylated material containing the target compound 
from ENZ 18 
 
Full 2D NMR analysis using HSQC, HMBC and COSY90 confirmed that the disaccharide 
possessed a β(1→2) glycosidic linkage (Figure 3.3.4.2n).  This is the same regioselectivity 
observed when NpCH2GlcOMe 32 was employed as the glycosyl acceptor.  We would 
conclude from this that both 32 and DEGNpGlcOMe 34 enter the enzyme active site in a 
different way to EGNpGlcOMe 33 which results in a different regioselectivity (β(1→3) linked 
disaccharide). 
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Figure 3.3.4.3n: “Gal-DEGNpGlcOMe” β-d-(-2,3,4,6-tetra-O-acetyl)-galactopyranoside-(1→2)-α-d-
methyl-((2,3,4-O-acetyl)-6-O-{2-[2-(2-naphthylmethoxy)ethoxy]ethyl}glucopyranoside 40 
 
 
Discussion of structural assignment 
The anomeric carbons are clear at 98.9 and 101.9 ppm in the 13C NMR spectrum. 
Examination of the HMBC spectrum reveals 3J coupling between the protons of the methoxy 
group at C1’ to this carbon at 98.9 ppm.  C1” is thus at 101.9 ppm with HSQC to the 
corresponding anomeric proton H1” at 4.54 ppm; H1’ is at 4.83 ppm.  The glycosidic linkage 
is, as expected, beta; confirmed by the coupling constant 3JH1”-H2” = 8.1 Hz, typical for a β-
linked disaccharide.  COSY90 allows assignment of the protons within the sugar rings which, 
in turn, identifies the carbons within the sugar rings by HSQC (Figure 3.3.4.3m). 
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Figure 3.3.4.3m: confirming the stereoselectivity of the glycosidic bond formation 
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Further examination of the HMBC spectrum in order to determine regioselectivity of 
glycosylation shows 3J coupling from H1” on the galactose ring to C2’ of the glucose ring.  3J 
coupling between H2’ and C1” is also observed, confirming that the glycoside is 1-2 linked 
(Figure 3.3.4.3n). 
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Figure 3.3.4.3n: determining the regioselectivity fo the glycosidic bond formation 
 
 
Summary 
In this part of the project we have successfully used our developed method for carrying out 
transglycosylation reactions, using the β-galactosidase from B. circulans, between lactose 
and two further novel methyl glucosides (33 and 34) functionalised with a naphthyl group at 
C6.   
 
The differences in regioselectivity caused by the naphthyl-functionalised glucosides 32, 33 
and 34 are both interesting and seemingly unusual as this enzyme generally favours β(1→4) 
linkages.  Using 32 and 34 as glycosyl acceptors gave a β(1→2) linkage, whereas 33 gave a 
β(1→3) linkage.  This must be to do with how the glycosyl acceptor sits in the active site of 
the enzyme and is thus presented to the glycosyl donor.   
 
The β(1→3) linked disaccharide was made using a β-methyl glucoside as the glycosyl 
acceptor, unlike the other two which were made with α-methyl glucosides.  Given the 
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promiscuity of the enzyme active site towards the glycosyl acceptor it is unlikely that the 
anomeric configuration of the glycosyl acceptor caused this difference in regioselectivity.  
However, we cannot say with absolute certainty that it did not. 
 
We postulate that it is much more likely that the length of the linker between the methyl 
glucoside and the naphthyl group caused this change in regioselectivity.  The naphthyl group 
is a relatively large, flat, hydrophobic residue which might interact with similar hydrophobic 
amino acid residues in or around the enzyme active site.  No other regioisomers of any of the 
disaccharides made were detected in our analysis, leading us to conclude that these 
transglycosylations are regioselective, and that the selectivity is most likely to be dependent 
on the linker length in the naphthyl-functionalised glycosyl acceptor. 
 
 
3.4 Conclusions upon Completion of the Transglycosylation 
Reactions using the β-Galactosidase from B. circulans 
 
During the course of this project we have investigated established methods to perform 
transglycosylation reactions catalysed by the β-galactosidase from B. circulans.  These 
methods were used successfully to carry out transglycosylation reactions between GalOpNP 
and GlcOMe, resulting in the formation of numerous different disaccharides. 
 
We then optimised the conditions used for the simple transglycosylation reactions for use 
with our three novel glycosyl acceptors 32, 33 and 34.  To do this we successfully overcame 
the aqueous insolubility of these three novel sugars by developing an optimised method 
using MeCN as a co-solvent to the buffer solution.  We quantitatively determined the activity 
of the enzyme in these unnatural conditions and from this were able to increase the enzyme 
function under these conditions by investigating the effect of increasing the amount of 
enzyme added to the reaction.   
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After these optimisation studies we then began work on making disaccharides containing our 
novel sugars.  Using naphthyl functionalised glucoside 32 to begin with, we determined that 
the pH of the reaction solution had a marked effect on enzyme activity; thus, pH 7.0 reaction 
conditions led to much higher enzyme function than pH 5.0.  We found that using GalOpNP 
or lactose as the glycosyl donor had similar effects and thus we could choose the glycosyl 
donor that was most appropriate/convenient for the transglycosylation we were to perform. 
 
The transglycosylation reaction using naphthyl functionalised glucoside 32 resulted in the 
production of a single β(1→2) linked disaccharide, the same glycosidic linkage was made 
when using naphthyl functionalised glucoside 34 as the glycosyl acceptor.  In constrast, 
when naphthyl functionalised glucoside 33 was used, a β(1→3)-linked disaccharide was 
produced.  The length of the linker used to attach the sensitiser to the glycosyl acceptor has 
a profound effect on the regioselectivity of the glycosidic bond formation.  This is most likely 
due to the way in which the glycosyl acceptor sits in the active site.  As previously discussed, 
other groups they have noted a strong preference of the enzyme from B. circulans for 
forming β(1→4) and β(1→6) linked disaccharide.  Because of the position of our sensitiser at 
C6, our novel glycosyl donors do not sit in the active site in the same way to the glycosyl 
acceptors in other studies of the enzyme, so the β(1→2) and β(1→3) glycosidic linkages that 
we have formed are, to our knowledge, particular to the novel glycosyl acceptor that we have 
synthesised. 
 
The purpose of this study was to determine if the enzyme was able to process our novel 
glycoside acceptors, and we have succeeded in that.  With regard to the development of a 
probe for β-galactosidases, the enzyme in its natural function hydrolyses lactose.  Out of the 
three novel naphthyl-functionalised disaccharides made, the β(1→3) linked disaccharide is 
perhaps closest to lactose structurally, as lactose is β(1→4) linked.  We can suggest that 
using a disaccharide with a glycosyl acceptor carrying a sensitiser linked via a relatively 
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short, four atom chain (an ethylene glycol linker in our case) to probe β-galactosidase activity 
may have the best chance of success.   
 
This method of screening for substrates, whilst effective, is very slow due to the long 
synthesis of the functionalised monosaccharides and the capricious nature of some of the 
reactions.  We felt that this screening process could be done more efficiently using a 
combinatorial approach.  By creating a library of glycosyl acceptors, and then glycosyl 
donors, we could screen for suitable substrates for the enzyme more quickly and definitively.  
Chapter 4 discusses our work on forming a combinatorial library of glycosyl acceptors and 
the ability of the enzyme to process this library. 
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Chapter 4       Results and Discussion 
4. A Dynamic Combinatorial Approach to Efficient Screening of 
Novel Substrates for the β-Galactosidase from B. circulans 
 
Combinatorial synthesis is based on efficient, parallel synthesis so that a large number of 
compounds can be generated to make a library of substrates without the need to synthesise 
each component as a separate entity.89  Using a combinatorial technique to generate such a 
library can save a lot of time and money in identifying suitable substrates for drug discovery 
and other research purposes.  The scheme in Figure 4a below outlines the basic principle 
behind the formation of a combinatorial library. 
Figure 4a:  Schematic for a dynamic combinatorial library 
  
The dynamic library is based on reversible connections between a set of building blocks – 
the components of substrates you wish to test – which exist in an ever changing mixture of 
the components.  This should equilibrate over time to form a statistical mixture of all the 
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possible combinations of the starting components, allowing for the simple, one step 
generation of extended libraries.90  At this point the library can be frozen when the 
equilibrium is reached, or further screening can be carried out on the library by adding in 
another component.  Because of the dynamic aspect of the library, it allows for self-screening 
processes that may lead to the preferential expression of active species which shows the 
strongest binding/interaction with that other component.91 
In order  to improve the efficiency of the screening process to identify suitable substrates to 
use in our luminescent probe we turned to combinatorial chemistry as a potentially fast 
method of producing  monosaccharides with a naphthyl group introduced at C6.  We knew 
from our earlier  work that the β-galactosidase from B. circulans can process a methyl 
glucoside with a naphthyl group at C6 as the glycosyl acceptor, but we do not yet know if it 
can accept a similarly functionalised galactoside as the glycosyl donor. We proposed to use 
combinatorial techniques to  find out which linker lengths and types are suitable for use in our 
probe much more easily and efficiently.  We would then identify substrates from the library by 
using the enzyme to ‘choose’ the best-fitting sugars.  Once we have identified the sugars that 
the enzyme is able to process we would then synthesise these individually (in a non-
combinatorial fashion) for use in the probe (Figure 4b). 
 
Figure 4b:  The planned process for our combinatorial library investigation 
Equilibrated 
combinatorial 
library 
Library exposed to 
the enzyme 
Equilibrated library 
frozen 
Individual library 
components 
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Our intention is to generate the library, allow it to equilibrate and then stop the reaction.  This 
static combinatorial library is what will be presented to the enzyme. 
 
4.1 Choosing the Method for the Generation of the Dynamic 
Combinatorial Library 
 
Dynamic combinatorial chemistry relies on reversible bond formation and a wide variety of 
these reactions has been used for dynamic combinatorial applications.  There are a number 
of ways of forming a combinatorial library using reversible covalent bond formation.  The 
early attempts were based on transesterification (Sanders), and then Schiff base exchange 
(Lehn), but transesterification requires harsh conditions.  The hydrazone exchange reaction 
and reversible C=N bond formation have also been used to form libraries of oximes.   
 
However, our attention was caught by the use of disulfides for forming combinatorial 
libraries.92,93  The mechanism of the disulfide exchange reaction had been studied 
extensively by Whitesides94 among others95 and their findings indicate that: 
• disulfides form readily from thiols in the presence of oxygen and small amounts of 
base; 
• disulfide exchange takes place efficiently under mild conditions in the presence of a 
substoichiometric amount of thiol; 
• disulfide exchange is neglible under acidic conditions; 
• disulfides are stable towards many different functional groups.96 
 
A disulfide exchange reaction will fit best with our intended experiments as we do not wish to 
introduce any moieties that differ too much from the ether linkage we are already using.  For 
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example, an imine exchange reaction would introduce a double bond  which would make the 
linkage much more rigid compared to the the single bonds in the ether linkage.  We also 
need to use a mixture of organic and aqueous solvents in the enzyme reaction; an ester 
exchange reaction is driven by removal of water from the system which would therefore not 
be suitable.  The need for pH control is crucial to our plan; we know that our enzyme works 
well at both pH 5 and pH 7 which is ideal for use with the disulfide.  This means we can do 
the disulfide exchange reaction in the pH range 7 – 9 , lower the pH to 5 to stop the reaction 
and add in the enzyme which will function at pH 5. An imine exchange reaction occurs 
between pH 8.5 and pH5 so this would not be compatible with our plans.  
 
The disulfide exchange reaction is compatible with biomolecules as long as surface exposed 
thiol or disulfide groups are not present.97   We do not know what amino acid residues might 
be present in the enzyme active site, however, this should not be a problem as the exchange 
itself will not be done in the presence of the enzyme.   We will be doing the experiments with 
the enzyme at pH 5 which means that disulfide exchange should not be taking place anyway.  
It is important to remember that this work is a screening experiment to find out quickly and 
efficiently what lengths of linker the enzyme will process.  When it comes to later work and if 
the disulfide is not suitable, it can be replaced with a similar functionality such as an ether or 
alkyl linker. 
 
4.2 Synthetic Targets for the Formation of the Dynamic 
Combinatorial Library 
 
To test the viability of using a combinatorial library with the β-galactosidase from B. circulans 
we first investigated conditions for forming the library using the glycosyl acceptor – methyl 
glucose.  Our target substrates would be based on the ether-linked naphthyl sugars that we 
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had made using stepwise synthesis as we knew from our initial investigation that the enzyme 
would accept this type of substrate (32, 33 and 34). 
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Figure 4.2a:  Glycosyl acceptor targets for the use in the dynamic combinatorial library 
 
These target substrates would be generated using combinatorial synthesis from a library 
shown in figure 4.2b. The combinatorial library generated from the components above would 
also contain dimers of all of the substrates. 
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Figure 4.2b: Library components for the glycosyl acceptor dynamic combinatorial library 
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Once the library has been formed, we plan to ‘freeze’ the library at a stage when all the  
desired sugar-naphthyl disulfides have been generated so that no disulfide exchange takes 
place duing the enzyme reaction.  It is not our intention to create a dynamic combinatorial 
library (DCL) for use with the enzyme.  In our case, if the enzyme were to make a 
disaccharide from a DCL of glycosyl acceptors there would be nothing to stop the disulfide 
bond between the glycosyl acceptor and its partner from exchanging with another thiol in the 
mixture.  This would then give us a false result as we would not be able to say definitively 
that the sulfide linked to the glycosyl acceptor was present at the time of the glycosyl 
transfer.  This is why we plan to freeze the library at an optimised point at which we have 
generated a library with the maximum product diversity (Figure 4.2c) and this is what would 
then be put through the trans glycosylation reaction. 
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Figure 4.2c:  Proposed scheme of work for the dynamic combinatorial library studies. 
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Once the viability of this technique has been proven on the glycosyl acceptor we would then 
test it using the glycosyl donor, GalOpNP.  The combinatorial library of glycosyl donors would 
be formed from the components in Figure 4.2d and would generate the sugars shown in 
Figure 4.2e (as well as the homo- and hetero-dimers of the naphthyl functionalised thiols).  
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Figure 4.2d: Library components for the glycosyl donors dynamic combinatorial library 
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Figure 4.2e:  Glycosyl donor targets for the use in the dynamic combinatorial library 
 
In total, for this combinatorial study  we only have to synthesise six components, all of which 
are relatively simple to produce as they can be made from compounds that we have already 
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synthesised or can buy directly.  This makes this approach potentially synthetically efficient 
with a potential fast turnaround on results.   
 
4.2.1 Synthesis of the thiol-functionalised naphthyl linkers 
 
There are four naphthyl linker substrates needed for the combinatorial library (Fig 4.2b).  The 
smallest, 2-naphthylmercaptan was purchased directly; the other three needed to be 
synthesised. 
 
We began our synthesis of the requisite thiols by starting from alcohols and bromides that we 
had already synthesised.  
 
The first reaction we attempted was to form a thiol from the alcohol 24 by refluxing the 
alcohol in conc. HCl with thiourea for 9 hours (Figure 4.2.1a).98   
   
 
 
Figure 4.2.1a: First attempt to convert an alchol 24 into a thiol 
 
Unfortunately this reaction did not work very well.  In the first part of the reaction a less polar 
spot was seen to move to a lower Rf value and there was consumption of starting material.  
However, the yellow oil which resulted from the basic work up procedure contained only 
trace amounts of the target thiol which were detected by EI mass spectrometry.  There was 
no evidence to suggest that we had produced the dimer.   NMR spectroscopy of the oil 
showed a very impure substance. 
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A further attempt of the reaction shown in Figure 4.2.1a was tried without success using the 
same conditions.  We then elected to instead use our previously synthesised bromides as a 
starting point for the synthesis of the thiols.   The bromides were successfully transformed to 
the thiols by heating under reflux with thiourea in ethanol.99  This reaction resulted in a crude 
mixture of both thiols and their disulfide dimers as a dark yellow oil directly from work up.  
The crude yields from this reaction were in the region of 90%.  The crude material obtained 
from this reaction was directly acetylated for ease of purification and characterisation (Figure 
4.2.1c).   
 
Br SAc S
i) 2.2 eq thiourea, 
  EtOH 0.9 M
  reflux 3 h
ii) 2.0 eq Ac2O,
  py 3.0 M, 
  rt overnight
          81%
1.6 eq NaOMe, 
MeOH 0.025 M
41
O
Br
n
i) 2.2 eq thiourea, 
  EtOH 0.9 M
ii) 2.0 eq Ac2O,
  py 3.0 M
 reflux overnight
O
SAc
n
1.6 eq NaOMe, 
MeOH 0.025 M
O
SH
n
O
S
n
O
S
nn = 1 25
n = 2 27
n = 1  43
n = 2  45
n = 1  43a
n = 2  45a
quant.
n = 1  quant.
n = 2  94%
n = 1  quant.
n = 2  quant.
40
n = 1  42
n = 2  44
S
Figure 4.2.1b: Successful syntheses of the thio-naphthyl linkers  
 
Purification of the acetylated thiols by column chromatography worked very well and yields of 
the combined thiol and disulfide products were high, between 84 and 100% over two steps.  
Deacetylation of the thiols was carried out in the usual manner using NaOMe.  This 
sometimes resulted in a mixture of thiols and disulfides or just the disulfide in the case of 46.  
This did not present a problem for forming the library of disulfides as homo-dimers added as 
starting material will be subject to disulfide exchange in the library-forming reaction.  Overall 
this process worked very well and gave us reliable, easy access to our naphthyl-based 
library components. 
 
46 9 
 n = 1  18 
 n = 2  19 
22 
 n = 1  50 
 n = 2  51 
 n = 1  47 
   2  48 
 n    7a 
 n = 2  48a 
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4.2.2 Synthesis of  thio-sugars 
 
4.2.2.1 Synthesis of Methyl-(6-thio-6-deoxy)-α-D-glucopyranoside 
 
6-Thio sugars can be prepared directly from 6-tosyl sugars and since we had previously 
synthesised methyl (6-tosyl)-α-D-glucopyranoside we chose to start from this compound 
(Figure 4.1.2.2a).  
 
 
Figure 4.2.2.1a: Attempted synthesis of 6-deoxy-6-thioacetyl-glucopyranoside 
 
Following a method by Gigg100 the 6-tosyl sugar was treated with potassium thioacetate by 
heating under reflux in methanol.  Gigg reported that this afforded the corresponding 6-thio-
acetyl sugar from a benzyl protected sugar.  We tried it first on the unprotected tosyl sugar as 
this would have given us a shorter route to our target.  Unfortunately, this reaction did not 
work and only starting material was recovered.  This method was also attempted on the 
acetyl protected tosyl sugar but again only starting material was recovered.  We decided not 
to continue with this method as our next step would be to benzyl protect the secondary 
alcohols prior to treatment with potassium thioacetate. This would introduce a longer 
protecting group strategy which we wanted to avoid.  The benzyl groups would have to be 
removed after the thioacetate was installed and replaced with acetates for characterisation.  
So, we chose a different route as detailed below. 
 
Our next approach was based on the use of thiourea to displace bromine in our synthesis of 
the naphthyl components of the library (Section 4.2.1).  When making 6-thio sugars it is usual 
to use iodine rather than bromine as iodine will selectively react at the primary alcohol of a 
O
HO
HO
OMe
HO
OTs
O
HO
HO
OMe
HO
SAc
KSAc 9 eq.
      X
MeOH 0.1 M 
reflux 2 h
9  
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free glycoside.  Figure 4.2.2.1b shows the successful synthesis of methyl 2,3,4-tri-O-acetyl-
(6-acetylthio-6-deoxy)-α-D-glucopyranoside (53). 
 
O
HO
HO
OMe
HO
OH
O
HO
HO
OMe
HO
I
O
AcO
AcO
OMe
AcO
SAc
i) PPh3 1.2 eq., 
I2 1.2 eq., 
imidazole 3.6 eq., 
toluene 0.5 M, 70 oC, 2 h
ii) H2O, rt, 15 min
i) thiourea 1.1 eq.
DMF 0.1 M, 70 oC, 2 d.
ii) NaOH(aq) 0.04 M, 1.8 eq.
∆, 1 h
iii) Ac2O 6 eq., 
py. 3.0 M, rt overnight87 %
46
52%
4712
 
Figure 4.2.2.1b: Successful synthesis of thio acetate 53 via a 6-iodo sugar 
 
The 6-iodo sugar 52 was prepared directly from methyl-α-D-glucose according to a method 
by Murphy.101 The reaction proceeded well and with a good yield of 87%.  The following 
transformation of the 6-iodo group to the 6-thioacetate group102 also proceeded well, 
although in a less satisfactory yield of 52% over the two steps. Again, the acetate-protected 
sugar was made for ease of storage and characterisation.  The deactetylation reaction was 
carried out in the usual manner by addition of NaOMe in MeOH with stirring overnight (see 
Experimental Section).  This furnished 45, methyl-(6-thio-6-deoxy)-α-D-glucopyranoside (see 
Figure 4.2b), in 99% yield, ready for use in the combinatorial library. 
 
4.3 Forming the Combinatorial Library 
 
Design of the conditions to be used for our combinatorial experiments has to be done 
sensitively to the needs of the disulfide exchange reaction and later the trans-glycosylation 
by the β-galactosidase from B. circulans.   A four-stage process to the investigation began 
with gathering the individual components, then involved forming the library and allowing it to 
equilibrate, followed by freezing the equilibrated library and exposing it to the enzyme to 
determine if it can process any of the sugars in the library. 
 
10 
52 53 
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4.3.1 Optimisation of Conditions for the Formation of the Combinatorial 
Library 
 
In order to determine the conditions under which our combinatorial libraries will form, it was 
necessary to consider: 
 
• the solvent and reaction concentration; 
• pH; 
• temperature; 
• method of initiating the disulfide exchange reaction; 
• stoichiometry of the library components. 
 
Our work to find suitable conditions to promote the formation of the combinatorial library and 
optimise them is described below. 
 
 
Initial investigation to identify suitable reaction conditions for the disulfide 
exchange reaction 
 
From our experience in the enzyme experiments, we knew that it would be necessary for 
some organic solvent to be present in the reaction mixture so that all components of the 
reaction would be fully dissolved – this is true for both the disulfide exchange and the trans-
glycosylation.  Our intention was to form the library under solvent conditions that would also 
be compatible with the enzyme.  Having already done a very thorough screening test on the 
solvent conditions under which the enzyme would function (see Section 3), we needed to 
investigate if any of those sets of conditions would work for the disulfide exchange.  Once we 
had established the solvent conditions for the disulfide exchange and the enzyme reaction, 
we would then form the library at pH 7.   When it had equilibrated the pH would be lowered to 
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5 to stop the disulfide exchange after which the enzyme would be added.  The enzyme 
reaction would then be followed by HPLC and MS to establish whether any of our target 
disulfide linked sugar-naphthalene compounds were generated.  
 
Our initial experiment involved the disulfide exchange on just two of the library components 
(Figure 4.3.1a).   
 
SH
40
O
HO
HO
OMe
HO
SH
48  
Figure 4.3.1a: First test subjects for forming the combinatorial library 
 
The disulfide exchange reaction is mediated by deprotonated thiol.  A reaction pH of 7 – 9 is 
usually adequate in order to generate enough thiolate anion for the reaction to proceed.  
There are two ways of starting the exchange reaction: i) using thiols in the presence of air; ii) 
using substoiciometric amounts of free thiol.97  Which of these methods to use will depend on 
the solvent used for the exchange reaction and the susceptibility of the thiol components to 
be oxidised in the presence of air. 
 
Comparing the two compounds in Figure 4.3.1a, it is apparent that their solubility will be very 
different.  A brief test confirmed that whilst the sugar 45 was partially soluble in a pH 7 buffer 
solution, (2-naphthyl)methanethiol (46) was not.  We therefore decided to first establish a 
method for the disulfide exchange between the two library components in organic solvent.   
However, this would not be compatible with the conditions needed for the enzyme 
experiment as the amount and type of organic solvent needed for the disulfide exchange 
would potentially inhibit the enzyme.  To get around this problem we came up with a simple 
solution:  to do the disulfide exchange in organic solvent and once it had equilibrated to 
remove the solvent under reduced pressure.  The resultant combinatorial library residue 
45 46 
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would then be taken up in a pH 5.0 buffer with 20% acetonitrile in order to perform the 
enzyme experiments. We expected the sugar-naphthalene compounds to be soluble in these 
conditions as the similar compounds we had tested in the preceding enzyme experiments 
were soluble enough to undergo the enzymatic reaction.  Moreover, any mixed naphthalene-
naphthalene disulfides should not be soluble in and would therefore not interfere with the 
enzyme experiment. 
 
We tested solvent conditions for the exchange reaction by adapting a method by Still et al.103 
for a non-aqueous disulfide exchange.  We used a mixed solvent system due to the different 
solubilities of 45 and 46. Two separate 8.6 mM solutions were made up: (A) 45 in MeOH and 
(B) 46 in CHCl3 .  1 mL of B was added to 0.5 mL of A and 2.3 mol% of an activating solution 
of thiophenol and Et3N was added (Figure 4.3.1b).   
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Figure 4.3.1b: Attempted initial screening reaction for disulfide bond formation 
 
20 µL aliquots were taken at 10, 30, 60 and 120 minutes and examined by HPLC and MS to 
check for the formation of any of the mixed disulfides we hoped to generate.  Since no mixed 
disulfides were found (neither the target nor the possible by product), we then resorted to a 
broader screening experiment in order to find a set of reaction conditions that would work. 
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4.3.1.1 Refinement of reaction conditions for disulfide exchange 
 
We began by addressing each issue that would affect the exchange reaction in order to 
design an optimal screening experiment. 
 
Stoichiometry:  It is stated in a paper by Nicolaou et. al.104 that: 
“If two homodimeric disulfides, A-SS-A and B-SS-B are mixed under basic conditions in the 
presence of a suitable catalyst they will undergo rapid exchange reactions to afford a 
statistical mixture of 3 disulfides A-SS-A, A-SS-B, B-SS-B in a ratio of 1:2:1 respectively, 
resulting from the degeneracy of A-SS-B and B-SS-A products.” 
  
This holds true if the homodimeric disulfides in question have similar activities to each other, 
and this depends upon sterics, pKa etc.  In our case, the starting thiols are similar to each 
other in terms of sterics (see Figure 4.2b) and the pKa values can also be approximated from 
available data (Figure 4.3.1.1a).   
 
SH
HS
O
SH
pKa 6.6 pKa 9.4 pKa 9.4  
Figure 4.3.1.1a: pKas of relevant thiols
105
 
 
Given this information we decided that the stoichiometry of our reaction components should 
be 1:1 sugar to naphthyl linker in order to maximise the amount of mixed disulfides produced.  
 
Activation of the exchange reaction: The disulfide exchange reaction needs to be 
activated. For this, the reaction solution should be basic and contain a substoiciometric 
amount of free thiol.  We would use an activating solution of thiophenol and Et3N since this is 
a common reagent combination for inducing the disulfide exchange reaction. We would try 
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adding varying amounts of the activating solution to the reaction and also investigate if 
adding additional activating solution over the course of the reaction had an effect on the 
exchange reaction.  
 
Figure 4.3.1a shows the two components we will be using to investigate optimal reaction 
conditions.  We would expect thiols 45 (sugar) and 46 (naphthyl) to have a pKa of ~9.5 by 
comparison with the thiols in Figure 4.3.1.1a.  Thiophenol is used to activate the disulfide 
exchange reaction in the presence of base (Et3N) as it has a lower pKa and is thus more 
susceptible to deprotonation than 45 and 46. We must also bear in mind that following 
deacetylation of the acetate-protected thiols some disulfide homodimers may be present.  
For this reason it is necessary to add the thiophenol to ensure activation of the disulfide 
exchange reaction.   
 
Reaction solution and temperature: The other two factors to investigate were the reaction 
concentration itself which tends to be quite low, between 1 and 10 mM, and the temperature 
of the reaction.  The solvents used also need to be miscible, so a standard solution of 46 
would be made up in CHCl3 whilst two standard solutions of the thio sugar 45 would be made 
up in MeOH and acetone. 
 
The first reaction we had tried had a concentration of 8.6 mM, so we planned to investigate 
reaction concentrations of 5 and 10 mM which seemed a good starting point either side of 
the literature suggestion. 
 
Heating can increase the rate of disulfide exchange which is desirable as many of these 
types of reactions can take days to equilibrate at room temperature.  Given the boiling points 
of the solvents we planned to use (CHCl3, MeOH and acetone), a reaction temperature of 40 
oC was chosen. 
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Having decided on the variables for the screening reaction, we set up an experiment to 
simultaneously test 12 sets of conditions. 
 
DCC1  Screening reaction to determine the best conditions for the generation of the 
combinatorial library 
 
Using a 12-reaction carousel, 1 mL of each of the equimolar solutions of the thio sugar and 
the thio-napthyl compound (stoichiometry thus 1:1) were mixed and stirred at 40 oC with the 
activating solution.  The concentration of the reaction and the amount of activating solution 
added is detailed in Table 4.3.1.1b.  Aliquots (40 µL) were taken at 0, 24, 48 and 72 h, then 
diluted in 500 µL of MeOH prior to analysis by MS.  
 
Reaction 
number 
46 
solvent 
46 
conc m/M 
45 (MeOH) 
conc /mM 
x equiv. of 
activating solution 
Activating 
solution added: 
i CHCl3 5 5 0.3 daily 
ii CHCl3 5 5 0.6 daily 
iii CHCl3 10 10 0.3 daily 
iv CHCl3 10 10 0.6 daily 
v acetone 5 5 0.3 daily 
vi acetone 5 5 0.6 daily 
vii acetone 10 10 0.3 daily 
viii acetone 10 10 0.6 daily 
ix CHCl3 5 5 0.6 once 
x CHCl3 10 10 0.6 once 
xi acetone 5 5 0.6 once 
xii acetone 10 10 0.6 once 
 
Table 4.3.1.1b: Reaction conditions for experiment DCC1 
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Results from mass spectrometry of each sample 
 
Each sample was analysed using mass spectrometry for the presence of sugar disulfides 
shown in Figure 4.3.1.1c. Hetero- and homo-dimers of (2-naphthyl)methanethiol and 
thiophenol were not monitored as the compounds of interest are the sugars.  
O
HO
HO
OMe
HO
S
S
O
HO
HO
OMe
HO
S
O
OH
OH
OMe
OH
S
O
HO
HO
OMe
HO
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S
GlcOMe-S-S-CH2NpGlcOMe-S-S-GlcOMe GlcOMe-S-S-Ph  
Figure 4.3.1.1c: Disulfide targets - glucosides 
 
In order to determine the optimum conditions for the formation of our combinatorial library we 
compared the ratio of the peak heights of the disulfides above (Fig 4.3.1.1c) in the mass 
spectra.  An example of the mass spectra recorded is below (Fig 4.3.1.1d).  By comparing 
the peak heights due to the three expected sugar disulfides this will give us an indication of 
the ratio of the components and thus allow us to semi-quantitatively assess when the 
disulfide exchange reaches equilibrium. 
 
 
 
 
 
 
 
 
 
Figure 4.3.1.1d: Example mass specrum from experiment DCC1, 
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The peaks of interest are: 
 
Disulfide RMM M 
GlcOMe-S-S-Ph 318 341 (+ 23) 
GlcOMe-S-S-CH2Np 382 405 (+ 23) 
GlcOMe-S-S-GlcOMe 418 441 (+ 23) 
 
 
Table 4.3.1.1e:  Target peaks in mass spectra analysis 
 
We measured the heights of the peaks of interest shown in Table 4.3.1.1e for each sample 
and assessed the ratio of products in each combinatorial reaction.  The peak heights 
obtained for GlcOMe-S-S-GlcOMe have been doubled in the comparison as the thio sugar 
starting material was added as a monomer.  Again, this investigation will give us an 
indication of the most suitable reaction conditions in a semi-quantitative fashion. 
 
Within the results we looked for the reactions conditions that matched or bettered our 
theoretical ratio of 1:2 GlcOMeSH:GlcOMe-S-S-CH2Np, where the latter is our target 
compound.  Table 4.3.1.1f shows the ratios of the peak heights obtained in the twelve 
experiments (refer to Table 4.3.1.1b for reaction conditions).  Selected bar graphs showing 
the ratio of peak heights follow Table 4.3.1.1f.  The most promising sets of results are 
highlighted. 
 
 
 
 
 
 
179 
 
reaction Disulfide** 0 h 24 h 48 h 72 h 
i GlcOMeSH 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.0 0.9 2.1 2.1 
GlcOMe-S-S-Ph 0.0 0.3 0.9 1.5 
ii GlcOMeSH 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.0 3.0 2.5 2.5 
GlcOMe-S-S-Ph 0.0 1.1 2.2 2.9 
iii GlcOMeSH 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.0 0.7 1.7 1.8 
GlcOMe-S-S-Ph 0.0 0.3 0.7 1.2 
iv GlcOMeSH 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.0 1.2 1.7 1.8 
GlcOMe-S-S-Ph 0.0 0.8 1.4 1.9 
v GlcOMeSH 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.0 2.0 2.1 2.0 
GlcOMe-S-S-Ph 0.0 0.4 1.1 1.4 
vi GlcOMeSH 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.0 1.4 2.4 2.4 
GlcOMe-S-S-Ph 0.0 0.7 2.2 2.8 
vii GlcOMeSH 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.0 0.8 1.3 1.8 
GlcOMe-S-S-Ph 0.0 0.3 0.7 1.3 
viii GlcOMeSH 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.0 1.3 2.2 2.5 
GlcOMe-S-S-Ph 0.0 0.8 2.0 2.1 
ix GlcOMeSH 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.0 2.5 2.5 1.6 
GlcOMe-S-S-Ph 0.0 1.2 1.2 0.8 
x GlcOMeSH 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.0 0.9 1.5 1.4 
GlcOMe-S-S-Ph 0.0 0.7 0.8 0.7 
xi GlcOMeSH 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.0 1.6 1.8 1.8 
GlcOMe-S-S-Ph 0.0 0.8 1.1 1.0 
xii GlcOMeSH 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.0 1.2 1.5 1.6 
GlcOMe-S-S-Ph 0.0 0.9 1.0 0.9 
 
Table 4.3.1.1f: comparison of peak height ratios found in mass spectra for DCC1 
                                                           
** GlcOMeSH is shown rather than the dimer as the comparison must be made with the amount of starting 
material added.  GlcOMeSH was added as the thiol but during the exchange reaction it exists solely as the dimer  
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Figure 4.3.1.1g: peak height ratios from reaction ii (CHCl3, 5 mM, 0.6 eq. daily addition) 
 
 
Figure 4.3.1.1h: peak height ratios from reaction ii (CHCl3, 5 mM, 0.6 eq. single addition) 
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The data collected†† show that our target product, GlcOMe-S-S-CH2Np, was successfully 
produced in all twelve test reactions.  This was a very pleasing result, more so that the 
majority of reactions produced a good proportion of this target disulfide.  Figure 4.3.1.1g 
shows the results from reaction ii, in this reaction 0.6 equivalents of the activating solution 
were added each day.  At 24 hours the ratio of GlcOMeSH to GlcOMe-S-S-CH2Np to 
GlcOMe-S-S-Ph is 1:3:1.  Due to the daily addition of 0.6 equivalents of activating solution at 
72 hours the ratio of GlcOMeSH to GlcOMe-S-S-CH2Np is around 1:2 but the relative 
amount of GlcOMe-S-S-Ph is greater than the target disulfide.  In contrast, Figure 4.3.1.1h 
shows the results from reaction ix where there was a single addition of 0.6 equivalents of the 
activating solution, the other reaction conditions are as in reaction ii.  This shows a much 
more promising result as the ratio of GlcOMeSH to GlcOMe-S-S-CH2Np is around 1:2 at 24 
and 48 hours and the relative amount of GlcOMe-S-S-Ph is much less than the target 
disulfide as less thiophenol is added.  At 72 hours, the relative amount of GlcOMe-S-S-
CH2Np has fallen so the optimum point at which to freeze the library from reaction ix would 
have been 48 hours.  For reaction ii, it would have been 24 hours. 
 
The reactions conditions which produced the target values of 1:2 starting material to target 
disulfide shared one particular factor:  the reaction concentration was 5 mM (See Table 
4.3.1.1i).   
Reaction 
number 
46 
solvent 
46  
conc m/M 
45 (MeOH) 
conc /mM 
x equiv. of 
activating solution 
Activating 
solution added: 
i CHCl3 5 5 0.3 daily 
ii CHCl3 5 5 0.6 daily 
v acetone 5 5 0.3 daily 
ix CHCl3 5 5 0.6 once 
 
Table 4.3.1.1i: Summary of reaction conditions giving the most promising results from DCC1 
 
                                                           
††
 The rest of the graphs showing the results from this experiment are in the Appendix, Section 4.3.2.1. 
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Of the twelve sets of reaction conditions the most promising were those for reaction ix:  
• 40 oC 
• 48 h 
• 5 mM reaction concentration 
• thio-naphthyl linker in CHCl3 
• sugar in MeOH 
• 0.6 equiv. of activating solution – single addition at t = 0 
 
A deciding factor in choosing this set of conditions was the single addition of the activating 
solution.  When adding more of the activating solution each day, the amount of GlcOMe-S-S-
Ph will increase which is undesirable.  The ratio of starting material to desired product using 
reaction conditions ix was 1.0:2.5, and although a higher ratio of 1.0:3.0 was seen using 
reaction conditions ii (the same conditions as ix but with daily addition of activating solution) 
we felt it best to use the conditions requiring less activating solution as this would ultimately 
lead to less by product. 
 
4.3.1.2 Further analysis of combinatorial library products 
 
To confirm that the desired disulfide GlcOMe-S-S-CH2Np had been produced in the 
reactions, preparative HPLC was carried out on a pooled mixture from all twelve test 
reactions.   
 
Analytical HPLC on the pooled samples revealed four UV-active peaks, those corresponding 
to sugar-naphthyl disulfides were found between 25 – 30 minutes, whilst those at 45 – 50 
minutes corresponded to naphthyl-thiol dimers and mixed disulfides.  Preparative HPLC was 
then used to separate the pooled reaction mixture.  The UV-active fractions were submitted 
for analysis by mass spectrometry.  The mixed disulfides GlcOMe-S-S-Ph and GlcOMe-S-S-
CH2Np were found at tr = 25.24 and tr = 28.95 min respectively.   
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Disulfide Mass recovered / mg Moles Yield wrt thiosugar 
 
GlcOMe-S-S-Ph 
9 2.83 x 10-5 17% 
GlcOMe-S-S-CH2Np 4 1.05 x 10
-5 6% 
 
Table 4.3.1.2a: Yields of glucosidic hetero disulfides from DCC1 – pooled reaction contents 
 
It can be seen from the results in Table 4.3.1.3a that the yield of our desired disulfide was 
very low when taken across all twelve reactions.  This was not a concern as this investigation 
was purely to discover a reliable method of forming a combinatorial library.  However, the 
amount of by-product due to thiophenol is almost three times that of our desired sugar.  We 
expect that our chosen best method, which has a single addition of the activating solution, 
will limit the amount of thiophenol by-products produced. 
 
These two compounds were then submitted for NMR to confirm their structures.  Using 1H 
and 13C NMR spectroscopy, the structure of the sugar GlcOMe-S-S-CH2Np was confirmed to 
be that shown in Figure 4.3.1.1c. 
 
4.3.1.3 Repeating the successful reaction conditions 
 
A larger scale reaction using the chosen conditions from the initial screening experiment was 
then undertaken to follow the progress of the reaction more closely.  The intention was also 
to use the resultant combinatorial reaction mixture in a test reaction with the enzyme. 
 
DCC2 larger scale reaction conditions ix 
The experiment was carried out in the same way as in the preceding section.  Two identical 
reactions were done on a slightly larger scale – 8 mL rather than 4 mL reaction volume – and 
under the following conditions: 
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• 40 oC 
• 48 h 
• 5 mM reaction concentration; thio-naphthyl linker in CHCl3, sugar in MeOH 
• 0.6 equiv. of activating solution – single addition 
Aliquots were taken at more frequent intervals (0, 1, 2, 4, 6, 8, 24, 30 and 48 h) so that the 
evolution of the desired products could be inspected more closely by mass spectrometry. 
 
As before, we compared the relative peak heights seen in the mass spectra for the three 
compounds of interest (shown in Table 4.3.1.3a and Figures 4.3.1.3b and c).   
 
reaction disulfide 0 h 1 h 2 h 4 h 6 h 8 h 24 h 30 h 48 h 
A GlcOMeSH 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.2 0.2 0.3 0.4 0.5 0.6 1.4 1.6 1.9 
GlcOMe-S-S-Ph 0.0 0.1 0.1 0.2 0.3 0.3 0.6 0.7 0.9 
B GlcOMeSH 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
GlcOMe-S-S-CH2Np 0.2 0.2 0.3 0.5 0.7 0.6 1.2 1.7 2.1 
GlcOMe-S-S-Ph 0.0 0.1 0.1 0.3 0.4 0.3 0.5 0.6 0.7 
 
Table 4.3.1.3a: Relative mass spectra peak heights of components in experiment DCC2 
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Figure 4.3.1.3b: DCC2 experiment A results 
 
 
Figure 4.3.1.3c: DCC2 experiment B results 
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The ratio of components GlcOMeSH to GlcOMe-S-S-CH2Np at 48 hours is 1:2, which is 
consistent with our results from the initial screening reaction (1:2.5, see Table 4.3.1.2f, 
reaction ix).  A small amount of GlcOMe-S-S-CH2Np can be seen at the very start of the 
reaction, indicating that the disulfide exchange reaction begins immediately upon adding the 
activating solution.  The amount of the target disulfide then increased steadily until the 
reaction was stopped at 48 hours (the point at which the predicted optimum ratios of 
components had been reached in the screening reaction).  No further characterisation was 
carried out on these two libraries. 
 
The results from this larger scale combinatorial library confirmed that we had designed and 
selected suitable reaction conditions for the generation of our combinatorial library. However, 
before we investigated the formation of the larger library featuring all of the thio-naphthyl 
linkers we performed a test reaction of the small test library with the enzyme.  At this stage 
we needed to test our plan to remove the organic solvent from the library, take up the residue 
in a pH 5 solution and then add the enzyme. 
 
4.3.2 Investigation into the use of the β-galactosidase from B. circulans 
with a test combinatorial library 
 
Using the pooled combinatorial libraries from experiments DCC1 and DCC2 we attempted a 
trans-glycosylation reaction using the β-galactosidase from B. circulans (Figure 4.3.2a). 
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Figure 4.3.2a:  Scheme for the test reaction using the glycosyl acceptor disulfide library with 
the β-galactosidase from B. circulans 
 
 
The free thiol-sugar 45 (initially present in the combinatorial library synthesis) may function 
as a glycosyl acceptor.  However, the combinatorial libraries had been examined by mass 
spectrometry and no peaks corresponding to the thio-sugar 45 had been found.  Any 
disulfides of the (2-naphthyl)methanethiol and thiophenol are not soluble in aqueous solution, 
and would not be expected to take any part in the enzyme reaction. 
 
DCC3 
The set of reaction conditions we had developed for the enzyme experiments (see Chapter 
3) would now be applied to this test reaction, with a few slight differences, as shown in Table 
4.3.2b. 
Conditions: enzyme experiments  enzyme/combinatorial library  
   
reaction conc. 
(wrt acceptor) 
0.4 M (20% MeCN) 0.2 M (20% MeCN) 
acceptor:donor 7:1 7:1 
pH pH 7 phosphate buffer pH 5 acetate buffer 
temperature 30 oC 30 oC 
units of enzyme 19.6/mmol acceptor 19.6/mmol acceptor 
Table 4.3.2b: Differences between the original enzyme experiment conditions and those we 
would use for the combinatorial library 
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We would halve the concentration for this enzyme reaction to aid the solubility of the library 
components. In the previous enzyme experiment a reaction concentration of 0.4 M was 
found to be optimal although the naphthyl-functionalised sugars were only partially soluble at 
that concentration.  We found that that the disulfide sugars had a lower solubility in the buffer 
solution, hence decreasing the concentration to 0.2 M.  This concentration has been shown 
to still allow the β-galactosidase mediated trans-glycosylation to occur (Chapter 3). 
 
As previously discussed, the enzyme reaction will done at pH 5 rather than pH 7.  This is so 
that no disulfide exchange can take place during the enzyme reaction.   
 
The rest of the reaction conditions would be the same as used previously for the enzyme 
experiments.   
 
4.3.2.1 Examination of the results from mass spectrometry 
 
Owing to the very small aliquot volume taken from the reaction solution (5 µL in this case 
compared to 40 and 24 µL in the two previous experiments respectively) it is not reasonable 
to attempt to quantify any peak height ratios seen in the mass spectra.  In this instance we 
simply look for the presence of peaks that correspond to any possible reaction constituents. 
 
Table 4.3.2.1a shows the peaks found in the mass spectra at various points in the 
experiment, Figure 4.3.2.1b shows the structures of the compounds found in the mass 
spectra. 
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Reaction time/h Peaks m/z Components RMM 
0 Error with sample – no peaks recorded 
1 341 GlcOMe-S-S-Ph 318 
405 
GlcOMe-S-S-CH2Np 382 
409 
441 GlcOMe-S-S-GlcOMe 418 
486 Gal-Gal-O-pNp  463 
2 405 
GlcOMe-S-S-CH2Np 382 
409 
441 GlcOMe-S-S-GlcOMe 418 
486 Gal-Gal-O-pNp  463 
567 Gal-GlcOMe-S-S-CH2Np 526 
3 341 GlcOMe-S-S-Ph 318 
405 
GlcOMe-S-S-CH2Np 382 
409 
441 GlcOMe-S-S-GlcOMe 418 
486 Gal-Gal-O-pNp  463 
567 Gal-GlcOMe-S-S-CH2Np 526 
4 341 GlcOMe-S-S-Ph 318 
405 
GlcOMe-S-S-CH2Np 382 
409 
441 GlcOMe-S-S-GlcOMe 418 
486 Gal-Gal-O-pNp  463 
503 Gal-GlcOMe-S-S-Ph 462 
567 Gal-GlcOMe-S-S-CH2Np 526 
5 441 GlcOMe-S-S-GlcOMe 418 
486 Gal-Gal-O-pNp  463 
567 Gal-GlcOMe-S-S-CH2Np 526 
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6 405 
GlcOMe-S-S-CH2Np 382 
409 
441 GlcOMe-S-S-GlcOMe 418 
486 Gal-Gal-O-pNp  463 
503 Gal-GlcOMe-S-S-Ph 462 
567 Gal-GlcOMe-S-S-CH2Np 526 
24 405 
GlcOMe-S-S-CH2Np 382 
409 
441 GlcOMe-S-S-GlcOMe 418 
486 Gal-Gal-O-pNp  463 
503 Gal-GlcOMe-S-S-Ph 462 
567 Gal-GlcOMe-S-S-CH2Np 526 
 
Table 4.3.2.1a: peaks found in the mass spectra during the enzyme experiment DCC3 
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Figure 4.3.2.1b:   structures and RMM of the compounds found in the mass spectra for DCC3. 
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We were extremely pleased to see the appearance of a peak corresponding to a 
disaccharide of galactose and GlcOMe-S-S-CH2Np.  At 2 hours, the peak at 567 m/z 
corresponded to Gal-GlcOMe-S-S-CH2Np (526 + 41); this same peak was then seen in each 
aliquot after 2 hours.  At 4 hours, a peak at 503 m/z corresponding to Gal-GlcOMe-S-S-Ph 
(462 + 41) was also observed. 
 
4.3.2.2 Examination of the results from HPLC 
 
Each of the aliquots submitted for mass spectrometry was also submitted for HPLC.  From 
the initial aliquot at 0 hours, new peaks are seen as the reaction progresses.  
 
In order to identify which peaks correspond to which reaction product it was necessary to 
submit the entire reaction mixture for preparative HPLC.  Mass spectrometry was then 
performed on each of the peaks obtained from this separation, the results from this are 
summarised in Table 4.3.2.1c below: 
 
Retention time/min m/z  Component 
14.0 603 Gas-phase dimer Gal-O-pNp + 1 
15.2 441 GlcOMe-S-S-GlcOMe +23 (Na) 
16.4 486 Gal-Gal-O-pNp +23 (Na) 
16.9 485 Gal-GlcOMe-S-S-Ph +23 (Na) 
21.0-23.0 
503 Gal-GlcOMe-S-S-Ph +41 (MeCN) 
665 Gal-Gal-GlcOMe-S-S-Ph +41 (MeCN) 
23.8 – 25. 567 Gal-GlcOMe-S-S-CH2Np +41 (MeCN) 
28.7 405 GlcOMe-S-S-CH2Np +23 (Na) 
 
Table 4.3.2.1c:  Results from the HPLC analysis and separation of the products from 
experiment DCC3 – the desired disaccharides containing a naphthyl- (or phenyl-) 
functionalised sugar are highlighted. 
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The highlighted section of the table shows the results of interest.  The disaccharide Gal-
GlcOMe-S-S-CH2Np can be clearly seen between 23.8 and 25.0 minutes retention time. 
Interestingly, and unsurprisingly, the disaccharide of GlcOMe-S-S-Ph (Gal-GlcOMe-S-S-Ph) 
can also be seen, though it has a shorter retention time.  A trisaccharide is also observed 
between 21-23 minutes Gal-Gal-GlcOMe-S-S-Ph. 
 
4.3.2.3 Summary from the first enzyme reaction using a test combinatorial library 
 
We were extremely pleased that during the experiment we detected the presence of di- and 
tri-saccharides of the disulfide sugars from the combinatorial library. It is clear from our 
results that our treatment of the combinatorial library and the conditions used for the enzyme 
study that our method is suitable for determining if the β-galactosidase from B. circulans can 
process our disulfide sugars.   
 
 
4.3.3 Formation of a combinatorial library of mixed glucose and naphthyl 
disulfides 
 
Up to this point we had established a set of reaction conditions for the formation of the 
combinatorial library and had also successfully used the test library with the enzyme.  The 
next task was to form the whole combinatorial library using the components shown in Figure 
4.2b (also shown in Figure 4.3.3a below).  
 
In terms of stoichiometry, all of the library components should be in employed in equimolar 
amounts in order to generate the maximum amount possible of sugar-naphthyl disulfides.  
This means that there must be a 1:1 ratio of the thio sugar to each of the thio naphthyl linkers 
giving an overall 4:1:1:1:1 stoichiometry (Figure 4.3.2a).   
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Figure 4.3.3a Library components and ratios for the glycosyl acceptor dynamic combinatorial 
library 
 
 
We would expect the experiment to result in the formation of nineteen disulfides (16 mixed, 5 
dimers) from the library components, all of the possible desired mixed disulfides (sugar-
naphthyl disulfides) we would expect from this experiment are shown in Figure 4.3.3b. 
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Figure 4.3.3b:  Glycosyl acceptor targets for the use in the dynamic combinatorial library 
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In order to form the library we used the successful conditions from DCC1.  Using a 12-
reaction carousel 12 identical reactions were set up in order to test the reproducibility of the 
method.  5 mM standard solutions were made up of all five components of the library.  One 
condition we did change was the omission of thiophenol as part of the activating solution.  
Since we were using 2-naphthalene thiol as a library component, we would expect this to 
have a similar pKa to thiophenol and thus initiate the disulfide exchange reaction in the same 
way. 500 µL aliquots were taken at 0, 2, 4, 6, 24, 48, 72, 96 hours.  There was no discernible 
change in the mass spectra of the libraries from 72 to 96 hours, but to be sure that 
equilibrium had been reached a final set of aliquots was taken at 11 days.  The mass spectra 
from these final aliquots showed no discernible change from those taken at 96 hours so the 
reaction was then stopped.   Acetic acid was added to each reaction solution to freeze the 
libraries in that equilibrated state. 
 
 
4.3.3.2 Analysis of the data from the formation of the combinatorial library of 
mixed glucose and naphthyl disulfides 
 
Table 4.3.3.1a lists the peaks found by mass spectrometry across all twelve library forming 
reactions.   Mixed disulfides and dimers due to naphthyl thiols are not noted here unless they 
are also possible candidates for peaks.  At this stage we are only interested in evidence of 
the formation of the sugar-naphthyl disulfides.  Mass spectrometry was done on all of the 
separate components of the library and peaks found in those spectra were useful when 
considering how to assign peaks in the mass spectra recorded for the formation of the 
library. 
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Reaction time/h Peaks m/z Components RMM 
0 441 GlcOMe-S-S-GlcOMe + Na 418 
1 441 GlcOMe-S-S-GlcOMe + Na 418 
2 405 GlcOMe-S-S-CH2Np + Na 382 
441 GlcOMe-S-S-GlcOMe + Na 418 
4 405 GlcOMe-S-S-CH2Np + Na 382 
441 GlcOMe-S-S-GlcOMe + Na 418 
6 405 GlcOMe-S-S-CH2Np + Na 382 
441 GlcOMe-S-S-GlcOMe + Na 418 
24 405 GlcOMe-S-S-CH2Np + Na 382 
441 GlcOMe-S-S-GlcOMe + Na 418 
457 
NpCH2EG-S-S-EGCH2Np + Na 
NpCH2-S-S-DEGCH2Np + Na 
434 
434 
493 GlcOMe-S-S-DEGCH2Np + Na 470 
501 NpCH2EG-S-S-DEGCH2Np + Na 478 
48 405 GlcOMe-S-S-CH2Np + Na 382 
441 GlcOMe-S-S-GlcOMe + Na 418 
449 GlcOMe-S-S-EGCH2Np + Na 426 
457 
NpCH2EG-S-S-EGCH2Np + Na 
NpCH2-S-S-DEGCH2Np + Na 
434 
434 
493 GlcOMe-S-S-DEGCH2Np + Na 470 
501 NpCH2EG-S-S-DEGCH2Np +Na 478 
72 405 GlcOMe-S-S-CH2Np + Na 382 
441 GlcOMe-S-S-GlcOMe + Na 418 
449 GlcOMe-S-S-EGCH2Np + Na 426 
457 
NpCH2EG-S-S-EGCH2Np + Na 
NpCH2-S-S-DEGCH2Np + Na 
434 
434 
493 GlcOMe-S-S-DEGCH2Np + Na 470 
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501 NpCH2EG-S-S-DEGCH2Np +Na 478 
96 405 GlcOMe-S-S-CH2Np + Na 382 
441 GlcOMe-S-S-GlcOMe + Na 418 
449 GlcOMe-S-S-EGCH2Np + Na 426 
457 
NpCH2EG-S-S-EGCH2Np + Na 
NpCH2-S-S-DEGCH2Np + Na 
434 
434 
493 GlcOMe-S-S-DEGCH2Np + Na 470 
501 NpCH2EG-S-S-DEGCH2Np +Na 478 
11 days 405 GlcOMe-S-S-CH2Np + Na 382 
441 GlcOMe-S-S-GlcOMe + Na 418 
449 GlcOMe-S-S-EGCH2Np + Na 426 
457 
NpCH2EG-S-S-EGCH2Np + Na 
NpCH2-S-S-DEGCH2Np + Na 
434 
434 
493 GlcOMe-S-S-DEGCH2Np + Na 470 
501 NpCH2EG-S-S-DEGCH2Np +Na 478 
 
Table 4.3.3.1a: results from analysis of the mass spectra carried out on all sample taken from 
experiment DCC4 
 
By examining the peaks found in the mass spectra of all twelve reactions over the whole time 
of the experiment we can say that we have formed a number of mixed sugar-naphthyl 
disulfides.  There are points to consider when evaluating these results however.    It was only 
at 24 hours that we began to see peaks at 493 m/z (corresponding to GlcOMe-S-S-
DEGCH2Np + Na) without having to examine the peaks near to the baseline of the spectrum.  
The new peaks emerging as time progressed were all initially identified by expansion of the 
baseline of the spectra. Also, the peak at 405 m/z is present in the mass spectrum of 48 as 
an impurity (MS of this compound alone prior to use in the library contained this peak). It is 
therefore unlikely that any material at this m/z prior to 24 hours – when other sugar-naphthyl 
disulfides began to show – is due to GlcOMe-S-S-CH2Np + Na.   
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Another point to note is that the results from the mass spectra indicate that we appear to 
have made just three of our target four sugar-naphthyl disulfides.  There is no evidence that 
the disulfide from thio-sugar 45 and 2-naphthylmercaptan was formed, since we expected 
this to react in a similar way to the thiophenol activator we had used in previous experiments 
we were surprised at the absence of this disulfide.  In our first two successful combinatorial 
library syntheses the peaks due to the sugar-naphthyl and sugar-phenyl disulfides were very 
prominent, eventually becoming much higher than the peaks due to the starting sugar (see 
Section 4.3.1.1).  In this larger library the peaks in the mass spectra due to our target sugars 
are relatively small in comparison to that due to the thio-sugar starting material.   
 
This means that we cannot say anything about the quantity of target disulfides produced or 
estimate a ratio.  In order to confirm that we had produced the three target sugars found in 
the mass spectrometry results we pooled the reaction solutions and submitted them for 
HPLC analysis.  Using the same HPLC conditions as in CCEXP7X we targeted the section at 
25 – 30 minutes retention time which had been shown to correspond only to UV active sugar-
naphthyl disulfides (see Section 4.3.1.3).  The peaks in this region were isolated as a 
group and then the sample submitted for mass spectrometry.  To our delight the mass 
spectrum showed three peaks, corresponding to the three peaks in the HPLC trace (see 
Figures 4.3.3.1b, c, d) at 405, 449 and 493 m/z.   
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Figure 4.3.3.1b entire HPLC run of partially purified combinatorial library 25-30 minutes 
 
 
Figure 4.3.3.1c: HPLC expansion of area of interest – there are three distinct peaks at tr = 24.96, 
25.14 and 25.84 minutes 
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Figure 4.3.3.1d: Mass spectrum of the HPLC run in Figure 4.3.3.1b; the three peaks shown 
correspond to the three desired naphthyl disulfides 42, 43 and 44 
 
 
In this first attempt at making a larger, mixed sugar-naphthyl disulfide library the following 
disulfides were generated:  GlcOMe-S-S-CH2Np (42), GlcOMe-S-S-EGCH2Np (43) and 
GlcOMe-S-S-DEGCH2Np (44) (Figure 4.3.3.1e). 
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Figure 4.3.3.1e:  methyl glucoside-naphthyl disulfides formed 
 
The results from our first attempt to form a larger combinatorial library indicate that we have 
had a degree of success in forming a library of sugar-naphthyl disulfides.  However, much 
42 43 44 
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more development is needed into the method to form this library, and those planned using a 
galactoside rather than a glucoside,  
 
4.3.4 Summary of work on combinatorial synthesis of a library of substrates 
for enzyme testing 
 
We have investigated the possibility of using combinatorial synthesis to generate suitable 
substrates for our work to develop a new type of sensor for monitoring β-galactosidase 
action. 
 
We have successfully synthesised methyl-(6-thio-6-deoxy)-α-D-glucopyranoside (45) and 
three thiol-functionalised naphthyl-linker molecules 46, 47 and 48.  45 and 46 were used to 
develop a suitable method for forming a novel DCL for use with the β-galactosidase from B. 
circulans.  The resultant DCL was then used in a β-galactosidase-catalysed 
transglycosylation reaction which resulted in the successful synthesis of disaccharides 
containing naphthyl- and phenyl moieties linked via a disulfide bond at C6 of methyl-α-D-
glucose.  This confirmed to us that our idea of using combinatorial synthesis to synthesise 
substrates suitable for use with the β-galactosidase from B. circulans was a viable method 
for this purpose.  
 
Following the success of the enzyme reaction, we then began work on forming the larger 
DCL that would be used in a β-galactosidase-catalysed trans-glycosylation reaction with thio-
sugar 45.  We succeeded in forming a DCL with the components in Figure 4.2.3a but work 
remained to optimise the formation of the larger DCL before using this with the enzyme. 
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4.3.5 Further Work 
 
The first step in the completion of this work would be to develop a reliable method for forming 
a large DCL of substrates to test with the enzyme. 
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Figure 4.3.5a: DCC enzyme experiment featuring the four sugar-naphthyl disulfide targets with 
GalOpNP as the glycosyl donor 
 
Initially the formation of the desired DCL shown in Figure 4.3.5a would need to be optimised 
and reproducible.  Once this library had been successfully developed, work would then move 
on to forming a DCL based on galactose.  As stated at the beginning of this chapter, we have 
already shown that the glycosyl acceptor (methyl α-D-glucose) when functionalised with a 
naphthyl group at C6 can be processed by the β-galactosidase from B. circulans.  Our next 
objective would be to investigate whether the glycosyl donor (p-nitrophenyl galactose) would 
be processed by the enzyme when similarly functionalised. 
 
42 
41 
43 
44 
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Future work for this chapter of the project is therefore to synthesise p-nitrophenyl (6-thio-6-
deoxy)-β-D-galactopyranoside and use this in the formation of the DCL shown in Figure 
4.3.5b below. 
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Figure 4.3.5b: Planned glycosyl donor disulfides 
 
Once this DCL has been successfully generated, our work would conclude with the 
investigation into the use of this DCL of glycosyl donors in a β-galactosidase-catalysed trans-
glycosylation reaction (Figure 4.3.5c). 
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Figure 4.3.5c:  Planned enzyme experiment using the library of glycosyl donor disulfides with 
GlcOMe as the glycosyl acceptor 
 
203 
 
4.3.5.1 Planned synthesis of p-nitrophenol (6-thio-6-deoxy)-β-D-galactopyranoside 
 
The planned synthesis of p-nitrophenyl (6-thio-6-deoxy)-β-D-galactopyranoside is broadly the 
same as that for the corresponding methyl glucoside. The retrosynthesis is shown in Figure 
4.3.5.1a. 
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Figure 4.3.5.1a: retrosynthesis for p-nitrophenyl (6-thio-6-deoxy)-β-D-galactopyranoside 
 
The first step would be to protect the alcohol at C6 with a trityl group and then to acetylate 
the remaining alcohols.  When we used trityl protection previously the orthogonal protecting 
group was PMB, but this would not be suitable in this case as a paper by Williams discussed 
the installation of iodide at the primary alcohol of methyl 2,3,4-tri-O-benzyl-β-D-galactoside.  
In a competing reaction the 3,6-anhydro sugar was also prepared as shown in Figure 
4.3.5.1b.106 
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Figure 4.3.5.1b:  The formation of a 3,6-anhydro sugar when attempting an iodination on a 
benzyl-protected 6-hydroxy galactoside 
 
Given this information we chose to avoid the use of any sort of benzylic protecting group.  
We planned to use acetates instead as the trityl group can be selectively removed using 
TMSI in the presence of acetates.107 
 
After the iodide has been installed we would then proceed as in the synthesis of 45  by using 
thiourea to displace the iodide and form the thiol to be used in the combinatorial experiments. 
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Chapter 5        Experimental Section 
5. Experimental Section 
Instrumentation 
Elemental analyses were recorded on a Carlo Erba EA1110 simultaneous CHNS analyser.  
Infrared spectra were recorded as thin films, or as a Nujol mull between sodium chloride 
discs, on a Perkin Elmer 1600 FTIR spectrometer.  The intensity of each band is described 
as s (strong), m (medium) or w (weak), and with the prefix v (very) and suffix br (broad) 
where appropriate.  1H- and 13C-NMR spectra were recorded on a Bruker AC300 (at 300.13 
MHz and 75.47 MHz respectively), a Bruker AV300 (at 300.13 MHz and 75.48 MHz 
respectively), a Bruker AMX400 (at 400.08 MHz and 100.61 MHz) or a Bruker DRX500 (at 
500.13 MHz and 125.77 MHz).  All 75 MHz 13C spectra were recorded using the PENDANT 
pulse sequence.  Chemical shifts are reported as δ values (ppm).  Individual spectra were 
referenced relative to residual solvent peaks according to the values quoted by Gottlieb and 
Nudelman.108 The multiplicity of signals in 1H NMR spectra is expressed as follows: s = 
singlet, br s = broad singlet, d = doublet, t = triplet, q = quartet, m = multiplet etc... Coupling 
constants J are reported in Hz.  The term “stack” is used to describe a region where 
resonances arising from non-equivalent nuclei are coincident, and multiplet, m, is used to 
describe a resonances arising from a single nucleus (or equivalent nuclei) where coupling 
constants cannot be readily assigned.  In analysing AB systems, where the resonance 
pattern forms two well separated groups, each of two lines, these are separately reported as 
“A of AB” or “B of AB”, along with JA-B.  Connectivities were deduced from COSY90, HSQC 
and HMBC experiments.  Mass spectra were recorded on a Micromass LCT spectrometer 
utilising electrospray ionisation (and a MeOH mobile phase).  HRMS were recorded on a 
Micromass LCT spectrometer using a lock mass incorporated in the mobile phase.  EI mass 
spectra were recorded on either a VG ProSpec or VG Zabspec instrument at 70 eV.  High 
resolution EI spectra were measured using perfluorokerosene (PFK) as an internal calibrant.  
Mass spectrometric monitoring of enzyme and combinatorial reactions was carried out on a 
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Waters/Micromass ZMD electrospray mass spectrometer.  All mass spectral data are 
reported as (m/z (%)).  Optical rotations were measured in H2O, CHCl3 or MeOH solution 
using an Optical Activity PolAAr2001 automatic polarimeter.  Unless otherwise stated, the 
cell path length used was 0.5 dm and concentrations used are expressed in grammes of 
solute per 100 mL.  Optical rotation calculated using:  [α]D = 100α/(l x c) where α is the 
measured rotation, l is the path length in decimetres and c is the concentration in g/100 mL. 
[α]D Values are reported in units of 10
-1 deg cm2 g-1.  UV absorption spectra were recorded on 
a Perkin-Elmer Lambda 17 UV-vis spectrometer, using 1 cm path length cuvettes using 
HPLC grade solvents.  Data fitting was carried out using Microsoft Excel 2007.  Melting 
points were determined in open glass capillaries using a Stuart Scientific SMP1 apparatus 
and are uncorrected. 
 
HPLC was performed on Dionex Summit HPLC systems using helium degassed HPLC grade 
solvents.  Data were collected, recorded and processed using the Dionex Chromeleon 6.11 
software package. 
 
Analytical HPLC: 
Pump: Summit P580 Quaternary Low Pressure Gradient Pump with built in vacuum 
degasser. 
Detector: Summit UVD 170s UV/Vis Multi-Channel Detector with analytical flow cell. 
Column: Phenomenex Luna 10µ C18 (250 mm x 4.6 mm). 
 
Preparative HPLC: 
Pump: Summit P580P High Pressure Binary Gradient Pump with built in vacuum 
degasser. 
Detector: Summit UVD 170s UV/Vis Multi-Channel Detector with preparative flow cell. 
Column: Phenomenex Luna 10µ C18 (250 mm x 21.2 mm) with Phenomenex Luna 
10µ C18 (60 mm x 21.1 mm) guard. 
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Analytical carbohydrate and combinatorial HPLC was carried out on a Dionex DX500 
HPLC system with an AS3500 Autosampler: 
Pump: GP40 Gradient Pump with GM4 Gradient Mixer with built in vacuum degasser. 
Detector:  AD20 Absorbance Detector and ED40 Electrochemical Detector 
Column:  Analytical Phenomenex Luna 10u C18(2) 100A (250 x 4.6mm) 
Liquid phase:  16 mM NaOH solution at 1 mL/min 
 
Chemicals and Reagents 
 
Tetrahydrofuran (THF) were distilled from sodium benzophenone ketyl. CH2Cl2 was distilled 
from CaH2.  MeOH was distilled under N2 from Mg turnings/I2 and stored over activated 4 Å 
molecular sieves.  Anhydrous pyridine and ‘Extra Dry’ DMF were purchased from Acros 
Organics (Fisher Scientific). Other chemicals were used as purchased, unless otherwise 
stated.  All aqueous solutions are saturated, unless otherwise stated. 
 
The buffer solutions used in the enzymatic reactions were  50 mM pH 5.0 sodium acetate 
buffer and 50 mM pH 7.0 sodium phosphate buffers. 
 
Analytical thin layer chromatography (TLC) was performed on Merck 60 Å F254 pre-coated 
glass-backed plates and visualised by UV (254 nm) and using ammonium molybdate 
solution.  Flash column chromatography was carried out using FluoroChem 60 (40-60 µm 
mesh) silica gel. 
‘Biolacta’ (β-galactosidase from B. circulans) was a gift from Daiwa Kasei K.K. (Japan) 
through Amano Enzyme Europe.  http://www.amano-enzyme.co.jp/aee/index.html 
 
 
 
 
208 
 
Reactions 
 
All synthetic reactions were carried out under a N2 atmosphere in flame-dried glassware, and 
at rt, unless otherwise stated.  Volumes under 1 mL were measured and dispensed with 
Hamilton gastight syringes.  Evaporation and concentration under reduced pressure was 
performed at 50-500 mbar.  Residual solvent was removed under high vacuum (1 mbar).  For 
UV-vis experiments, and enzymatic and combinatorial reactions, all volumes were measured 
using Brand Transferpette® S Single Channel Pipettes (100 µL and 1000 µL).  Enzymatic 
reactions were carried out in 2 mL and 10 mL reaction vessels as appropriate.  Larger 
enzymatic reactions and combinatorial work were carried out using a ‘Radleys Carousel 12 
Classic’ parallel reaction system.   
 
Convention for Carbohydrate numbering 
In this Experimental Section, all characterisation of monosaccharides will be described using 
the following numbering convention unless otherwise stated. 
O
HO
HO
OH
OH
OMe
1'
2'
3'
4'
5'
6'
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5.1 General Experimental Procedures 
 
General procedure A: acetylation of alcohols and thiols53 
Ac2O (2 equiv. per hydroxyl/thiol group) was added to a stirred solution of the alcohol or thiol 
in pyridine (3.0 M reaction concentration).  Full conversion was usually complete within 12 h.  
The reaction mixture was then concentrated under reduced pressure and the residue purified 
by column chromatography. 
 
General procedure B: deacetylation of acetates and thioacetates53 
NaOMe (1.6 equiv. per ester group) was added to a solution of the ester (1.0 equiv.) in 
MeOH (0.025 M reaction concentration).  The reaction mixture was stirred overnight at rt and 
then acidified to pH 2 with Amberlite IR120 H+ resin.  The resin was removed by filtration, 
and the filtrate concentrated under reduced pressure to yield the deprotected product, which 
required no further purification. 
 
General procedure C: bromination of alcohols83 
CBr4 (1.5 equiv.) was added to a stirred solution of the alcohol (1.0 equiv.) in THF (0.1 M 
reaction concentration) at rt.  After 15 min, PPh3 (1.5 equiv.) was added and the reaction 
mixture was stirred until consumption of starting alcohol was evidenced by TLC.  The 
reaction was then quenched with H2O (1 x volume of organic phase) and extracted with 
CH2Cl2 (2 x volume of organic phase).  The combined organic fractions were washed with 
brine (1 x volume of organic phase), dried (MgSO4) and concentrated under reduced 
pressure to provide a residue, which was purified by column chromatography. 
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General procedure D:  etherification of methyl (2,3,4-tris-O-p-methoxybenzyl)-6-
hydroxy-D-glucopyranoside  
NaH (1.1 equiv. per OH group, 60 wt% dispersion in mineral oil) was added portionwise over 
2 min to a stirred solution of methyl (2,3,4-tris-O-p-methoxylbenzyl)-D-glucopyranoside (1.0 
equiv.) in DMF (0.5 M reaction concentration) at 0 °C.  After 30 min, the bromide (3.0 equiv.) 
was added at 0 °C and the reaction mixture allowed to warm to rt over the course of 1 h.  The 
reaction mixture was stirred at rt until no further progress was evidenced by TLC and then 
diluted with CH2Cl2 (20 x reaction volume).  The reaction mixture was washed with H2O 
(twice with 15 x reaction volume) and brine (15 x reaction volume) and then dried (MgSO4).  
Removal of the solvent under reduced pressure and purification of the residue by column 
chromatography provided the desired ether. 
General procedure E: deprotection of PMB ethers74 
CAN (1.9 equiv.) was added to a solution of the glycoside (1.0 equiv.) in acetone/H2O (9:1, 
0.1 M reaction concentration) at 0 °C.  Once the initial exotherm had ceased, more CAN (6.0 
equiv.) in acetone/H2O (9:1, 0.05 M solution concentration) was added dropwise over 10 min.  
After stirring at rt overnight, the reaction mixture was poured into NaHCO3 solution (4 x total 
reaction volume) and the mixture was extracted with EtOAc (10 x reaction volume).  The 
combined organic phases were dried (MgSO4) and concentrated under reduced pressure to 
provide the product, which was purified by column chromatography. 
General procedure F: conversion of bromides to thiols 
Thiourea (2.2 equiv.) was added to a solution of the bromide in EtOH (0.9 M reaction 
concentration).  The reaction mixture was heated under reflux overnight and then cooled to 
rt.  40% aq. KOH solution (0.5 equiv.) was added and the mixture heated under gentle reflux.  
After 1 h, this solution was cooled, acidified to pH 1 with 10% aq. hydrochloric acid and then 
extracted 3 times with Et2O (2 x reaction volume).  The organic extracts were dried over 
MgSO4 and then concentrated under reduced pressure. 
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5.2 Synthesis 
Methyl D-glucopyranoside 10 
 
 
 
D-Glucose (5.00 g, 28.0 mmol) was added to a suspension of DOWEX 50WX8-400 resin 
(10.00 g) in MeOH (100 mL).  The reaction mixture was stirred at 65 ºC for 24 h and then 
cooled to rt.  The resin was removed by filtration and the filtrate concentrated under reduced 
pressure to yield methyl glucoside 10 as a white, crystalline solid, which was used in the next 
step without further purification (5.42 g, 99%, α:β 1.0:0.8).  Data on the mixture: mp 101 ºC - 
120 ºC; (Found: C, 43.18; H, 7.13. C7H14O6 requires C, 43.30; H, 7.27%); νmax(Nujol mull)/cm
-
1 3242 br, m (O-H), 1593w, 1401w, 1304w, 1224w, 1187m, 1100m, 1030s, 992m, 898w, 
843w, 722w; δH(300 MHz, D2O)
∗ 3.21 – 3.91 (9H, stack, including 2 x OCH3 from both 
anomers), 4.33 (0.4H, d, J 8.0, H1’ (β-anomer)), 4.76 (0.6H, d, J 3.7, H1’ (α-anomer)); δC(75 
MHz, D2O) [53.4, 55.5 (CH3, OCH3)], [58.9, 59.1 (CH2, C6’)], [67.9, 68.0, 69.6, 69.9, 71.4, 
74.1, 74.2 (CH) - some resonance overlap], 97.6 (CH, C1’ (α anomer)), 101.6 (CH, C1’ (β 
anomer)); m/z (TOF ES+) 217.0 (100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 
217.0684. C7H14O6Na requires 217.0688]. 
 
 
 
 
                                                           
∗ Note: since ratio of α:β is 1.0:0.8; then total number of protons should be 14 + (14 x 0.8)  = 25.2 
O
HO
HO
OMeHO
OH
C7H14O6
Exact Mass: 194.079
Mol. Wt.: 194.1825
C, 43.30; H, 7.27; O, 49.44
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Methyl 6-O-tosyl-D-glucopyranoside 9 
 
O
HO
HO
HO
OTs
OMe
C14H20O8S
Exact Mass: 348.0879
Mol. Wt.: 348.3688
C, 48.27; H, 5.79; O, 36.74; S, 9.20
 
TsCl (4.90 g, 26.0 mmol) was slowly added to a stirring solution of methyl D-glucopyranoside 
10 (5.44 g, 28.0 mmol) and DMAP (0.34 g, 2.8 mmol) in pyridine (90 mL) at 0 oC.  The 
reaction solution was stirred overnight.  The solvent was then removed under reduced 
pressure and the residue purified by column chromatography (1% MeOH in EtOAc; Rf = 0.09) 
to yield the tosylate 9 as white, crystalline solid (2.56 g, 30%, α:β 1.0:0.8 mixture of 
anomers).  Data on the mixture: mp 26 ºC - 34 ºC; (Found: C, 48.27; H, 5.79. C14H20O8S 
requires C, 48.02; H, 5.97%); νmax(CH2Cl2)/cm
-1 3396 br, m (O-H), 3056m, 2843w, 1732w, 
1361s, 1266 s; δH(300 MHz, CDCl3) 2.42 (3H, s, ArCH3), 3.32 (3H, s, OCH3), 3.40 – 3.50 
(2.5H, stack),,3.68 – 3.74 (1.5H, stack), 4.16 – 4.32 (2.5H, stack), 4.66 (0.5H, d, J 3.2, H1’ 
(α-anomer)), 7.32 (2H, d, J 8.2, ArH), 7.78 (2H, d, J 8.2, ArH); δC(75 MHz, CD3OD) 21.6 
(CH3, ArCH3), [55.3, 57.0 (CH3, OCH3)], [69.2 (CH2, CH2OTs) resonance overlap], [69.4, 
69.6, 70.9, 71.0, 71.7, 73.1, 73.3, 74.0, (CH)], 99.4 (CH, C1’ (α anomer)), 103.2 (CH, C1’ (β 
anomer)), [128.0, 129.0 (CH, Ar)], 132.7 (quat. C, Ar), 144.9 (quat. C, Ar); m/z (TOF ES+) 
371.1 (100%, [M+Na]+).  [HRMS m/z (TOF ES+) Found: [M+Na]+ 371.0779. C14H20O8SNa 
requires 371.0777]. 
 
Methyl 6-azido-6-deoxy-2,3,4-tri-O-acetyl-D-glucopyranoside109 8 
 
OAcO
AcO
AcO
N3
OMe
C13H19N3O8
Exact Mass: 345.1172
Mol. Wt.: 345.3053
C, 45.22; H, 5.55; N, 12.17; O, 37.07
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Tosylate 9 (0.50 g, 1.4 mmol) was dissolved in DMF (4.8 mL) and the solution was heated to 
60 oC.  NaN3 (1.03 g, 16.0 mmol) was then added portionwise over 10 min and the reaction 
mixture heated at 60 oC overnight.  The solution was then cooled to rt and the white 
precipitate removed by filtration.  The reaction solvent was removed under reduced pressure 
and the resultant azide residue was then acetylated according to general procedure A using 
Ac2O (0.88 mL, 8.6 mmol) and pyridine (0.1.76 mL).  The reaction solution was stirred 
overnight at rt and then the solvent removed under reduced pressure.  The acetylated sugar 
residue was purified by column chromatography (4:6 Et2O/hexane; Rf = 0.36) to yield the 
acetylated azido-sugar 8 as a mixture of anomers and as a white, crystalline solid (0.35 g, 
70%, α:β 1.0:0.8); Data on the mixture: (Found: C, 45.44; H, 5.49; N 12.01. C14H19O8N3 
requires C, 45.22; H, 5.55; N 12.17%); δH(300 MHz, CDCl3) 1.86 – 1.93 (9H, stack, 3 x 
C(O)CH3), 3.06 – 3.38 (5H, stack, including (3.31 (1.5H, s, OCH3), 3.38 (1.5H, s, OCH3)), 
3.60-3.64 (0.5H, m), 3.81-3.86 (0.5H, m), 4.36 (0.5H, d, J 8.0, H1’ (β-anomer)), 4.72 – 4.89 
(2.5H, stack), 5.08 (0.5H, app. t, J 9.5), 5.31 (0.5H, app. t, J 9.8); δC(75 MHz, CDCl3) 20.2 
(CH3, C(O)CH3 (resonance overlap)), [50.6, 50.8 (CH2, CH2N3,)], [55.1, 56.5 (CH3, OCH3) 
resonance overlap], [68.2, 69.4, 69.5, 70.4, 70.9, 72.3, 73.3 (CH) resonance overlap], 96.3 
(CH, C1’ (α anomer)), 101.0 (CH, C1’ (β anomer)), [168.9, 169.9, 169.2, 169.6, 169.6, 169.7 
(quat. C, C=O)]; m/z (TOF ES+) 368.0 (100%, [M+Na]+).  [HRMS m/z (TOF ES+) Found: 
[M+Na]+ 368.1054.  C13H19O8N3Na requires 368.1070]. 
 
Methyl 6-amino-6-deoxy-2,3,4-tri-O-acetyl-D-glucopyranoside 7 
 
OAcO
AcO
AcO
NH2
OMe
C13H21NO8
Exact Mass: 319.1267
Mol. Wt.: 319.3077
C, 48.90; H, 6.63; N, 4.39; O, 40.09
 
Azide 8 (0.35 g, 1.0 mmol) was dissolved in degassed EtOAc (5.8 mL).  Pd/C (0.34 g) was 
added to the reaction solution which was then stirred under a H2 atmosphere for 2 d.  The 
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reaction mixture was filtered through Celite and the solvent in the filtrate removed under 
reduced pressure to yield the acetyl-protected amino sugar 7 as a pale yellow solid without 
the need for further purification (0.31 mg, 97%, α:β 1.0:0.8 mixture of anomers); 
νmax(CH2Cl2)/cm
-1 3374 br, m (NH2), 3062m, 2942m, 1749s (C=O), 1653s (NH2), 1551m, 
1374s, 1165m, 1054s; δH(300 MHz, CDCl3) 2.03 (3H, s, COCH3), 2.05 (3H, s, COCH3), 2.06 
(3H, s, COCH3), 3.07-3.21 (1.5H, stack), 3.27-3.36 (3.5H, stack), 3.48 (1.5H, s, OCH3), 3.63-
3.71 (0.5H, m), 3.97-4.10 (1H, stack), 4.38 (0.5H, d, J 8.0, H1’ (β-anomer)), 4.75 (0.5H, dd, J 
10.2, 3.7), 4.81-4.87 (1H, stack), 5.08-5.15 (0.5H, m), 5.38 (0.5H, app t, J 9.9), 6.07-6.15 
(1H, stack); δC(75 MHz, CDCl3) [20.7 (CH3, C(O)CH3), 20.8 (CH3, C(O)CH3), 23.0 (CH3,  
C(O)CH3) for both anomers], [38.7, 38.8 (CH2, C6’)], [55.2, 57.3 (CH3, OCH3)], 68.2 (CH, 
(α anomer)), [69.0, 70.5, 70.9, 71.3 (CH, (β anomer))], [71.7, 73.5, 75.0 (CH (α anomer))], 
97.0 (CH, C1’ (α anomer)), 103.4 (CH, C1’ (β anomer)), [169.7, 170.5, 172.4, 172.7 (quat. C, 
C=O) resonance overlap]; m/z (TOF ES+) 342.1 (100%, [M+Na]+). [HRMS m/z (TOF ES+) 
Found: [M+Na]+ 342.1171. C13H21NO8Na requires 342.1165]. 
 
N-(methyl-2,3,4-tris-O-acetyl-D-glucopyranose-6-succinamic acid  6 
 
OAcO
AcO
AcO
HN
OH
O
O
OMe
C17H25NO11
Exact Mass: 419.1428
Mol. Wt.: 419.3805
C, 48.69; H, 6.01; N, 3.34; O, 41.97
 
Amino sugar 7 (2.10 g, 6.6 mmol) and succinic anhydride (0.73 g, 7.2 mmol) were 
suspended in CH2Cl2 (16.5 mL), and DIPEA (2.3 mL, 13.2 mmol) was added.  The reaction 
mixture was allowed to stir at rt for 1 d.  More succinic anhydride (0.73 g, 7.2 mmol) was then 
added and the reaction mixture was stirred at rt for a further 1 d.  The reaction mixture was 
diluted with CH2Cl2 (50 mL) and washed with hydrochloric acid (1.0 M solution, 2 x 30 mL).  
The organic layer was dried over MgSO4 and then the solvent removed under reduced 
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pressure to yield amide 6 as a pale yellow syrup without the need for further purification (2.52 
g, 91%, α:β 1.0:0.8 mixture of anomers); νmax(thin film)/cm
-1 3056m, 2987m, 1788s (C=O), 
1754s (C=O), 1653s (NH2), 1535w, 1371m, 1265s, 1243br, s, 1047s; 
 
Chloro-N-(2-methyl-4-quinolyl)ethanamide 14a38 and  
bromo-N-(2-methyl-4-quinolyl)ethanamide 14b 
HN
N
Cl
O
HN
N
Br
O
C12H11ClN2O
Exact Mass: 234.056
Mol. Wt.: 234.6815
C, 61.41; H, 4.72; Cl, 15.11; N, 11.94; O, 6.82
C12H11BrN2O
Exact Mass: 278.0055
Mol. Wt.: 279.1325
C, 51.63; H, 3.97; Br, 28.63; N, 10.04; O, 5.73
XX7 XX8
 
4-Aminoquinaldine (2.00 g, 12.6 mmol) and Et3N (2.6 mL, 18.5 mmol) were dissolved in THF 
(42mL) and the mixture cooled to −10 oC.  Subsequently a solution of the appropriate acyl 
halides, chloroacetyl chloride or bromoacetyl bromide, (1.5 equiv.) in THF (1.0 M) was added 
over the course of 20 min to the solution containing 4-amino quinaldine.  The resulting 
suspension was then stirred at −10 oC for 1 h and then at room temperature for 4 h.  The 
precipitate was removed by filtration and the filtrate washed once with hydrochloric acid (1 M, 
15 mL).  The acidic solution was then washed with CH2Cl2 (20 mL) and basified using 
NaHCO3 solution.  The basic solution was extracted with CH2Cl2 (3 x 20 mL) and the organic 
solution dried over MgSO4.  The solvent was removed under reduced pressure and the 
resultant residue purified by column chromatography (both 14a and 14b – 1:1 
EtOAc/hexane; Rf = 0.50) to yield chloride 14a as a yellow oil (1.23 g, 42%), and bromide 
14b as yellow oil (0.70 g, 20%). Data for the chloride 14a: δH(300 MHz, CDCl3) 2.74 (3H, s, 
CH3), 4.34 (2H, s, CH2), 7.52 – 7.57 (1H, m, ArH), 7.68 – 7.74 (1H, m, ArH), 7.78 (1H, app d, 
J 8.35), 8.05 (1H, app d, J 8.35, ArH), 8.17 (1H, s, ArH), 9.16 (1H, br s, NH); δC(75 MHz, 
14a 14b 
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CDCl3) 26.8 (CH3), 44.5 (CH2), 112.5 (CH, Ar), 119.5 (quat. C, Ar), [119.7, 127.1, 130.6, 
130.8 (CH, Ar)], 140.1 (quat. C, Ar), 149.5 (quat. C, Ar), 161.1 (quat. C, Ar), 166.0 (quat. 
C=O); m/z (TOF ES+) 235.1 (100%, [M+H]+ 35Cl), 237.1 (20%, [M+H]+ 37Cl). [HRMS m/z (TOF 
ES+) Found: [M+H]+ 235.0632. C12H12N2O1
35ClNa requires 23.0633].  
Data were in agreement with those reported in the literature38 
 
Selected data for 14b: δH(300 MHz, CDCl3) 2.75 (3H, s, CH3), 4.20 (2H, s, CH2), 7.54 – 7.59 
(1H, m, ArH), 7.708 – 7.76 (1H, m, ArH), 7.78 (1H, app d, J 8.38), 8.07 (1H, app d, J 8.38, 
ArH), 8.16 (1H, s, ArH), 9.12 (1H, br s, NH); m/z (TOF EI+) 280.0 (35%, [M]+ 81Br), 199.0 
(28%, [M − 81Br]+), 158.0 (100, [M−COCH2
81Br]+). 
 
Methyl 6-O-(t-butyldiphenylsilyl)-D-glucopyranoside59 13 
OHO
HO
OH
OTBDPS
OMe
C23H32O6Si
Exact Mass: 432.1968
Mol. Wt.: 432.5821
C, 63.86; H, 7.46; O, 22.19; Si, 6.49
 
Imidazole (0.39 g, 5.7 mmol) and TBDPSCl (0.74 mL, 2.8 mmol) were added sequentially to 
a stirring solution of 10 (0.50 g, 2.6 mmol) in DMF (2.60 mL).  The reaction mixture was 
stirred at rt for 24 h, after which time it was diluted with Et2O (10 mL) and washed with H2O 
(5 mL) and NH4Cl solution (2 x 5 mL).  The organic phase was dried over MgSO4 and 
purified by column chromatography (8:2 hexane/EtOAc; Rf anomer 1 = 0.51, Rf anomer 2 = 
0.59).  The silylated sugar 13 was isolated as a mixture of anomers as a white, crystalline 
solid (0.68 g, 86%); Data on the mixture: mp 40 ºC – 56 ºC; (Found: C, 63.75; H, 7.50. 
C23H32O6Si requires C, 63.86; H, 7.46%); νmax(CH2Cl2)/cm
-1 3338br, w (O-H), 2931s, 2858s, 
1428s, 1050br, s, 702s; δH(300 MHz, CDCl3) 1.08 (9H, stack, C(CH3)3), 3.36 – 4.23 (10.5H, 
stack), 4.2 (0.5H, d, J 7.6, H1’ (β-anomer)), 7.37 – 7.40 (7H, stack, ArH), 7.76 – 7.74 (5H, 
stack, ArH);  δC(125 MHz, CDCl3) 19.0 (quat. C, C(CH3)3), 26.5 (CH3, C(CH3)3), [54.6 (CH3, 
OCH3 (β-anomer)), 56.4 (CH3, OCH3 (α-anomer))], [63.8 (CH2, C6’ (β-anomer)), 64.0 (CH2, 
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C6’ (α-anomer))], [70.8 (CH) resonance overlap], [71.4, 71.8 (CH, β-anomer)], 73.1 (CH, α-
anomer), 74.1 (CH, β-anomer), [75.4, 76.3 (CH, α-anomer)], [98.9 (CH, C1’ (β-anomer)), 
103.0 (CH, C1’ (α-anomer))], [127.4, 129.4, (CH, Ph) resonance overlap], [133.0, 133.1 
(quat. C, Ph)], [135.4 (CH, Ar) resonance overlap]; m/z (TOF ES+) 455.2 (100%, [M+Na]+). 
[HRMS m/z (TOF ES+) Found: [M+Na]+ 455.1872. C23H32O6Si Na requires 455.1866]. 
 
Methyl 2,3,4-tri-O-benzyl-6-O-(t-butyldiphenylsilyl)-D-glucopyranoside 12 
OBnO
BnO
BnO
OTBDPS
OMe
C44H50O6Si
Exact Mass: 702.3377
Mol. Wt.: 702.9497
C, 75.18; H, 7.17; O, 13.66; Si, 4.00
 
NaH (0.18 g, 60 wt% dispersion in mineral oil, 4.4 mmol) was added to a solution of 13  (0.32 
g, 0.7 mmol) in DMF (3.0 mL) at 0 oC.  After 30 min, BnBr (0.53 mL, 4.4 mmol) was added 
over the course of 5 min.  The reaction mixture was then allowed to warm to rt and then 
stirred overnight.  The reaction solution was slowly quenched with H2O (5 mL) at 0 
oC.  The 
solution was diluted with Et2O (10 mL) and washed with NH4Cl solution (2 x 10 mL), the 
organic solution was dried over MgSO4 and purified by column chromatography (9:1 
hexane/Et2O; Rf both anomers = 0.23) to yield the benzylated silyl sugar 12 as a pale yellow 
syrup (0.37 g, 71%, mixture of anomers). Selected data for the mixture of anomers 12: m/z 
(TOF ES+) 725.3 (100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 725.3247. 
C44H50O6NaSi requires 725.3247].  Very careful separation by column chromatography 
allowed separation of the two anomers for characterisation (9.5:0.5 hexane/Et2O; Rf 12b (β-
anomer) = 0.18, Rf 12a (α-anomer) = 0.17) in order of elution: Data on the β anomer 12b:
59   
pale yellow syrup; [α]D
20 -3.6° (c 1.0 in CHCl3); (Found: C, 74.96; H, 7.08. C44H50O6Si 
requires C, 75.18; H, 7.17%); νmax(thin film)/cm
-1 3068w, 3031w, 2975s, 2930s, 2857s, 
1958w, 1888w, 1816w, 1736m, 1454s, 1428s, 1113br, s, 1070br, s, 738s, 701s; δH(300 MHz, 
CDCl3) 1.08 (9H, stack, C(CH3)3), 3.36 (1H, app dt, J 9.5, 2.8), 3.49 (1H, dd, J 9.0, 7.8), 3.62 
(3H, s, OCH3), 3.69 (1H, t, J 9.1), 3.80 (1H, t, J 9.3), 4.00 (2H, app d, J 2.8), 4.35 (1H, d, J 
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7.7, H1’), 4.74 (2H, app t, J 11.2, CH2Ar), 4.82 – 5.00 (4H, stack, CH2Ar), 7.20 – 7.47 (21H, 
stack, ArH) 7.71 – 7.74 (2H, m, SiArC)  7.77 – 7.80 (2H, m, SiArC);  δC(75 MHz, CDCl3) 21.1 
(quat. C, C(CH3)3), 28.4 (CH3, C(CH3)3), 58.4 (CH3, OCH3), (64.3 (CH2, C6’), [76.5, 76.8 
(CH2, ArCH2)], 77.3 (CH), 77.6 (CH2, ArCH2), [79.3, 84.3, 86.4 (CH)], 106.2 (CH, C1’), 
[129.23, 129.29, 129.4, 129.6, 130.06, 130.10 (CH, SiPh) resonance overlap], [131.3 (CH, 
Ph), [134.8, 135.2 (quat. C, SiArC)], [137.3, 137.6 (CH, Ph)], [140.1, 141.2 (quat. C, 
CH2ArC)]; m/z (TOF ES
+) 725.3 (100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 
725.3298. C44H50O6SiNa requires 725.3274]. 
Data were in agreement with those reported in the literature.59 
Data on the α anomer 12a: white crystalline solid; mp 109 ºC – 111 ºC, [α]D
20 +10.0° (c 1.0 
in CHCl3); (Found: C, 75.04; H, 7.21. C44H50O6Si requires C, 75.18; H, 7.17%); νmax(thin 
film)/cm-1 3584w, 3032w, 2923br, s, 2855s, 1588w, 1464s, 1428m, 1160s, 1106s, 1075s, 
10.74s, 1035s, 743m, 700s; δH(300 MHz, CDCl3) 1.05 (9H, stack, C(CH3)3), 3.38 (3H, s, 
OCH3), 3.54 – 3.65 (2H, stack), 3.70 (1H, app dt, J 10.6, 3.0), 3.87 (2H, app d, J 3.0), 4.03 
(app t, J 8.9),  4.60 (1H, A of AB, JAB 10.8, CHaHbAr), 4.67 (1H, d, J 3.6, H1’), 4.71 (1H, A of 
AB, JAB 12.1, CHaHbAr), 4.81 – 4.90 (3H, stack, CH2Ar), 4.99 (1H, B of AB, JBA 10.8, 
CHaHbAr), 7.13 – 7.16 (2H, stack, ArH) 7.24 – 7.45 (19H, stack, ArH)  7.66 – 7.71 (4H, m, 
SiArC); δC(75 MHz, CDCl3) 20.9 (CH3, C(CH3)3), 28.7 (CH3, C(CH3)3), 56.8 (CH3, OCH3), 
(64.9 (CH2, C6’),73.4 (CH), [75.3, 77.0, 77.9 (CH2, ArCH2)], [79.7, 82.2, 84.2 (CH)], 99.8 (CH, 
C1’), [129.5, 129.6, 129.8, 130.0, 130.1, 130.3, 130.4, 131.50 (CH, SiPh) resonance 
overlap], 131.52 (CH, Ph), [134.9, 134.2 (quat. C, SiArC)], [137.6, 137.7 (CH, Ph)], [139.0, 
139.4 (quat. C, CH2ArC)]; m/z (TOF ES
+) 725.3 (100%, [M+Na]+). [HRMS m/z (TOF ES+) 
Found: [M+Na]+ 725.3247. C44H50O6SiNa requires 725.3274]. 
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Methyl 2,3,4-tri-O-benzyl-D-glucopyranoside 11 
OBnO
BnO
BnO
OH
OMe
C28H32O6
Exact Mass: 464.2199
Mol. Wt.: 464.5501
C, 72.39; H, 6.94; O, 20.66
 
TBAF (1.04 mL of a 1 M solution in THF, 1.0 mmol) was added to a solution of 12 (0.37 g, 
0.5 mmol) in THF (2.6 mL) at rt.  The reaction mixture was stirred overnight and then 
quenched with H2O (10 mL), diluted with CH2Cl2 (15 mL) and washed with brine (2 x 10 mL).  
The organic layers were dried over MgSO4 and purified by column chromatography (7:3 
hexane/EtOAc; Rf both anomers = 0.11) to yield the benzylated 6-hydroxy sugar 11 as a pale 
yellow syrup (0.22 g, 90%, mixture of anomers); Very careful separation by column 
chromatography allowed separation of the two anomers for characterisation (7:3 
hexane/Et2O; Rf 11b (β-anomer) = 0.11, Rf 11a (α-anomer) = 0.10) in order of elution:  
Selected data on the β anomer 11b: pale yellow syrup; νmax(thin film)/cm
-1 3583w, 3470br, 
m (O-H), 3031m, 2922s, 1736m, 1496m, 1454s, 1360s, 1159s, 1071br, s,1028s, 738s, 698s; 
δH(300 MHz, CDCl3) 3.40 – 3.51 (2H, stack), 3.63 (3H, s, OCH3), 3.65 – 3.82 (3H, stack), 
3.94 (1H, app dd, J 12.0, 2.6), 4.42 (1H, d, J 7.8, H1’), 4.71 (1H, A of AB, JAB 10.9), 4.78 (1H, 
A of AB, JAB 11.0), 4.88 (1H, A of AB, JAB 10.9), 4.91 – 5.02 (3H, stack, including 5.00,  (B of 
AB, JBA 10.9)), 7.31 – 7.42 (15H, stack, ArH); δC(75 MHz, CDCl3) 57.5 (CH3, OCH3), 62.1 
(CH2, C6’), [75.1, 75.3 (CH2, ArCH2)], 75.4 (CH), [77.8, 82.6, 84.7 (CH)], 105.1 (CH, C1’), 
[127.8, 127.9, 128.3, 128.6, 128.7 (CH, ArCH) resonance overlap], [138.3, 138.76, 138.84 
(quat. C, ArC)]; m/z (TOF ES+) 487.2 (100%, [M+Na]+).  Data on the α anomer 11a: pale 
yellow syrup; δH(300 MHz, CDCl3) 3.40 (3H, s, OCH3), 3.54 – 3.62 (2H, stack), 3.69 – 3.84 
(3H,stack), 4.07 (app t, J 9.2), 4.62 (1H, d, J 3.5), 4.68 (1H, d J 2.6), 4.72 (1H, d, J 3.8), 4.82 
– 4.96 (3H, stack), 5.05 (1H, B of AB, JBA 10.9, CHaHbAr), 7.33 – 7.43 (15H, stack, ArH);  
δC(75 MHz, CDCl3) 55.1 (CH3, OCH3), 61.7 (CH2, C6’), 70.8 (CH), [73.3, 75.0, 75.7 (CH2, 
ArCH2)], [77.4, 78.0, 81.9 (CH)], 98.1 (CH, C1’), [127.6, 127.8, 127.9, 128.0, 128.3, 128.4 
(CH, ArCH) resonance overlap], [138.1, 138.2, 138.7 (quat. C, ArC)]; m/z (TOF ES+) 487.2 
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(100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 487.2086. C28H32O6Na requires 
487.2097].  
 
Methyl 2,3,4-tri-O-benzyl-6-O-(N-(2-methyl-4-quinolyl)ethanamide)-β-D-glucopyranoside 
15 
OBnO
BnO
BnO
O
OMe
O
H
N
N C40H42N2O7
Exact Mass: 662.2992
Mol. Wt.: 662.7707
C, 72.49; H, 6.39; N, 4.23; O, 16.90
 
NaH (0.04 g, 60 wt% dispersion in mineral oil, 1.00 mmol) was added to a solution of 11a 
(0.15 g, 0.03 mmol) in DMF (0.7 mL) at 0 oC.  After 30 min, bromide 14b (0.53 mL, 4.44 
mmol) was added over the course of 5 min.  The reaction mixture was allowed to warm to rt 
and then stirred overnight.  The reaction solution was slowly quenched with H2O (1 mL) at 0 
oC.  The solution was diluted with CH2Cl2 (5 mL) and washed with NH4Cl solution (2 x 5 mL).  
The organic solution was dried over MgSO4, concentrated under reduced pressure, and 
purified by column chromatography (1:1 hexane/EtOAc; Rf = 0.26) to yield the quinaldine 
functionalised sugar 15 as a white crystalline solid (0.12 g, 57%).  [α]D
20 +18.4° (c 1.0 in 
CHCl3); δH(300 MHz, CDCl3) 2.76 (3H, s, CH3), 3.42 (3H, s, OCH3), 3.49 – 3.54 (2H, stack), 
3.69 – 3.84 (3H, stack),  3.90 (1H, app dd, J 10.3, 3.8), 4.12 (2H, s, COCH2), 4.39 (1H, d, J 
7.8, H1’), 4.66 (1H, A of AB, JAB 11.2), 4.76(1H, A of AB, JAB 11.0), 4.85 (1H, A of AB, JAB 
10.9), 4.90 – 5.02 (3H, stack), 7.26 – 7.40 (15H, stack, PhH), 7.47 – 7.52 (1H, m, ArH), 7.67 
– 7.72 (1H, m, ArH), 7.90 (1H, d, J 8.4, ArH), 8.05 (1H, d, J 8.4, ArH), 8.30 (1H, s, ArH), 9.41 
(1H, s, NH); δC(75 MHz, CDCl3) 25.8 (CH3, CCH3) 57.5 (CH3, OCH3), [70.1, 70.8 (CH2)], 73.9 
(CH), [74.8, 75.0, 75.6 (CH2, ArCH2)], [76.9, 82.3, 84.5 (CH)], 104.9 (CH, C1’), 110.7 (CH), 
118.3 (quat. C), 125.8 (CH), [127.6, 127.7, 127.8, 128.1, 128.3, 128.5, (CH, PhCH) 
resonance overlap], [129.3, 129.5 (CH)] [137.8, 138.2, 138.3 (quat. C, ArC)], 139.6 (quat. C, 
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CO); m/z (TOF ES+) 663.4 (100%, [M+H]+). [HRMS m/z (TOF ES+) Found: [M+H]+ 663.3084. 
C40H43N2O7 requires 663.3084]. 
Methyl 6-O-trityl-D-glucopyranoside 20 
 
 
 
 
TrCl (10.87 g, 39.0 mmol) and DMAP (0.16 g, 1.3 mmol) were added to a solution of methyl 
D-glucopyranoside 10 (5.00 g, 26.0 mmol) in pyridine (80 mL).  The reaction mixture was 
heated at 80 ºC for 5 h, cooled, and the solvent removed under reduced pressure.  The 
resulting syrup was dissolved in CH2Cl2 (150 mL) and washed with NH4Cl solution (2 x 100 
mL).  The organic layer was dried over MgSO4 and the solvent removed under reduced 
pressure.  The crude solid was purified by column chromatography (gradient: 5% hexane in 
EtOAc to EtOAc; Rf = 0.22 in EtOAc) to yield the trityl ether 20 as a white, crystalline solid 
(9.78 g, 86%, 1.0:0.8 mixture of α:β anomers).  Data on the mixture: mp 73 ºC – 90 ºC; 
(Found: C, 71.29; H, 6.25. C26H28O6 requires C, 71.54; H, 6.47%); νmax(film)/cm
-1 3338br,w 
(O-H), 1595w, 1489w, 1264w, 1213w, 1048br,s, 889w, 701m; δH(300 MHz, CD3OD) data for 
α-anomer: 3.14 – 3.25 (2H, stack), 3.33 – 3.40 (2H, stack), 3.44 (3H, s, OCH3), 3.52 – 3.58 
(1H, m), 3.68 – 3.73 (1H, m), 4.69 (1H, d, J 3.6, H1’), 7.11 – 7.23 (9H, stack, Ar-H), 7.40 – 
7.42 (6H stack, Ar-H); selected data for β-anomer: 4.18 (1H, d, J 7.5, H1’); δC(75 MHz, 
CDCl3) data for α-anomer: 55.5 (CH3, OCH3), 65.0 (CH2, C6’), [72.3, 72.5, 73.6 (CH)], 75.4 
(CH), 87.7 (quat. C, OCPh3), 101.1 (CH, C1’), [128.0, 128.7, 130.0 (CH, Ph)], [145.6 (quat. 
C, Ph); selected data for β-anomer: 57.1 (CH3, OCH3), 72.0 (CH), 75.1 (CH), 76.9 (CH), 78.3 
(CH), 105.3 (CH, C1’); m/z (TOF ES+) 459.2 (100%, [M+Na]+). 
 
O
HO
HO
OMeHO
O
Ph
Ph
Ph
C26H28O6
Exact Mass: 436.1886
Mol. Wt.: 436.4969
C, 71.54; H, 6.47; O, 21.99
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Methyl (2,3,4-O-p-methoxylbenzyl)-6-O-trityl-α-D-glucopyranoside 21a 
Methyl (2,3,4-O-p-methoxylbenzyl)-6-O-trityl-α-D-glucopyranoside 21b 
 
 
 
 
 
 
NaH (1.16 g 60 wt% dispersion in mineral oil, 29.0 mmol) was added portionwise over 10 min 
to a solution of triol 20 (3.84 g, 8.80 mmol) in DMF (20 mL) at 0 °C.  After 30 min, PMBCl 
(3.93 mL, 29.0 mmol) was added dropwise over 5 min and the reaction temperature 
maintained at 0 °C for 1 h before allowing the solution to warm to rt over the course of 1 h.  
After stirring overnight, the reaction mixture was quenched with MeOH (10 mL) and then 
diluted with CH2Cl2 (200 mL) and extracted with H2O (2 x 60mL) and brine (60 mL).  The 
organic layer was dried over MgSO4, concentrated under reduced pressure and subjected to 
column chromatography (8:2 hexane/EtOAc) to yield the PMB ethers as a white, crystalline 
solid, (5.16 g, 74%, 1.0:0.8 mixture of α:β anomers).  This mixture was usually used directly 
in the next step; however, careful purification by column chromatography (Rf (α anomer) = 
0.13, Rf (β anomer) = 0.20, in 8:2 hexane/EtOAc) enabled separation of the two anomers for 
full characterisation. 
Data on the α anomer 21a: white, crystalline solid; mp 41 ºC – 46 ºC; [α]D
25 +12.8° (c 1.0 in 
CHCl3); (Found: C, 75.33; H, 6.53. C50H52O9 requires C, 75.35; H, 6.58%); νmax(Nujol 
mull)/cm-1 1610m, 1511m, 1301w, 1246m, 1171w, 1032br,m; δH(300 MHz; CDCl3) 3.20 (1H, 
A of ABX, JAB 10.0, JAX 4.8, C6’HaHb), 3.45 (3H, s, OCH3), 3.52 (1H, B of ABX, JBA 10.0, JBX 
1.5, C6’HaHb), 3.60 – 3.64 (2H, stack), 3.81 – 3.84 (10H, stack including: 3.81 (3H, s 
ArOCH3), 3.83 (3H, s, ArOCH3), 3.85 (3H, s, ArOCH3)), 3.97 (1H, t, J 9.3), 4.26 (1H, A of AB, 
O
PMBO
PMBO
PMBO
O
Ph
Ph
Ph
C50H52O9
Exact Mass: 796.3611
Mol. Wt.: 796.9425
C, 75.35; H, 6.58; O, 18.07
OMe
O
PMBO
PMBO
PMBO
O
Ph
Ph
Ph
OMe
XE3a XE3b21a 21b 
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JAB 10.2, CHaHbAr), 4.65 – 4.85 (5H, stack including 4.72 (1H, d, J 3.7, H1’), 2 x AB 
CHaHbAr,), 4.91 (1H, B of AB, JBA 10.2 CHaHbAr), 6.73 – 6.83 (4H, stack, ArH), 6.90 – 6.95 
(4H, stack, ArH), 7.23 – 7.39 (13H, stack, ArH), 7.49 – 7.52 (6H, stack, Ar-H); δc(75 MHz; 
CDCl3) [54.8, 55.2 (CH3, OCH3) resonance overlap], 62.6 (CH2, C6’), 70.2 (CH), [72.9, 74.5, 
75.5 (CH2, CH2Ar)], [77.8, 79.9, 82.0 (CH)], 86.2 (quat. C, OCPh3), 97.9 (CH, C1’), [113.5, 
113.8, 126.8, 127.7, 128.8, (CH, Ar) ,resonance overlap], [129.5, 129.6, 129.7 (CH, Ar), 
resonance overlap], [130.2, 130.4, 131.0 (quat. C, PMB)], [143.9 (quat. C, Tr)], [159.0, 159.2, 
159.3 (quat. C, PMB)]; m/z (TOF ES+) 819.5 (100%, [M+Na]+). [HRMS m/z (TOF ES+) 
Found: [M+Na]+ 819.3515. C50H52O9Na requires 819.3509]. 
Data on the β anomer 21b: white, crystalline solid: mp 105 ºC – 109 ºC, [α]D
20 +10.4° (c 1.0 
in CHCl3); (Found: C, 75.31; H, 6.75. C50H52O9 requires C, 75.35; H, 6.58%); 
νmax(CH2Cl2)/cm
-1 1613m, 1514s, 1449w, 1302w, 1248s, 1173w, 1069s, 1036s; δH(300 MHz; 
CDCl3) 3.26 (1H, dd, J 10.0, 3.7, H4’), 3.41 (1H, app dd, J 9.3, 1.7, H5’), 3.50 – 3.63 (4H, 
stack, C6’Ha,Hb, H2’, H3’), 3.70 (3H, s, C1’OCH3), 3.79 (3H, s ArOCH3), 3.82 (3H, s ArOCH3), 
3.83 (3H, s ArOCH3), 4.32 (1H, A of AB, JAB 9.9), 4.37 (1H, d, J 7.2, H1’), 4.65 (1H, B of AB, 
JBA 9.9), 4.73 (1H, A of AB, JAB 10.6), 4.76 (1H, A of AB, JAB 9.8)), 4.86 (1H, B of AB, JBA 
9.8), 4.93 (1H, B of AB, JBA 10.6), 6.72 – 6.81 (4H, stack, ArH), 6.88 – 6.92 (4H, stack, ArH), 
7.26 – 7.37 (13H, stack, ArH), 7.54 – 7.57 (6H, stack, ArH); δc(75 MHz; CDCl3) [55.2 (CH3, 
ArOCH3), resonance overlap], 56.6 (CH3, C1’OCH3), 62.3 (CH2, C6’), [74.5, 74.6, 75.5 (CH2, 
CH2Ar), resonance overlap], 76.1 (CH, C4’), 77.8 (CH, C5’), 82.3 (CH, C2’), 84.4 (CH, C3’), 
86.3 (quat. C, OCPh3), 104.6 (CH, C1’), [113.6, 113.8, 126.8, 127.7, 128.8 (CH, Ar), 
resonance overlap], [129.6, 129.7, 129.8 (CH, Ar), resonance overlap], [130.1, 130.9 (quat. 
C, Ar), resonance overlap], [143.9, 159.2 (quat. C, Ar), resonance overlap]; m/z (TOF ES+) 
819.5 (100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 819.3525. C50H52O9Na 
requires 819.3509]. 
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Methyl (2,3,4-O-p-methoxylbenzyl)-α-D-glucopyranoside 17a 
Methyl (2,3,4-O-p-methoxylbenzyl)-β-D-glucopyranoside 17b 
 
 
 
 
 
 
 
A solution of trityl ethers 21a and 21b (5.16 g, 6.5 mmol, 1.0:0.8 mixture of anomers) in 
AcOH/EtOH (1:1; 28 mL) was heated at 80 °C overnight.  After cooling to rt, the solvent was 
removed under reduced pressure to yield a pale residue, which was purified by column 
chromatography to yield the two anomers (3.33 g, 92%) in order of elution: the β anomer 17b 
as a white, crystalline solid; (Rf (β anomer) = 0.32 in 1:1 hexane/EtOAc): mp 56 ºC – 58 ºC; 
[α]D
20 +10.4° (c 1.0 in CHCl3); (Found: C, 66.94; H, 6.71. C31H38O9 requires C, 67.13; H, 
6.91%); νmax(Nujol mull)/cm
-1 3282br,w (O-H), 2924s (C-H), 2854s (C-H), 1613m, 1514s, 
1302w, 1250s, 1068m, 1034m, 820m; δH(300 MHz, CDCl3) 1.92 (1H, s, OH), 3.31 – 3.40 
(2H, stack, including 3.37 (1H, dd, J 9.0, 7.8)), 3.53 (1H, app t, J 9.2), 3.59 (3H, s, C1’OCH3), 
3.63 (1H, app t, J 9.0), 3.70 (1H, dd, J 11.9, 4.6), 3.79 (3H, s, ArOCH3), 3.80 (3H, s, 
ArOCH3), 3.81 (3H, s, ArOCH3), 3.86 (1H, dd, J 11.9, 2.7), 4.34 (1H, d, J 7.8, H1’), 4.57 (1H, 
A of AB, JAB 10.6), 4.66 (1H, A of AB, JAB 10.6), 4.75 (1H, A of AB, JAB 10.6), 4.80 (1H, B of 
AB, JBA 10.6), 4.84 (1H, B of AB, JBA 10.6), 4.87 (1H, B of AB, JBA 10.6), 6.85 – 6.89 (6H, 
stack, ArH), 7.20 – 7.32 (6H, stack, ArH); δC(75 MHz, CDCl3) [55.2, 57.2 (CH3, OCH3), 
resonance overlap], 62.0 (CH2), 74.4 (CH2), 74.7 (CH2), 74.9 (CH), 75.3 (CH2), 77.2 (CH), 
82.0 (CH), 98.0 (CH), 104.8 (CH, C1’), [113.7, 113.8, 129.4, 129.7 (CH, Ar), resonance 
overlap], [130.1, 130.5, 130.7 (quat. C, Ar)], [159.1, 159.2, 159.3  (quat. C, Ar-COCH3)]; m/z 
(TOF ES+) 577.3 (100%, [M+Na]). [HRMS m/z (TOF ES+) Found: [M+Na]+ 577.2402. 
C31H38O9Na requires 577.2414]; and then the α anomer 17a as a white, crystalline solid: (Rf 
O
PMBO
PMBO
PMBO
OH
OMe
O
PMBO
PMBO
PMBO
OH
OMe
C31H38O9
Exact Mass: 554.2516
Mol. Wt.: 554.628
C, 67.13; H, 6.91; O, 25.96
XE4a XE4b17a 17b 
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(α anomer) = 0.17 in 1:1 hexane/EtOAc); mp 74 °C – 76 ºC; [α]D
20 +3.2 ° (c 1.0 in CHCl3); 
νmax(film)/cm
-1 3252br,w (O-H), 1615m, 1515s, 1301w, 1254s, 1098m, 1081m, 1057m, 
1032m, 819m; δH(300 MHz; CDCl3) 1.94 (1H, s, OH), 3.38 (3H, s, OCH3), 3.48 – 3.53 (2H, 
stack, H2’, H3’), 3.63 – 3.71 (2H, stack, H5’, HaHb6’), 3.74 (1H, B of ABX, J BA 11.5, JBX 2.6, 
HaHb6’), 3.80 (3H, s, ArOCH3), 3.81 (6H, s, 2 x ArOCH3), 3.95 (1H, app t, J 9.2, H4’), 4.47 
(1H, d, J 3.5, H1’), 4.60 (1H, A of AB, JAB 10.5), 4.63 (1H, A of AB, JAB 11.5), 4.77 (1H, B of 
AB, JBA 11.5), 4.80 (1H, A of AB, JAB 10.6), 4.84 (1H, B of AB, JBA 10.5), 4.94 (1H, B of AB, 
JBA 10.6), 6.88 – 6.91 (6H, stack, ArH), 7.24 – 7.26 (2H, stack, ArH), 7.31 – 7.34 (4H, stack, 
ArH); δc(75 MHz; CDCl3) [54.9, 55.0 (CH3, OCH3), resonance overlap], 61.5 (CH2, C6’), 70.6 
(CH, C5’), [72.7, 74.4, 75.1 (CH2)], 77.0 (CH, C3’), 79.5 (CH, C2’), 81.5 (CH, C4’), 98.0 (CH, 
C1’), [113.7, 129.4, 129.4 (CH, Ar), resonance overlap], [130.1, 130.2, 130.8 (quat. C, Ar)], 
[158.9, 159.1, 159.2 (quat. C, Ar)]; m/z (TOF ES+) 577.3 (100, [M+Na]+). [HRMS m/z (TOF 
ES+) Found: [M+Na]+ 577.2420. C31H38O9Na requires 577.2414]. 
 
2-bromomethylnaphthalene 22 110,111 
Br
C11H9Br
Exact Mass: 219.9888
Mol. Wt.: 221.0932
C, 59.76; H, 4.10; Br, 36.14  
 
NBS (6.35 g, 36.0 mmol) and then AIBN (0.58 g, 3.5 mmol) were added to a solution of 2-
methyl naphthalene (5.00 g, 35.0 mmol) in CH2Cl2 (293 mL) at rt.  The reaction mixture was 
then heated under reflux overnight.  The reaction mixture was cooled to rt and then 
refrigerated overnight to facilitate the precipitation of succinamide.  The resultant white solid 
was removed by vacuum filtration and the filtrate washed with NaOH solution (0.1 M, 100 
mL) and H2O (100 mL).  The organic layers were then dried over MgSO4 and the solvent 
removed under reduced pressure to yield a brown solid, which was purified by 
recrystallisation from hexane to yield the naphthylmethyl bromide as a pale yellow crystalline 
solid (7.00 g, 91%). Selected data for 22: δH(300 MHz, CDCl3) 4.64 (2H, s, CH2Br), 7.46 – 
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7.52 (3H, stack, ArH), 7.78 – 7.81 (4H, stack, ArH); δC(75 MHz, CDCl3) 35.6 (CH2, CH2Br), 
[128.0, 128.1, 128.3, 129.2, 129.4, 129.5, 130.3 (CH, Ar)], [134.6, 134.7, 136.6 (quat. C, Ar)]. 
Data were in agreement with those reported in the literature110,111 
 
2-[(2-Hydroxyethoxy)methyl]naphthalene 24 
 
 
 
Ag2O (1.40 g, 6.0 mmol) was added to a solution of ethylene glycol (0.25 g, 4.0 mmol) in 
CH2Cl2 (27 mL) and the reaction vessel was wrapped in foil.  After 30 min, 2-
bromomethylnaphthalene (0.97 g, 4.4 mmol) was added, and the reaction mixture was stirred 
for 2 d at rt.  The reaction mixture was then filtered through Celite, washing with CH2Cl2 (50 
mL), and the solution concentrated under reduced pressure.  Purification of the residue by 
column chromatography (6:4 hexane/EtOAc, Rf = 0.23 in 1:1 hexane/EtOAc) yielded the 
naphthyl ether 24 as a pale, waxy solid (0.56 g, 71%): mp 27 ºC – 29 ºC; νmax(Nujol mull)/cm
-
1 3340br,m (O-H), 1597w, 1506w, 1276w, 1170w, 1122m, 1106s, 1078m, 1065m, 1038m, 
896m, 824m, 748m; δH(300 MHz, CDCl3) 2.52 (1H, s, OH), 3.61 – 3.64 (2H, br m, 
OCH2CH2O), 3.77 – 3.80 (2H, br m, -OCH2CH2O-), 4.71 (2H, s, ArCH2), 7.47 – 7.53 (3H, 
stack, ArH), 7.79 (1H, s, ArH), 7.83 – 7.86 (3H, stack, ArH); δC(75 MHz, CDCl3) [61.7, 71.4, 
73.2 (CH2)], [125.6, 125.8, 126.0, 126.4, 127.6, 127.7, 128.1 (CH, Ar)], [132.9, 133.1, 135.3 
(quat. C, Ar)]; m/z (TOF ES+) 225.0 (100%, [M+Na]). [HRMS m/z (TOF ES+) Found: [M+Na]+ 
225.0888. C13H14O2Na requires 225.0891]. 
 
 
O
HO C13H14O2
Exact Mass: 202.0994
Mol. Wt.: 202.2491
C, 77.20; H, 6.98; O, 15.82
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2-[(2-Bromoethoxy)methyl]naphthalene 18 
 
 
 
CBr4 (2.56 g, 7.8 mmol) was added to a solution of alcohol 24 (1.05 g, 5.2 mmol) in THF (52 
mL) at rt, followed by PPh3 (2.05 g, 7.1 mmol) after 15 min, according to the general 
procedure C.  After 3 h, work up and purification by column chromatography (9:1 
hexane/EtOAc, Rf = 0.44 in 8:2 hexane/EtOAc) furnished bromide 18 as a pale yellow, waxy 
solid (1.37 g, 99%): mp 28 ºC – 30 ºC; (Found: C, 58.92; H, 4.95. C13H13BrO requires C, 
58.89; H, 4.94%); νmax(Nujol mull)/cm
-1 3048m, 1600w, 1509w, 1421w, 1274s, 1225w, 
1180w, 1123m, 1109s, 1040m, 1008m, 813s, 749s; δH(300 MHz, CDCl3) 3.52 (2H, br t, J 6.2, 
CH2CH2), 3.83 (2H, br t, J 6.2, CH2CH2), 4.76 (2H, s, ArCH2), 7.47 – 7.52 (3H, stack, ArH), 
7.80 (1H, s, ArH), 7.83 – 7.87 (3H, stack, ArH); δC(75 MHz, CDCl3) 30.5 (CH2, BrCH2), [69.9, 
73.2 (CH2, 2 x OCH2)], [125.6, 125.9, 126.1, 126.5, 127.7, 127.8, 128.3 (CH, Ar)], [133.0, 
133.2, 135.1 (quat. C, Ar)]; m/z (EI+) 264.0 ([M79Br]+, 52%) 266.0 ([M81Br]+, 50%) 141.0 (100, 
[NpCH2]
+). [HRMS m/z (EI+) Found: [M]+ 264.0149. C13H13
79BrO requires 264.0150]. 
 
2-[2-[2-hydroxyethoxy]ethoxymethyl]naphthalene 25 
 
 
Ag2O (1.40 g, 6.0 mmol) was added to a solution of diethylene glycol (0.43 g, 4.0 mmol) in 
CH2Cl2 (40 mL) and the reaction vessel was wrapped in foil.  After 30 min, 2-bromomethyl 
naphthalene (0.97 g, 4.4 mmol) was added.  The reaction mixture was stirred for 2 d at rt, 
and then filtered through Celite, washing with CH2Cl2 (80 mL).  Concentration of the solution 
under reduced pressure and purification of the residue by column chromatography (Rf = 0.14 
O
Br
C13H13BrO
Exact Mass: 264.015
Mol. Wt.: 265.1457
C, 58.89; H, 4.94; Br, 30.14; O, 6.03
O
O
HO
C15H18O3
Exact Mass: 246.1256
Mol. Wt.: 246.3016
C, 73.15; H, 7.37; O, 19.49
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in 1:1 hexane/EtOAc) yielded alcohol 25 as a colourless oil (0.98 g, 98%); (Found: C, 73.24; 
H, 7.49. C15H18O3 requires C, 73.15; H, 7.37%); νmax(film)/cm
-1 3429br,m (O-H), 3053w, 
2868s (C-H), 1602w, 1508w, 1457w, 1351m, 1270w, 1097br,s,  893w, 819m, 750m; δH(300 
MHz, CDCl3) 2.94 (1H, s, OH), 3.58 – 3.61 (2H, br m, OCH2CH2O), 3.64 – 3.70 (4H, stack, 
internal OCH2CH2O), 3.71 – 3.75 (2H, br m, OCH2CH2O), 4.73 (2H, s, ArCH2), 7.44 – 7.52 
(3H, stack, ArH), 7.79 (1H, s, ArH), 7.82 – 7.85 (3H, stack, ArH); δC(75 MHz, CDCl3) [61.6, 
69.3, 70.3, 72.4, 73.2 (CH2)], [125.6, 125.8, 126.0, 126.4, 127.5, 127.7, 128.1 (CH, Ar)],  
[132.8, 133.1, 135.3 (quat. C, Ar)]; m/z (TOF ES+) 269.0 (100%, [M+Na]). [HRMS m/z (TOF 
ES+) Found: [M+Na]+ 269.1157. C15H18O3Na requires 269.1154]. 
 
2-[2-[2-bromoethoxy]ethoxymethyl]naphthalene 19 
 
 
 
CBr4 (0.84 g, 2.5 mmol) was added to a solution of alcohol 25 (0.42 g, 1.7 mmol) in THF (17 
mL) at rt.  After 15 min, PPh3 (0.66 g, 2.5 mmol) was added and the reaction mixture was 
stirred for a further 3 h according to the general procedure C.  After work up, column 
chromatography of the residue (9:1 hexane/EtOAc, Rf = 0.33 in 8:2 hexane/EtOAc) furnished 
bromide 19 as a pale brown semi-solid (0.50 g, 92%):  (Found: C, 58.39; H, 5.53. C15H17BrO2 
requires C, 58.27; H, 5.54%); νmax(CH2Cl2)/cm
-1 2868s (C-H), 1602w, 1509w, 1461w, 1354m, 
1275m, 1101s,  895w, 818m, 750m; δH(300 MHz, CDCl3) 3.50 (2H, br t, J 6.3, CH2CH2), 3.67 
– 3.75 (4H, stack, internal OCH2CH2O), 3.84 (2H, br t, J 6.3, CH2CH2), 4.75 (2H, s, ArCH2), 
7.44 – 7.52 (3H, stack, ArH), 7.80 (1H, s, ArH), 7.82 – 7.85 (3H, stack, ArH); δC(75 MHz, 
CDCl3) 30.3 (CH2, BrCH2), [69.4, 70.6, 71.2, 73.4 (CH2)], [125.7, 125.8, 126.1, 126.5, 127.7, 
127.8, 128.2 (CH, Ar)], [133.0, 133.2, 135.6 (quat. C, Ar)]; m/z (TOF ES+) 333.0 ([M81Br + 
O
O
Br
C15H17BrO2
Exact Mass: 308.0412
Mol. Wt.: 309.1983
C, 58.27; H, 5.54; Br, 25.84; O, 10.35
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Na]+, 89%), 331.0 ([M79Br + Na]+, 100%), 333.0 ([M81Br + Na]+, 99%).  [HRMS m/z (TOF ES+) 
Found: [M79Br +Na]+ 331.0314. C15H17
79BrO2Na requires 331.0310]. 
 
Methyl (2,3,4-tris-O-p-methoxylbenzyl)-6-O-(2-naphthylmethyl)-α-D-glucopyranoside 26 
 
 
 
 
 
NaH (0.05 g, 60 wt% dispersion in mineral oil, 1.4 mmol) was added to a solution of alcohol 
17a (0.50 g, 0.9 mmol) in DMF (1.8 mL) at 0 °C, followed by 2-bromomethylnaphthalene 
(0.30 g, 1.4 mmol) according to the general procedure D.  After stirring overnight and work 
up, the resultant yellow residue was purified by column chromatography (gradient: 8:2 to 6:4 
hexane/EtOAc, Rf = 0.52 in 1:1 hexane/EtOAc) to yield the naphthyl glucoside 26 as a pale 
yellow syrup (0.58 g, 92%): [α]D
20 −13.2 ° (c 1.0 in CHCl3); νmax(film)/cm
-1 2999s (C-H), 
2910br,s (C-H), 2836s, 1613s, 1586s, 1513s, 1463s, 1359s, 1301s, 1244br,s, 1037br,s, 
906s, 819s, 732s; δH(300 MHz; CDCl3) 3.38 (3H, s, C1’OCH3), 3.55 (1H, A of ABX, JAB 9.6, 
JAX 3.5, HaHb6’), 3.60 – 3.75 (7H, stack including 3.72 (3H, s, ArOCH3), H2’, H3’, H5’, 
HaHb6’), 3.81 (6H, s, 2 x ArOCH3), 3.95 (1H, app t, J 9.2, H4’), 4.34 (1H, A of AB, JAB 10.6), 
4.58 – 4.65 (3H, stack including 4.58 (1H, d, J 3.6, H1’)), 4.73 – 4.82 (4H, stack including 
4.78 (1H, A of AB, JAB 10.5), 4.77 (1H, B of AB, J BA10.6)), 4.91 (1H, B of AB, JBA 10.5), 6.63 
(2H, d, J 8.6, ArH), 6.87 – 6.93 (6H, stack, Ar-H), 7.30 (4H, d, J  8.5, ArH), 7.50 – 7.46 (3H, 
stack, ArH), 7.84 – 7.78 (4H, stack, ArH); δc(75 MHz; CDCl3) [55.1, 55.2 , 55.3 (OCH3), 
resonance overlap], 68.3 (CH2, C6’), 70.0 (CH, C5’), [73.0, 73.5, 74.6, 75.7 (CH2)], 77.3 (CH, 
C3’), 79.4 (CH, C2’), 81.8 (CH, C4’), 98.2 (CH, C1’), [113.6, 113.7, 125.8, 125.9, 126.0, 
C42H46O9
Exact Mass: 694.3142
Mol. Wt.: 694.8092
C, 72.60; H, 6.67; O, 20.72
O
PMBO
PMBO
OMe
PMBO
O
1'
2'
3'
4' 5'
6'
7'
9'
8'
10'
11'
12' 13'
14'
15'
16'
17'
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126.7, 127.6, 127.8, 128.2, 129.3, 129.6, 129.7 (CH, Ar), resonance overlap], [130.2, 131.0, 
133.0, 133.1, 135.3 (quat. C, Ar), resonance overlap], [159.0, 159.1, 159.3 (quat. C, Ar)]; m/z 
(TOF ES+) 717.3 (100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 717.3045.  
C42H46O9Na requires 717.3040]. 
 
Methyl (2,3,4-tris-O-acetyl)-6-O-(2-naphthylmethyl)-α-D-glucopyranoside 29 
 
 
 
 
 
 
According to general procedure E; CAN (0.86 g, 1.6 mmol) was added to a solution of 26 
(0.58 g, 0.8 mmol) in acetone/H2O (9:1, 8.3 mL) at 0 °C.  Further CAN (2.72 g, 5.0 mmol) in 
acetone/H2O (9:1, 10 mL) was added dropwise over 10 min after the initial exotherm had 
ceased.  After stirring overnight, work up yielded a yellow oil which was directly acetylated 
following general procedure A.  Work up and purification by column chromatography (8:2 
hexane/EtOAc, Rf = 0.28 in 1:1 hexane/EtOAc) furnished the triacetate 29 as a pale yellow 
syrup (0.26 g, 64%): [α]D
20 +112.0 ° (c 1.0 in CHCl3); (Found: C, 62.52; H, 6.11. C24H28O9 
requires C, 62.60; H, 6.13%); νmax(film)/cm
-1 2937br,w (C-H), 1749s (C=O), 1435w, 1370s, 
1225s, 1045br,s; δH(400 MHz, CDCl3) 1.77 (3H, s, COCH3), 1.94 (3H, s, COCH3), 1.99 (3H, 
s, COCH3), 3.43 (3H, s, OCH3), 3.48 – 3.56 (2H, stack, C6’H2), 3.90 (1H, app td, J 10.2, 3.6, 
H5’), 4.57 (1H, A of AB, JAB 12.2, HaHb7’), 4.69 (1H, B of AB, JBA 12.2, HaHb7’), 4.88 (1H, dd, 
J 10.0, 3.7, H2’), 4.93 (1H, d, J 3.7, H1’), 5.13 (1H, app t, J 9.8, H4’), 5.43 (1H, app t, J 10.0, 
H3’), 7.36 – 7.42 (3H, stack, ArH), 7.69 (1H, s, H9’), 7.38 – 7.77 (3H, stack, ArH); δC(125 
MHz, CDCl3) [20.6, 20.7 (CH3, COCH3), resonance overlap], 55.3 (CH3, C1’OCH3), 68.1 
C24H28O9
Exact Mass: 460.1733
Mol. Wt.: 460.4737
C, 62.60; H, 6.13; O, 31.27
O
AcO
AcO
OMe
AcO
O
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(CH2, C6’), 58.2 (CH, C5’), 69.1 (CH, C4’), 70.3 (CH, C3’), 70.9 (CH, C2’), 73.6 (CH2, C7’), 
96.7 (CH, C1’), [125.8, 125.9, 126.1 (CH, Ar)], 126.6 (CH, C9’), [127.6, 127.8, 128.1 (CH, 
Ar)], [133.0, 133.1, 135.1 (quat. C, Ar)], [169.6, 170.1, 170.2 (quat. C, C=O)]; m/z (TOF ES+) 
499.2 ([M+K]+, 5%) 483.1 (100, [M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 483.1617. 
C24H28O9Na requires 483.1631]. 
 
Methyl 6-O-(2-naphthylmethyl)-α-D-glucopyranoside 32 
 
 
 
 
 
NaOMe (0.27 g, 4.9 mmol) was added to a solution of triacetate 29 (0.63 g, 1.4 mmol) in 
MeOH (55 mL) according to general procedure B.  After stirring overnight, work up afforded a 
pale syrup which was then taken up in H2O (approx. 5 mL) and lyophilised to yield the triol 32 
as a white solid (0.45 g, quant.): mp 70 °C – 73 °C; δH(300 MHz, CD3OD) 3.22 – 3.38 (5H, 
stack), 3.54 – 3.74 (4H, stack), 4.62 (1H, d, J 3.7, H1’), 4.64 (2H, s, C7’H2), 7.35 – 7.42 (3H, 
stack, ArH), 7.72 – 7.75 (4H, stack, ArH); δC(75 MHz, CD3OD) 55.7 (CH3, OCH3), 70.9 (CH2), 
[71.9, 72.5, 73.5 (CH)], 74.6 (CH2), 75.2 (CH), 101.3 (CH, C1’), [126.8, 126.9, 127.1, 127.4, 
128.7, 128.9, 129.1 (CH, Ar)], [134.4, 134.9, 137.2 (quat. C, Ar)]; m/z (TOF ES+) 357.1 (100, 
[M+Na]+).  [HRMS m/z (TOF ES+) Found: [M+Na]+ 357.1308, C18H22O6Na requires 357.1314].  
UV spectrum in Section 2 of the Appendix. 
 
C18H22O6
Exact Mass: 334.1416
Mol. Wt.: 334.3637
C, 64.66; H, 6.63; O, 28.71
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HO
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Methyl (2,3,4-tris-O-p-methoxybenzyl)-6-O-[2-(2-naphthylmethoxy)ethyl]-β-D-
glucopyranoside 27 
 
 
 
 
 
 
 
NaH (0.05 g, 60 wt% dispersion in mineral oil, 1.1 mmol) was added to a solution of alcohol 
17b (0.55 g, 1.0 mmol) in DMF (2.0 mL) at 0 °C, followed by bromide 18 (0.79 g, 3.0 mmol) 
after 30 min, as detailed in general procedure D.  After 4 d, work up furnished a yellow 
residue which was purified by column chromatography (6:4 hexane/EtOAc, Rf = 0.45 in 1:1 
hexane/EtOAc) to yield ether 27 as a pale yellow syrup (0.38 g, 52%): [α]D
20 −1.3 ° (c 1.00 in 
CHCl3); (Found: C, 71.42; H, 6.70. C44H50O10 requires C, 71.52; H, 6.82%); νmax(film)/cm
-1 
3052w, 3001w, 2926br,s (C-H), 1612s, 1513s, 1461m, 1355s, 1248s, 1174m, 1070br,s; 
δH(300 MHz, CDCl3) 3.42 – 3.50 (2H, stack), 3.61 (3H, s, OCH3), 3.63 – 3.66 (2H, stack), 
3.72 – 3.83 (15H, stack including 3.79 (3H, s, ArOCH3), 3.82 (3H, s, ArOCH3), 3.83 (3H, s, 
ArOCH3)), 4.33 (1H, d, J 7.8, H1’), 4.65 (1H, A of AB, JAB 10.5), 4.70 (1H, A of AB, JAB 10.6), 
4.76 (2H, s, H29’), 4.79 (1H, A of AB, JAB 10.6), 4.82 (1H, B of AB, JBA 10.5)), 4.89 (1H, B of 
AB, JBA 10.6), 4.91 (1H, B of AB, JBA 10.6), 6.84 – 6.92 (6H, stack, ArH), 7.22 – 7.35 (6H, 
stack, ArH), 7.47 – 7.52 (3H, stack, ArH), 7.81 – 7.86 (4H, stack, ArH); δC(75 MHz, CDCl3) 
[55.1, 57.0 (CH3, OCH3), resonance overlap], [69.5, 70.0, 71.1, 73.1, 74.3, 74.5 (CH2)], 74.8 
(CH), 75.2 (CH2), [77.5, 81.9, 84.2 (CH)], 104.6 (CH, C1’), [113.6, 125.6, 125.9, 126.2, 127.5, 
127.7, 128.0, 129.3, 129.5, 129.6 (CH, Ar), resonance overlap], [130.3, 130.6, 130.8, 132.8, 
133.1, 135.7 (quat. C, Ar)], [159.0, 159.1 (quat. C, Ar), resonance overlap]; m/z (TOF ES+) 
761.5 (100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 761.3309. C44H50O10Na 
requires 761.3302]. 
O
PMBO
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C44H50O10
Exact Mass: 738.3404
Mol. Wt.: 738.8618
C, 71.52; H, 6.82; O, 21.65
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Methyl (2,3,4-tris-O-acetyl)-6-O-[2-(2-naphthylmethoxy)ethyl]-β-D-glucopyranoside 30 
 
 
 
 
 
 
CAN (0.77 g, 1.4 mmol) was added to ether 27 (0.54 g, 0.74 mmol) in acetone/H2O (9:1, 7.4 
mL) at 0 °C as described in general procedure E.  Further CAN (2.43 g, 4.4 mmol) in 
acetone/H2O (9:1, 9.0 mL) was added after the initial exotherm had ceased.  After stirring at 
rt overnight, and subsequent work up, the resultant yellow oil was directly acetylated 
following general procedure A.  Purification of the crude acetylated material by column 
chromatography (8:2 hexane/EtOAc, Rf = 0.5, in 1:1 hexane/EtOAc) furnished the triacetate 
30 as a pale yellow syrup (0.22 g, 59%): [α]D
20 +1.7 ° (c 1.0 in CHCl3); (Found: C, 61.63; H, 
6.24. C26H32O10 requires C, 61.90; H, 6.39%); νmax(film)/cm
-1  3486w , 3056w, 2941 br,s (C-
H), 2871br,s (C-H), 1756br,s (C=O), 1603w, 1510m, 1447m, 1373s, 1220br,s, 1039br,s, 
906m , 820m, 754m; δH(400 MHz, CDCl3) 1.88 (3H, s, COCH3), 1.90 (3H, s, COCH3), 1.95 
(3H, s, COCH3), 3.37 (3H, s, OCH3), 3.49 – 3.59 (7H, stack, H5’, H6’, H7’, H8’), 4.30 (1H, d, 
J 8.0, H1’), 4.60 (2H, s, H9’), 4.90 (1H, dd, J 9.6, 8.0, H2’), 4.97 (1H, app t, J 9.4, H4’), 5.14 
(1H, app t, J 9.5, H3’), 7.34 – 7.39 (3H, stack, 3 x ArH), 7.69 (1H, s, H11’), 7.72 – 7.74 (3H, 
stack, 3 x ArH); δC(125 MHz, CDCl3) [20.4, 20.5 (CH3, COCH3), resonance overlap], 56.7 
(CH3, OCH3), 69.2 (CH), [69.3, 70.2, 71.1 (CH2) ], [71.2, 72.8 (CH)], 73.1 (CH2), 73.2 (CH), 
101.2 (CH, C1’), [125.5, 125.6, 125.9, 126.2, 127.5, 127.6, 127.9 (CH, Ar)], 132.7, 133.0, 
135.5 (quat. C, Ar)], [169.2, 169.4, 170.1 (quat. C, C=O)]; m/z (TOF ES+) 527.2 (100%, 
[M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 527.1902. C26H32O10Na requires 
527.1893]. 
C26H32O10
Exact Mass: 504.1995
Mol. Wt.: 504.5263
C, 61.90; H, 6.39; O, 31.71
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β-Methyl 6-O-[2-(2-naphthylmethoxy)ethyl]-D-glucopyranoside 33 
 
 
 
 
 
NaOMe (0.17 g, 3.1 mmol) was added to a solution of triacetate 30 (0.43 g, 0.85 mmol) in 
MeOH (34 mL).  The reaction was carried out according to general procedure B.  After 
stirring overnight, work up afforded triol 33 as a pale yellow syrup (0.22 g, 75%); Selected 
data for XE10b: m/z (TOF ES+) 401.1 (100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: 
[M+Na]+ 401.1584. C20H26O7Na requires 401.1576].  Structure inferred from previous 
compound 30. UV spectrum in Section 2 of the Appendix. 
 
Methyl (2,3,4-tris-O-p-methoxybenzyl)-6-O-{2-[2-(2-naphthylmethoxy)ethoxy]ethyl}-α-D-
glucopyranoside 28 
 
 
 
 
 
 
 
 
NaH (0.03 g, 60 wt% dispersion in mineral oil, 0.66 mmol) was added to a solution of alcohol 
17a (0.33 g, 0.60 mmol) in DMF (1.0 mL) at 0 °C.  After 30 min, a solution of bromide 19(0.55 
g, 1.8 mmol) in DMF (5 mL) was added and the reaction carried out according to general 
O
HO
HO
OH
O
1'
2'3'
4' 5'
6'
7'
O8'
9'
10'
11' 12'
13' 14'
15'
16'
17'
18'
19'
OMe
C20H26O7
Exact Mass: 378.1679
Mol. Wt.: 378.4162
C, 63.48; H, 6.93; O, 29.60
O
PMBO
PMBO
PMBO
O
1'
2'3'
4' 5'
6'
7'
O8'
9'
10'
11'
OMe
12' 13'
14' 15'
16'
17'18'
19'
O
20'
21'
C46H54O11
Exact Mass: 782.3666
Mol. Wt.: 782.9144
C, 70.57; H, 6.95; O, 22.48
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procedure D.  After 4 d, work up afforded a yellow residue which was purified by column 
chromatography (Rf = 0.30 in 6:4 hexane/EtOAc) to yield ether 28 as a pale yellow syrup 
(0.26 g, 56%): [α]D
20 −12.7 ° (c 1.0 in CHCl3); (Found: C, 70.39; H, 7.10. C46H54O11 requires 
C, 70.57; H, 6.95%); νmax(film)/cm
-1 3000m, 2907s (C-H), 2836s (C-H), 1613s, 1586m, 1514s, 
1464m, 1357s, 1302s, 1249s, 1173s, 1077br,s, 820s; δH(300 MHz, CDCl3) 3.34 (3H, s, 
OCH3), 3.49 (1H, A of ABX, JAB 9.6, JAX 3.6, HaHb6’), 3.54 – 3.71 (12H, stack), 3.75 (3H, s, 
ArOCH3), 3.78 (3H, s, ArOCH3), 3.76 (3H, s, ArOCH3), 3.93 (1H, t, J 9.2), 4.52 (1H, d, J 3.5, 
H1’), 4.58 (1H, A of AB, JAB 11.8), 4.59 (1H, A of AB, JAB 10.7), 4.65 (2H, s, H211’), 4.73 (1H, 
A of AB, JAB 11.8), 4.77 (1 H, A of AB, JAB 10.5), 4.81 (1H, B of AB, JBA 10.7)), 4.89 (1H, B of 
AB, JBA 10.5), 6.83 – 6.88 (6H, stack, ArH), 7.22 – 7.31 (6H, stack, ArH), 7.41 – 7.48 (4H, 
stack, ArH), 7.73 (1H, s, ArH), 7.73 – 7.81 (2H, stack, ArH); δC(75 MHz, CDCl3) [55.0, 55.1 
(CH3, OCH3), resonance overlap], [69.4, 69.7 (CH2)], 69.9 (CH), [70.4, 70.6, 70.8, 72.9, 73.2, 
74.6, 75.3 (CH2)], [77.3, 79.4, 81.7 (CH)], 98.14 (CH, C1’), [113.7, 125.7, 125.9, 126.3, 
127.5, 127.7, 128.0, 129.4, 129.5, 129.6 (CH, Ar), resonance overlap], [130.2, 130.6, 131.0, 
132.8, 133.1, 135.6 (quat. C, Ar)], [159.0, 159.1, 159.2 (quat. C, Ar)]; m/z (TOF ES+) 805.5 
(100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 805.3577. C46H54O11Na requires 
805.3564]. 
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Methyl (2,3,4-tris-O-acetyl)-6-O-{2-[2-(2-naphthylmethoxy)ethoxy]ethyl}-α-D-
glucopyranoside 31 
 
 
 
 
 
 
 
CAN (0.83 g, 1.5 mmol) was added to a solution of ether 28 (0.63 g, 0.80 mmol) in 
acetone/H2O (9:1, 8.0 mL) at rt as detailed in general procedure E.  Further CAN (2.63 g, 4.8 
mmol) in acetone/H2O (9:1, 12.0 mL) was added after the initial exotherm had ceased.  After 
stirring at rt overnight, work up yielded a dark oil which was directly acetylated following 
general procedure A.  Purification of the crude product by column chromatography (Rf =0.17 
in 6:4 hexane/EtOAc) afforded the triacetate 31 as a pale yellow syrup (0.22 g, 51%): [α]D
20 
+85.5 ° (c 1.0 in CHCl3); νmax(film)/cm
-1  3056w, 2911br, m (C-H), 1748s (C=O), 1441w, 
1369s, 1226br,s, 1126 m, 1048br,s, 931m, 820m, 733m, (Ar-H); δH(400 MHz, CDCl3) 1.95 
(3H, s, COCH3), 1.96 (3H, s, COCH3), 2.01 (3H, s, COCH3), 3.33 (3H, s, OCH3), 3.53 (1H, A 
of ABX, JAB 11.1, JAX 5.1, C6’HaHb), 3.56 – 3.65 (9H, stack, C6’HaHb, 2 x H7’, 2 x H8’, 2 x H9’, 
2 x H10’), 3.88 (1H, app ddd, J 9.9, 4.8, 2.9, H5’), 4.67 (2H, s, 2 x H11’), 4.81 (1 H, dd, J 9.9, 
3.6, H2’), 4.89 (1H, d, J 3.6, H1’), 5.02 (1H, app t, J 9.9, H4’), 5.44 (1H, app t, J 9.9, H3’), 
7.39 – 7.44 (3H, stack, 3 x ArH), 7.72 (1H, s, C13’), 7.76 – 7.78 (3H, stack, 3 x ArH); δC(125 
MHz, CDCl3) [20.5 (CH3, COCH3), resonance overlap], 55.1 (CH3, OCH3), 68.2 (CH, C5’), 
69.0 (CH, C4’), [69.2, 69.7 (CH2)], 70.0 (CH, C3’), [70.4 (2 x CH2), resonance overlap], 70.7 
(CH2), 71.0 (CH, C2’), 73.0 (CH2, C11’), 96.3 (CH, C1’), [125.5, 125.6, 125.8, 126.2, 127.4, 
127.6, 127.9 (CH, Ar)], [132.7, 133.0, 135.5 (quat. C, Ar)], [169.4, 169.8 (quat. C, C=O), 
C28H36O11
Exact Mass: 548.2258
Mol. Wt.: 548.5788
C, 61.30; H, 6.61; O, 32.08
O
AcO
AcO
AcO
O
1'
2'3'
4' 5'
6'
7'
O8'
9'
10'
11'
OMe
12' 13'
14' 15'
16'
17'18'
19'
O
20'
21'
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resonance overlap]; m/z (TOF ES+) 571.1 (100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: 
[M+Na]+ 571.2131. C28H36O11Na requires 571.2155]. 
 
Methyl 6-O-{2-[2-(2-naphthylmethoxy)ethoxy]ethyl}-α-D-glucopyranoside 34 
 
 
 
 
 
 
 
NaOMe (0.03 g, 0.7 mmol) was added to a solution of triacetate 31 (0.10 g, 0.18 mmol) in 
MeOH (7.0 mL) as directed in general procedure B.  After stirring overnight, work up yielded 
triol 34 as a pale brown syrup (0.08 g, quant.): [α]D
20 +7.9 ° (c 1.0 in H2O); δH(300 MHz, 
CD3OD) 3.24 – 3.36 (5H, stack including 3.25 (3H, s, C1’OCH3)), 3.53 – 3.70 (12H, stack), 
4.57 (1H, d, J 3.7, H1’), 4.60 (2H, s, H11’), 7.37 – 7.41 (3H, stack, ArH), 7.72 – 7.67 (4H, 
stack, ArH); δC(75 MHz, CD3OD) 55.6 (CH3, OCH3), [70.6, 71.5, 71.6, 71.7 (CH2)], 71.8 (CH), 
72.0 (CH2), [72.4, 73.5 (CH)], 74.1 (CH2), 75.0 (CH), 101.2 (CH, C1’), [126.9, 127.0, 127.5, 
128.7, 128.9, 129.1 (CH, Ar), resonance overlap], [134.4, 134.7, 137.1 (quat. C, Ar)]; m/z 
(TOF ES+) 445.1 (100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 445.1848. 
C22H30O8Na requires 445.1838]. UV spectrum in Section 2 of the Appendix. 
 
 
 
 
O
HO
HO
OH
O
1'
2'
4' 5'
6'
7'
O8'
9'
10'
11'
OMe
12' 13'
14' 15'
16'
17'18'
19'
O
20'
21'
C22H30O8
Exact Mass: 422.1941
Mol. Wt.: 422.4688
C, 62.55; H, 7.16; O, 30.30
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Methyl (6-iodo-6-deoxy)-α-D-glucopyranoside 52 
 
O
HO
HO
HO
I
OMe
C7H13IO5
Exact Mass: 303.9808
Mol. Wt.: 304.0796
C, 27.65; H, 4.31; I, 41.73; O, 26.31
 
 
Ph3P (1.62 g, 6.2 mmol), I2 (1.57 g, 6.2 mmol) and imidazole (1.26 g, 18.5 mmol) were added 
to a solution of methyl α-D-glucose 10 (1.00 g, 5.2 mmol) in toluene (10.3 mL) at 70 °C.  The 
reaction vessel was then covered in foil and heated at 70 °C for 3.5 h, after which time, the 
reaction mixture was allowed to cool to rt.  H2O (20 mL) was added and the reaction mixture 
was stirred vigorously for 15 min.  The aqueous phase was retained and the organic phase 
extracted with H2O (1 x 20 mL).  The combined aqueous extracts were concentrated under 
reduced pressure and purified by column chromatography through a short silica plug.  The 
combined fractions were then concentrated under reduced pressure to yield the iodo sugar 
52 as a white, crystalline solid (1.36 g, 87%, Rf = 0.29; 3:4 MeOH/EtOAc); [α]D
20 +97.9 ° (c 
1.0 in CHCl3); (Found: C 27.48; H 4.50. C7H13O5I requires C 27.65; H 4.31%); νmax(Nujol 
mull)/cm-1 3438s, br (OH), 2521m, br, 1329w, 1252w, 1185m, 113m, 1041s, 1020s, br; 
δH(300 MHz, D2O) 3.23 – 3.44 (6H, s, including OCH3), 3.54 – 3.70 (3H, stack), 4.76 (1H, d, J 
3.7, H1’); δC(75 MHz, D2O) 8.9 (CH2, CH2I), 57.4 (CH3, OCH3), [75.5, 74.5, 73.2, 72.2 (CH)], 
101.4 (CH, C1’); m/z (TOF ES+) 329.6 ([M + Na]+ 100%); [HRMS Found: 326.9709. 
C7H13O5INa requires 326.9705]. 
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Methyl 2,3,4-tri-O-acetyl-(6-acetylthio-6-deoxy)-α-D-glucopyranoside 53  
 
O
AcO
AcO
OMe
AcO
SAc
1'
2'3'
4' 5'
6'
C15H22O9S
Exact Mass: 378.0985
Mol. Wt.: 378.3948
C, 47.61; H, 5.86; O, 38.05; S, 8.47
O
AcO
AcO
OMe
AcO
S
O OAc
OAc
OMe
OAc
S C26H38O16S2
Exact Mass: 670.1601
Mol. Wt.: 670.7003
C, 46.56; H, 5.71; O, 38.17; S, 9.56
 
 
Thiourea (0.33 g, 4.4 mmol) was added to a solution of XE30 (1.20 g, 3.95 mmol) in DMF (40 
mL).  The reaction mixture was then covered in foil and heated to 70 °C for 2 d after which 
time the reaction mixture was allowed to cool to rt and the DMF was removed under reduced 
pressure.  The residue was dissolved in H2O (100 mL) and NaOH (0.30 g, 7.1 mmol) was 
added before heating the resulting solution under reflux for 1 h.  The reaction mixture was 
cooled to rt and acidified with hydrochloric acid (0.1 M) to ~ pH 4 and then concentrated to ~ 
30 mL under reduced pressure.  The concentrated mixture was extracted with EtOAc (3 x 20 
mL), the aqueous phase was retained and concentrated under reduced pressure.  The 
residue was acetylated according to general procedure A:  Ac2O (3.01 mL, 31.6 mmol) in 
pyridine (6.00 mL) overnight.  The resultant reaction mixture was concentrated under 
reduced pressure and the crude residue was purified by column chromatography (1:1 
hexane/EtOAc; Rf = 0.34) to yield the thioacetate 47a, along with disulfide 47b, as a 
colourless oil (0.72 g, 52%).  Careful separation by column chromatography (7:3, 
hexane/EtOAc , Rf(monomer) = 0.22, Rf(dimer) = 0.23) allowed separation of the two 
compounds for characterisation.  Data for the thioacetate:112  [α]D
20 +98.5 ° (c 1.0 in CHCl3); 
νmax(Nujol mull)/cm
-1 3478w, 3375w, 2941s, br (C-H), 2844m (C-H), 1748s, br (C=O), 1694s, 
br (C=O), 1433m, br, 1372s, 1224s, br, 1167s, 1129s, 1046s, br, 929s, 734s; δH(300 MHz, 
CDCl3) 1.94 (3H, s, C(O)CH3), 2.01 (3H, s, C(O)CH3), 2.02 (3H, s, C(O)CH3), 2.29 (3H, s, 
SC(O)CH3), 2.98 - 3.05 (1H, dd, J 14.2, 6.8), 3.12 – 3.17 (1H, dd, J 14.2, 3.1), 3.34 (3H, s, 
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OCH3), 3.86 (1H, app. ddd, J 10.0, 6.9, 3.0), 4.77 – 4.92 (3H, stack), 5.37 (1H, app. t, J 9.6); 
δC(75 MHz, CDCl3) 20.6 (CH3, C(O)CH3), 29.9 (CH2, CH2SC(O)CH3), 30.2 (CH3, SC(O)CH3), 
55.2 (CH3, OCH3), [68.1, 69.9, 70.8, 70.8 (CH)], 96.5 (CH, C1’), 170.0 (quat C, OCOCH3 
resonance overlap), 194.4 (quat. C, -SCOCH3); m/z (TOF ES+) 401.4 ([M + Na]
+ 100%); m/z 
401.0890 ([M + Na]+ C15H22O9NaS requires 401.0882).  Data for the disulfide:  [α]D
20 +197.2 ° 
(c 1.0 in H2O); νmax(Nujol mull)/cm
-1 3479w, 2922s, br (C-H), 2852s, br (C-H), 1745s, br 
(C=O), 1376s, 1217s, br, 1165m, 1125m, 1033s, br, 929m; δH(300 MHz, CDCl3) 1.91 (6H, s, 
C(O)CH3), 1.97 (6H, s, C(O)CH3), 1.98 (6H, s, C(O)CH3), 2.63-2.86 (4H, stack), 3.35 (6H, s, 
OCH3), 3.81-3.97 (2H, m), 4.75-4.89 (4H, stack), 5.30-3.39 (2H, m); δC(75 MHz, CDCl3) 
[20.5 (CH3, 3 x C(O)CH3), resonance overlap], 34.3 (CH2, CH2S), 55.4 (CH3, OCH3), [67.3, 
69.7, 70.7, 71.6 (CH)], 96.3 (CH, C1’), [169.6, 169.7, 169.8 (quat. C, C=O)]; m/z (TOF ES+) 
693.4 ([M + Na]+ 100%); m/z 693.1488  ([M + Na]+ C26H38O16NaS2 requires 693.1499). 
 
Methyl (6-thio-6-deoxy)-α-D-glucopyranoside 45  
O
HO
HO
OMe
HO
SH
1'
2'
3'
4'
5'
6'
C7H14O5S
Exact Mass: 210.0562
Mol. Wt.: 210.2481
C, 39.99; H, 6.71; O, 38.05; S, 15.25
O
HO
HO
OMe
HO
S
1'
2'3'
4' 5'
6'
O
OH
OH
MeO
OH
S
1' 2'
3'
4'5'
6'
C14H26O10S2
Exact Mass: 418.0967
Mol. Wt.: 418.4802
C, 40.18; H, 6.26; O, 38.23; S, 15.32
 
 
Following general procedure B:  NaOMe (1.28 g, 4.9 mmol) was added to a solution of 
thioacetate 53 (1.86 g, 2.9 mmol) in MeOH (200 mL) and stirred overnight.  After work up, 
the solution was concentrated under reduced pressure to furnish the deprotected thiol as a 
mixture of the thiol and disulfide as a pale yellow, crystalline solid (1.02g, 99 %): selected 
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data: mp 78 oC - 91 oC; [α]D
20 +33.5 ° (c 1.0 in H2O); δC(75 MHz, CD3OD) 32.9 (CH2, 
CH2SC(O)CH3), 39.8 (CH2, CH2S-S), [52.5, 52.6 (CH3, OCH3) for thiol and disulfide], [68.2, 
70.5, 71.6, 71.7, 72.0 (CH) resonance overlap], [97.9 (CH, C1’) resonance overlap]; m/z 
(TOF ES+) 441.2 ([M + Na]+ 100%); m/z 441.0857 ([M + Na]+ C14H26O10NaS2 requires 
441.0865). 
 
2-(acetylthio) methylnaphthalene 49 
SAc
C13H12OS
Exact Mass: 216.0609
Mol. Wt.: 216.2988
C, 72.19; H, 5.59; O, 7.40; S, 14.82
 
Following general procedure F, thiourea (0.52 g, 6.8 mmol) was added to a solution of 2-
bromomethylnaphthalene 22 (1.00 g, 4.5 mmol) in EtOH (5 mL) and the reaction mixture was 
heated under reflux for 3 h.  The solution was cooled to rt.  40% aq. KOH solution (5 mL) was 
added and the mixture heated under gentle reflux for 1 h.  This solution was cooled to rt, 
acidified to pH 1 with 10% aq. hydrochloric acid and then extracted with Et2O (3 x 15 mL).   
The organic extracts were dried over MgSO4 and concentrated under reduced pressure.  The 
residue was acetylated according to general procedure A: Ac2O (1.00 mL, 4.5 mmol) in 
pyridine (2.00 mL).  The reaction mixture was then concentrated under reduced pressure and 
purified by column chromatography to furnish the thioacetate 49 as a pale yellow oil (0.80 g, 
81%; 9:1 hexane/EtOAc; Rf = 0.33); νmax(Nujol mull)/cm
-1 3054w, 1637s (C=O), 1132s, br, 
827m, 748s; δH(300 MHz, CDCl3) 2.39 (3H, s, CH3), 4.31 (2H, s, CH2S), 7.34 – 7.52 (3H, 
stack, ArH), 7.78 – 7.84 (4H, stack, ArH); δC(75 MHz, CDCl3) 30.3 (CH3, SC(O)CH3), 33.7 
(CH2, CH2SAc), [125.9, 126.2, 126.8, 127.4, 127.6, 127.7, 128.4 (CH, Ar)], [132.5, 133.3, 
134.9 (quat. C, Ar)]; m/z (TOF ES+) 239.0 ([M + Na]+ 100%); m/z 239.0501 ([M + Na]+ 
C13H12ONaS requires 239.0507). 
 
 
 
242 
 
2-Naphthylmethyl disulfide113 46 
S
S
C22H18S2
Exact Mass: 346.085
Mol. Wt.: 346.5083
C, 76.26; H, 5.24; S, 18.51
 
 
Following general procedure B, NaOMe (0.185 g, 3.4 mmol) was added to a solution of 
thioacetate 49 (0.616 g, 2.85 mmol) in MeOH (114 mL).  After stirring overnight at rt, CH2Cl2 
(20 mL) was added to aid dissolution before continuing the work up as per general procedure 
B.  The resultant solution was concentrated under reduced pressure to furnish the 
deprotected disulfide as a pale yellow, crystalline solid (0.014 g, quant.): mp 43oC - 48 oC 
νmax(Nujol mull)/cm
-1 3054w, 1598w, 1377m, 842s, 744s; δH(300 MHz, CDCl3) 3.73 (4H, s, 
CH2SH), 7.35 (2H, dd, J 8.4, 1.7, ArH), 7.46 – 7.55 (6H, stack, ArH), 7.77 – 7.85 (6H, stack, 
ArH); δC(75 MHz, CDCl3) 43.6 (CH2, CH2SH), [125.9, 126.2, 127.2, 127.7, 128.2, 128.3 (CH, 
Ar), resonance overlap], [132.6, 133.2, 134.5 (quat. C, Ar)]; m/z (TOF ES+) 346.1 ([M + Na]+ 
100%). 
Data were in agreement with those reported in the literature113 
 
2-(2Acetylthioethoxy)ethoxy methylnaphthalene 50 
O
SAc
C15H16O2S
Exact Mass: 260.0871
Mol. Wt.: 260.3513
C, 69.20; H, 6.19; O, 12.29; S, 12.32
Following general procedure F, thiourea (0.64 g, 8.3 mmol) was added to a solution of 
bromide 18 (1.00 g, 3.8 mmol) in EtOH (4.2 mL).  The reaction mixture was heated under 
reflux overnight.  The solution was then cooled to rt and aq. KOH solution (40% w/v, 2.5 mL) 
was added and the resulting mixture heated under gentle reflux for 1 h.  This solution was 
then cooled to rt, acidified to pH 1 with 10% aq. hydrochloric acid and then extracted with 
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Et2O (3 x 10 mL).  The organic extracts were concentrated under reduced pressure and then 
acetylated using general method A:  Ac2O (0.80 mL, 3.8 mmol) in pyridine (1.60 mL).  The 
resultant residue was purified by column chromatography (9:1 hexane/EtOAc; Rf = 0.30) to 
yield the thioacetate 50 as a colourless oil (0.82 g, quant.); (Found: C, 68.91; H, 6.07. 
C15H16O2S requires C, 69.20; H, 6.19%); νmax(film)/cm
-1 3055m, 2932 (C-H), 2858 (C-H), 
1691s (C=O), 1602w, 1509m, 1366m, 1353m, 1124s, 1101s, br, 817m; δH(300 MHz, CDCl3) 
2.35 (3H, s, SC(O)CH3), 3.19 (2H, t, J 6.3, OCH2CH2SAc), 3.66 (2H, t, J 6.3, OCH2CH2SAc), 
4.70 (2H, s, NpCH2O), 7.49 - 7.52 (3H, stack, ArH), 7.80 (1H, s, ArH), 7.85-7.88 (3H, stack, 
ArH); δC(75 MHz, CDCl3) 28.9 (CH2, AcSCH2), 30.3 (CH3, SC(O)CH3), 68.5 (CH2), 72.8 
(CH2), [125.5, 125.7, 125.9, 126.2, 127.5, 127.7, 128.0 (CH, Ar)],  [132.8, 133. , 135.3 (quat. 
C, Ar)], 195.1 (quat. C, C=O); m/z (TOF ES+) 283.1 ([M + Na]+ 100%); m/z 283.0771  ([M + 
Na]+ C15H16O2NaS requires 283.0769). 
 
2-(2-mercaptoethoxy) methylnaphthalene 47 and 47a 
O
SH
O
S
O
S
C13H14OS
Exact Mass: 218.0765
Mol. Wt.: 218.3147
C, 71.52; H, 6.46; O, 7.33; S, 14.69
C26H26O2S2
Exact Mass: 434.1374
Mol. Wt.: 434.6134
C, 71.85; H, 6.03; O, 7.36; S, 14.76
 
 
Following general procedure B:  NaOMe (0.20 g, 3.7 mmol) was added to a solution of 
thioacetate 50 (0.80 g, 3.1 mmol) in MeOH (124 mL).  After work up, the solution was 
concentrated under reduced pressure to furnish the thiol and disulfide 47 and 47a (ratio 
4.4:1.0), as a pale brown oil (0.014 g, quant.); Data on the mixture: νmax(film)/cm
-1 3053w, 
2931m, 2855m, 1601w, 1508m, 1366m, 1124s, 1100s, br; δH(300 MHz, CDCl3) 1.74 (1H, t, J 
8.2, SH), 2.80 (2H, app. q, J 6.4, OCH2CH2SH), 3.02 (4H, t, J 6.4, OCH2CH2S-S), 3.67 (2H, t, 
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J 6.4, CH2CH2SH), 3.82 (4H, t, J 6.4, OCH2CH2S-S), 4.72 (2H, s, NpCH2O for both thiol and 
disulfide), 7.56 – 7.59 (3H, stack, ArH for both thiol and disulfide), 7.87 (1H, s, ArH for both 
thiol and disulfide), 7.92 – 7.94 (3H, stack, ArH for both thiol and disulfide); δC(75 MHz, 
CDCl3) 24.1 (CH2, OCH2CH2SH), 38.5 (CH2, OCH2CH2S-S), 68.1 (CH2, 1 x CH2O for 
disulfide), [71.5, 72.6 (CH2, 2 x CH2O in thiol with resonance overlap with 1 x CH2O disulfide], 
[125.3, 125.6, 125.8, 126.0, 127.4, 127.5, 127.9 (CH, Ar, for thiol and disulfide)], [132.6, 
132.9, 135.3 (quat. C, Ar, resonance overlap for both thiol and disulfide]; m/z (TOF ES+) 
241.1 ([M + Na]+ 100%); m/z 241.0666  ([M + Na]+ C13H14ONaS requires 241.0663). 
  
2-[2-(2-Acetylthioethyl)ethoxy] methylnaphthalene 51 
 
 
Following general procedure F, thiourea (0.54 g, 7.1 mmol) was added to a solution of XE8 
(1.00 g, 3.2 mmol) in EtOH (3.6 mL) and the reaction mixture was heated under reflux 
overnight.  The solution was cooled to rt, 40% aq. KOH solution (2.0 mL) was added and the 
mixture heated under gentle reflux for 1 h.  This solution was cooled, acidified to pH 1 with 
10% aq. hydrochloric acid and then extracted with Et2O (3 x 10 mL).  The organic extracts 
were concentrated under reduced pressure and then subjected to acetylation overnight 
following general method A:  Ac2O (1.36 mL, 6.4 mmol) in pyridine (2.72 mL).  After this time, 
the reaction mixture was concentrated under reduced pressure and the residue purified by 
column chromatography (gradient: 9:1 hexane/EtOAc to 1:1 hexane/EtOAc, Rf = 0.16) to 
yield the thioacetate 44 as a colourless oil (0.80 g, 94%); (Found: C, 67.16; H, 6.21. 
C17H20O3S requires C, 67.08; H, 6.62%); νmax(film)/cm
-1 3054m, 2863 (C-H), 1690s (C=O), 
1602w, 1509m, 1354m, 1124s, 1100s, br, 818m; δH(300 MHz, CDCl3) 2.31 (3H, s, 
SC(O)CH3), 3.13 (2H, t, J 6.4, OCH2CH2SAc), 3.61 – 3.65 (6H stack, (including  3.61 (2H, t, J 
O
O
SAc
C17H20O3S
Exact Mass: 304.1133
Mol. Wt.: 304.4039
C, 67.08; H, 6.62; O, 15.77; S, 10.53
245 
 
6.4, CH2SAc), 2 x OCH2, CH2SAc), 4.72 (2H, s, NpCH2O), 7.44 – 7.50 (3H, stack, ArH), 7.80 
– 7.85 (4H, stack, ArH); δC(75 MHz, CDCl3) 28.6 (CH2, AcSCH2), 30.2 (CH3, SC(O)CH3), 
[69.1, 69.5, 70.1, 73.0 (CH2)], [125.46, 125.53, 125.8, 126.1, 127.4, 127.6, 127.8 (CH, Ar)],  
[132.7, 133.0, 135.5 (quat. C, Ar)], 195.0 (C=O); m/z (TOF ES+) 327.2 ([M + Na]+, 100%); 
m/z 327.1039  ([M + Na]+ C17H20O3NaS requires 327.1031). 
 
 
2-[2-(2-mercaptoethyl)ethoxy]naphthalene 48 and 48a 
 
O
O
SH
C15H18O2S
Exact Mass: 262.1028
Mol. Wt.: 262.3672
C, 68.67; H, 6.92; O, 12.20; S, 12.22
 
 
 
Following general procedure B:  NaOMe (0.20 g, 3.7 mmol) was added to a solution 
of thioacetate 51 (0.80 g, 3.1 mmol) in MeOH (124 mL).  After work up, the solution 
was concentrated under reduced pressure to furnish the thiol and disulfide 48 and 
48a (ratio 4.4:1.0), as a pale brown oil (0.014 g, quant.); selected data on the 
mixture: δH(300 MHz, CDCl3) 1.74 (1H, t, J 8.2, SH), 2.71 (2H, t, J 6.4, OCH2CH2SH), 
3.02 (2H, t, J 6.4, OCH2CH2S-S), 3.62 – 3.66 (4H, stack), 3.68 (4H, s s, NpCH2O for 
disulfide), 4.72 (2H, s, NpCH2O for thiol), 7.44 – 7.51 (6H, stack, ArH for both thiol 
and disulfide), 7.80 – 7.85 (8H, stack, ArH for both thiol and disulfide); δC(75 MHz, 
CDCl3) 24.3 (CH2, OCH2CH2SH), (31.8 (CH2, OCH2CH2S-S), 38.5 (CH2, OCH2CH2S-
S), [68.3, 69.6, 70.3, 70.4, 72.9, 73.3 (CH2, OCH2 for thiol and disulfide) resonance 
overlap], [125.5, 125.8, 126.1, 126.4, 127.6, 127.8, 128.1 (CH, Ar, for thiol and 
disulfide)], [132.9, 133.2, 135.6 (quat. C, Ar, resonance overlap for both thiol and 
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disulfide]; m/z (TOF EI+) 262.0 ([M]+, 12%); m/z 262.1016  ([M]+ C15H18O2S requires 
262.1028). 
 
D-Galactose-penta-O-acetate114 54 
O
AcO
AcO
AcO
OAc
OAc
C16H22O11
Exact Mass: 390.1162
Mol. Wt.: 390.3393
C, 49.23; H, 5.68; O, 45.09
 
D-Galactose (5.0 g, 28.0 mmol) was added portion-wise over 10 minutes to a solution of I2 
(0.5 g, 4.0 mmol) in Ac2O (56.0 mL).  The reaction mixture was stirred for 2 h at rt, after 
which time the reaction solution was diluted with CH2Cl2 (175 mL) and poured onto a mixture 
of saturated Na2SO3 solution (75 mL) and ice (50 mL).  Once the ice had melted the organic 
phase was retained and washed with further saturated Na2SO3 solution (75 mL) and 
saturdated NaHCO3 solution (4 x 75 mL).  The organic layers were dried over MgSO4 and 
then the solvent removed under reduced pressure to yield the per-acetylated galactoside 54 
without the need for further purification as a white, crystalline solid (10.9 g, quant.); δH(300 
MHz, CDCl3) 1.92 (3H, s, C(O)CH3), 1.94 (3H, s, C(O)CH3), 1.95 (3H, s, C(O)CH3), 2.07 (3H, 
s, C(O)CH3), 2.08 (3H, s, C(O)CH3), 3.95 – 4.07 (2H, stack), 4.27 (1H, app. t, J 6.7, CH), 
5.23 – 5.24 (2H, stack), 5.41 (1H, app. s, CH), 6.28 (1H, d, J  2.2, H1’); δC(75 MHz, CDCl3) 
[20.3, 20.4, 20.6 (CH3, C(O)CH3 (resonance overlap))], 61.0 (CH2), [66.2, 67.1, 67.2, 68.5 
(CH)], 89.5 (CH, C1’), [168.7, 169.6, 169.8, 169.9, 170.0 (quat. C, C=O)]. 
 
 
Bromo (2,3,4,6-tetra-O-acetyl)-α-D-galactoside115 55 
 
O
AcO
AcO
AcO
OAc
Br
C14H19BrO9
Exact Mass: 410.0212
Mol. Wt.: 411.1993
C, 40.89; H, 4.66; Br, 19.43; O, 35.02
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AcBr (11.1 g, 90.0 mmol) and MeOH (1.46 mL, 36.0 mmol) were added sequentially to a 
solution of 54 (10.9 g, 28.0 mmol) in AcOH (93 mL).  The reaction mixture was stirred at rt for 
4 h, after which time the solvent was removed under reduced pressure to yield the galactosyl 
bromide 55 as a pale yellow syrup without the need for further purification (11.5 g, quant.); 
[α]D
20 +150.4 ° (c 1.0 in CHCl3); νmax(film)/cm
-1 2967br, s (C-H), 1749br, s (C=O), 1431m, 
1372s, 1221br, s, 1079br, s; δH(300 MHz, CDCl3) 1.93 (3H, s, C(O)CH3), 1.97 (3H, s, 
C(O)CH3), 2.03 (3H, s, C(O)CH3), 2.07 (3H, s, C(O)CH3), 3.99 – 4.14 (2H, stack), 4.41 (1H, 
app. t, J 6.5, CH), 4.95 (1H, dd, J 10.7, 3.9), 5.31 (1H, dd, J 10.7, 3.3), 5.43 (1H, app. dd, J 
3.3, 1.2),  6.28 (1H, d, J 2.2, H1’); δC(75 MHz, CDCl3) [19.6, 20.3, 20.5 (CH3, C(O)CH3 
(resonance overlap))], 60.6 (CH2), [66.8, 67.6, 67.8, 70.9 (CH)], 88.0 (CH, C1’), [169.4, 
169.6, 169.7, 170.0 (quat. C, C=O)]. 
 
p-Nitrophenyl (2,3,4,6-tetra-O-acetyl)-β-D-galactoside116 56 
 
 
O
AcO
AcO
AcO
OAc
O
NO2
C20H23NO12
Exact Mass: 469.122
Mol. Wt.: 469.3961
C, 51.18; H, 4.94; N, 2.98; O, 40.90
 
p-Nitrophenol (7.6 g, 0.20 mol) and then Et3N (24 mL, 0.18 mol) were added 
sequentially to a solution of   (4.0 g, 9.7 mmol) in MeCN (200 mL).  The reaction 
mixture was stirred at rt for 4 d after which time the reaction solution was diluted with 
CH2Cl2 (100 mL) and washed with 0.1M NaOH solution (4 x 200 mL) and then H2O 
(2 x 200 mL).  The organic phases were dried over MgSO4 and then the solvent 
removed under reduced pressure.  The resultant residue was purified by column 
chromatography to yield the pNP-functionalised acetyl sugar as a white crystalline 
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solid¤ (1.84 g, 42%; Rf = 0.50, 6:4 hexane/EtOAc): mp 138 
oC – 140 oC; [α]D
20 -14.4° 
(c 1.0 in CHCl3); (Found: C, 51.27; H, 4.70; N, 2.68. C20H23NO12 requires C, 51.18; H, 4.94; 
N, 2.98%); νmax(film)/cm
-1 3057m, 2986m, 2306w, 1753br,s (C=O), 1594m, 1522m, 
1370m, 1346s, 1266s, 1233br, s, 1078s, 738s; δH(300 MHz, CDCl3) 2.00 (3H, s, 
C(O)CH3), 2.05 (6H, s, 2 x C(O)CH3), 2.17 (3H, s, C(O)CH3), 2.07 (3H, s, C(O)CH3), 
4.11 – 4.24 (3H, stack), 5.12 (1H, dd, J 10.4, 3.4, CH), 5.18 (1H, d, J 7.9), 5.46 – 
5.53 (2H, stack), 7.04 – 7.10 (2H, m, ArH), 8.16 – 8.21 (2H, m, ArH); δC(75 MHz, 
CDCl3) [20.5, 20.6 (CH3, C(O)CH3 (resonance overlap))], 61.3 (CH2), [66.7, 68.2, 
70.5, 71.4(CH)], 98.5 (CH, C1’), [116.5, 125.7 (CH, ArH)],143.1 (quat. C, ArCNO2), 
143.13 (quat. C, ArCO), [169.1, 169.9, 170.0, 170.2 (quat. C, C=O)]; m/z (TOF ES+) 
492.1 ([M + Na]+, 100%); m/z 492.1111  ([M + Na]+ C20H23NO12Na requires 492.1118). 
 
 
p-Nitrophenyl β-D-galactoside 57 
 
O
OH
HO
OH
O
OH
NO2
C12H15NO8
Exact Mass: 301.0798
Mol. Wt.: 301.2494
C, 47.84; H, 5.02; N, 4.65; O, 42.49
 
 
NaOMe (1.33 g, 24.3 mmol) was added to a solution of GalOpNPOAc (1.84 g, 3.9 mmol).) in 
MeOH (156 mL).  The reaction mixture was stirred overnight at rt and then acidified to pH 2 
with Amberlite IR120 H+ resin.  The resin was removed by filtration, and the filtrate 
concentrated under reduced pressure to yield the p-NP-functionlised galactoside as a white 
solid which required no further purification (1.16 g, quant.); mp 171 oC – 174 oC; [α]D
20 -
147.2° (c 1.0 in H2O); (Found: C, 47.77; H, 5.27; N, 4.35. C12H15NO8 requires C, 47.84; H, 
                                                           
¤
 On large scale the compound was isolated as a pale yellow syrup, but when lyophilised gave a white 
crystalline solid. 
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5.02; N, 4.65%); νmax(nujol mull)/cm
-1 3339br, s (O-H), 1495m, 1376m, 1346s, 1256m, 
1086s, 1031m; δH(300 MHz, CDCl3)   3.62 (1H, dd, J 9.7, 3.4) 3.73 – 3.88 (4H, 
stack), 3.92 (1H, d, J 3.36), 5.02 (1H, d, J 7.7, H1’), 7.22- 7.28 (2H, m, ArH), 8.19 – 
8.24 (2H, m, ArH); δC(75 MHz, CD3OD) 62.5 (CH2), [70.2, 72.0, 74.8, 77.3 CH)], 
102.3 (CH, C1’), [117.8, 126.6 (CH, ArH)],143.9 (quat. C, ArC), 164.0 (quat. C, ArC); 
m/z (TOF ES+) 324.1 ([M + Na]+, 100%).  
 
5.3 Enzymatic Reactions 
Method for the determination of the activity of the enzyme 
 
Method ENZ 1 
Methyl α-D-glucose (1.0 mmol, 0.194 g [glycosyl acceptor]) and p-nitrophenyl galactose (0.1 
mmol, 0.030 g [glycosyl donor]) suspended in aq. NaOAc buffer (0.5 mL, 50 mM, pH 5.0) 
were stirred at 55 oC with β-galactosidase from B. circulans (1.2 U/mmol acceptor).  20 mL 
aliquots were taken at 5, 10, 20, 40, 80 and 120 min and were heated for 5 min at 100 oC to 
terminate the reaction prior to analysis by HPLC.   
 
Method ENZ 2 
Methyl α-D-glucose (0.6 mmol, 0.116 g) and p-nitrophenyl galactose (0.1 mmol, 0.030 g) 
dissolved in aq. NaOAc buffer (3.0 mL, 50 mM, pH 5.0) were stirred at 30 oC with β-
galactosidase from B. circulans (30.0 U/mmol acceptor).  20 mL aliquots were taken at 2, 4, 
6, 8, 10, 15, 20, 30, 45, 60, 90, 120, 180 and 240 min and were heated for 5 min at 100 oC to 
terminate the reaction prior to analysis by HPLC.  
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ENZ 3a and ENZ 3b 
These experiments were carried out according to the method for ENZ1 but omitting the 
glycosyl acceptor GlcOMe.  ENZ 3a was carried out at 55 oC and ENZ 3b at 30 oC. 
 
Control Experiments 
These experiments were carried out according to the method for ENZ1 in the following 
conditions: 
 
C1:  no glycosyl donor added 
C2: D-galactose added as the glycosyl donor, p-nitrophenol added as the glycosyl donor. 
C3: only GalOpNP added as glycosyl donor 
C4: Lactose as the glycosyl donor, Methyl α-D-glucose as the glycosyl acceptor. 
 
ENZ 4a and ENZ 4b 
These experiments were carried out according to the method for ENZ1 but ENZ 4a using 
GalOpNP as the glycosyl donor and ENZ 4b using Lac as the glycosyl  donor.   
 
Method for experiment ENZ 5 
Lactose (0.30 mmol, 0.100 g) was suspended in a mixed solvent system (0.73 µL, 0.4 M, see 
Table 3.3.1a for permutations) and was stirred at a given temperature (see Table 3.3.1.1d) 
with the β-galactosidase from B. circulans (0.7 U, 0.002 mg).  10 µL aliquots were taken at 5, 
10, 15, 30, 60 and 120 min then at 24 h and 48 h.  Aliquots heated for 5 min at 100 oC to 
terminate the reaction and diluted in H2O (600 µL) prior to analysis by HPLC.  
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ENZ 6 & 7 
Variables: 
Reaction  pH % MeCN Temperature oC 
D 5.0  20 30 
F 7.0  40 30 
G 7.0  30 30 
H 7.0  20 30 
P 7.0  20 55 
Table 3.3.1.2b 
 
Method for experiment ENZ 6 
 Lactose (0.14 mmol, 0.048 g) and α-methyl glucose (1.00 mmol, 0.194 g) were suspended 
in a mixed solvent system (2.50 mL, 0.4 M wrt acceptor, see Table 3.3.1.2b for details) and 
was stirred at a given temperature (see Table 3.3.1.1f) with the β-galactosidase from B. 
circulans (2.45 U/mmol acceptor, 0.008 mg).  10 µL aliquots were taken at 10, 30, 60, 120, 
240 and 360 min and then at 24, 48 and 72 h.  Aliquots were heated for 5 min at 100 oC to 
terminate the reaction and diluted in H2O (600 µL) prior to analysis by HPLC and mass 
spectrometry. 
 
Method for experiment ENZ 7 
GalOpNP (0.14 mmol, 0.042 g) and α-methyl glucose (1.00 mmol, 0.194 g) were suspended 
in a mixed solvent system (2.50 mL, 0.4 M wrt acceptor, see Table 3.3.1.1f for details) which 
was stirred at a given temperature (see Table 3.3.1.1f) with the β-galactosidase from B. 
circulans (2.45 U/mmol acceptor, 0.008 mg).  10 µL aliquots were taken at 10, 30, 60, 120, 
240 and 360 min and then at 24 h and 48 h.  Aliquots were heated for 5 min at 100 oC to 
terminate the reaction and diluted in H2O (600 µL) prior to analysis by HPLC and mass 
spectrometry. 
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ENZ 8 & ENZ 9 
Variables: 
Reaction  pH % MeCN Temperature oC 
D 5.0  20 30 
F 7.0  40 30 
G 7.0  30 30 
H 7.0  20 30 
P 7.0  20 55 
Table 3.3.1.2b 
 
Method for experiment ENZ 8 
Lactose (0.14 mmol, 0.048 g) and α-methyl glucose (1.00 mmol, 0.194 g) were suspended in 
a mixed solvent system (2.50 mL, 1.2 M wrt acceptor, see Table 3.3.1.1f for details), which 
was stirred at a given temperature (see Table 3.3.1.1f) with the β-galactosidase from B. 
circulans (2.45 U/mmol acceptor, 0.008 mg).  10 µL aliquots were taken at 10, 30, 60, 120, 
240 and 360 min and then at 24, 48 and 72 h.  Aliquots were heated for 5 min at 100 oC to 
terminate the reaction and diluted in H2O (600 µL) prior to analysis by HPLC and mass 
spectrometry. 
 
Method for experiment ENZ 9  
GalOpNP (0.14 mmol, 0.042 g) and α-methyl glucose (1.00 mmol, 0.194 g) were suspended 
in a mixed solvent system (2.50 mL, 1.2 M wrt acceptor, see Table 3.3.1.1f for details), which 
was stirred at a given temperature (see Table 3.3.1.1f) with the β-galactosidase from B. 
circulans (2.45 U/mmol acceptor, 0.008 mg).  10 µL aliquots were taken at 10, 30, 60, 120, 
240 and 360 min and then at 24 h and 48 h.  Aliquots were heated for 5 min at 100 oC to 
terminate the reaction and diluted in H2O (600 µL) prior to analysis by HPLC and mass 
spectrometry. 
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ENZ10 
Method for experiment ENZ 10C1 
GalOpNP (0.14 mmol, 0.042 g) was dissolved in aqueous buffer solution (2.50 mL, 0.056 M 
or 0.17030 M; see Table 3.3.2b for details) and was stirred at a given temperature (see Table 
3.3.2b) with the β-galactosidase from B. circulans (1.2 U, 0.007 mg).  10 µL aliquots were 
taken at 0, 0.5, 1, 2, 4, 6 and 10 min.  Aliquots were heated for 5 min at 100 oC to terminate 
the reaction and diluted in aqueous NaOH solution (0.1 M) prior to analysis by UV-vis 
spectroscopy. UV-vis spectroscopy was carried out on 2.8 mL of the solution at a 
concentration of 1 x 10-5 M in a 1cm path length cuvette. 
 
Method for experiment ENZ 11 
Variables: 
Reaction number pH Concentration/M % MeCN Temperature/oC 
ENZ 
11 
C1 
D 5.0 0.170 20 30 
F 7.0 0.170 40 30 
G 7.0 0.170 30 30 
H 7.0 0.170 20 30 
P 7.0 0.170 20 55 
ENZ 
11 
C2 
D 5.0 0.056 20 30 
F 7.0 0.056 40 30 
G 7.0 0.056 30 30 
H 7.0 0.056 20 30 
P 7.0 0.056 20 55 
Table 3.3.2f 
 
GalOpNP (0.14 mmol, 0.042 g) was dissolved in a mixed solvent system (2.50 mL, 0.056 M 
or 0.170 M; see Table 3.3.2f for details) and stirred at a given temperature (see Table 3.3.2f) 
with the β-galactosidase from B. circulans (1.2 U, 0.007 mg).  10 µL aliquots were taken at 0, 
30, 60, 90, 120, 180, 210, 240, 270, 300, 330 and 360 min.  Aliquots were heated for 5 min 
at 100 oC to terminate the reaction and diluted in aqueous NaOH solution (0.1 M) prior to 
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analysis by UV-vis spectroscopy.  UV-vis spectroscopy was carried out on 2.8 mL of the 
solution at a concentration of 1 x 10-5 M in a 1cm path-length cuvette. 
 
ENZ 12 
Variables: 
Reaction 
conditions 
Standard amount of enzyme 
added/g 
Increased amount of enzyme 
added/g 
X2 X4 X8 X16 
 0.007 0.014 0.028 0.056 0.112 
D  pH 
5.0 reaction number 2D 4D 8D 16D 
H  pH 
7.0 reaction number 2H 4H 8H 16H 
Table 3.3.3a 
 
Method for experiment ENZ 12 
GalOpNP (0.14 mmol, 0.042 g) was dissolved in a mixed solvent system (2.50 mL, 0.056 M; 
20 % MeCN, see Table 3.3.3a for pH) and was stirred at a 30 oC with the β-galactosidase 
from B. circulans (see Table 3.3.3a for details).  10 µL aliquots were taken at 0, 10, 30, 60, 
90, 120, 180, 210, 240, 270, 300, 330 and 360 min.  Aliquots were heated for 5 min at 100 
oC to terminate the reaction and diluted in aqueous NaOH solution (0.1 M) prior to analysis 
by UV-vis spectroscopy.  UV-vis spectroscopy was carried out on 2.8 mL of the solution at a 
concentration of 1 x 10-5 M in a 1 cm path-length cuvette. 
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ENZ 13 & ENZ 14 
Variables:  
Reaction number pH Glycosyl donor 
ENZ 13D 5.0 GalOpNP 
ENZ 13H 7.0 GalOpNP 
ENZ 14D 5.0 Lac 
ENZ 14H 7.0 Lac 
Table 3.3.41.a 
 
Method for experiments ENZ 13 and ENZ 14 
The reactions were carried out by suspending the glycosyl donor (0.05 mmol [GalOpNP or 
Lac]) and naphthyl-functionalised methyl glucoside 32 ( 0.4 mmol, 0.128 g) in the mixed 
solvent system (pH 5.0 [ENZ13] or 7.0 [ENZ 14] buffer/MeCN 80:20, 1 mL) at 30 oC.  The β-
galactosidase from B. circulans (7.84 U, 0.024 g [19.6 U mmol-1 acceptor]) was then added 
and aliquots of the reaction solution were taken at 0, 15, 30, 45, 60, 90, 120, 150, 180, 210, 
240, 270, 300, 330 and 360 min, and 24h for analysis by HPLC and mass spectrometry.  
HPLC monitoring was done using a UV (224 nm) and an ECD detector simultaneously.  After 
24 hours the reaction was stopped by denaturing the enzyme by heating.  The reaction 
mixture was then freeze-dried and the carbohydrate residues were acetylated to facilitate 
separation (by column chromatography, 6:4 hexane/EtOAc) of starting material from the 
products which were recovered by flushing the column with 5% MeOH in EtOAc.  This 
flushed fraction was further analysed and separated using analytical HPLC (H2O/MeCN (+ 
0.05 % TFA) gradient 20% to 100 % over 40 minutes, 10 mL min-1) and then mass 
spectrometry was performed on the components.   
 
ENZ 15 and ENZ 16 
The reactions were carried out by suspending the glycosyl donor (0.16 mmol [GalOpNP or 
Lac]) and naphthyl-functionalised methyl glucoside 32 ( 0.75 mmol, 0.250 g) in the mixed 
solvent system pH 7.0 buffer/MeCN 80:20 (1.87 mL) at 30 oC.  The β-galactosidase from B. 
circulans (14.7 U, 0.044 g [19.6 U mmol-1 acceptor]) was then added and aliquots of the 
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reaction solution were taken at 0, 15, 30, 45, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330 
and 360 min, and 24h for analysis by HPLC and mass spectrometry.  HPLC monitoring was 
done using a UV (224 nm) and an ECD detector simultaneously.  After 24 hours the reaction 
was stopped by denaturing the enzyme by heating.  The reaction mixture was then freeze-
dried and the carbohydrate residues were acetylated to facilitate separation (by column 
chromatography, 6:4 hexane/EtOAc) of starting material from the products which were 
recovered by flushing the column with 5% MeOH in EtOAc.  This flushed fraction was further 
analysed and separated using analytical HPLC (H2O/MeCN (+ 0.05 % TFA) gradient 20% to 
100 % over 40 minutes, 10 mL min-1) and then mass spectrometry was performed on the 
components.  Acetylated disaccharide 36 was recovered in 12% yield from ENZ 15 and 9.5% 
yield from ENZ 16. 
 
β-D-(-2,3,4,6-tetra-O-acetyl)-galactopyranoside-(1→2)-α-D-methyl-((2,3,4-tris-O-acetyl)-
6-O-(2-naphthylmethyl))-glucopyranoside 36 
 
 
 
 
 
 
 
Appearance: white powder; [α]D
20 +66.0 ° (c 1.0 in CHCl3); νmax(film)/cm
-1  3022w, 2935br, m 
(C-H), 1747s (C=O), 1433w, 1368s, 1227br,s, 1044br,s, 753m; δH(500 MHz, CDCl3) 1.80 
(3H, s, C4’COCH3), 1.96 (3H, s, C3”COCH3), 2.00 (3H, s, C2”COCH3), 2.05 (3H, s, 
C3’COCH3), 2.06 (3H, s, C6”COCH3), 2.15 (3H, s, C4”COCH3), 3.52 (3H, s, OCH3), 3.51 
O
AcO
AcO
OMe
O
O
O
AcO
AcO
OAc
AcO
1'
2'3'
4'
5'
6'
7'
1"
2"
3"
4"
5"
6"
9'
8'
10'
11'
12' 13'
14'
15'
16'
17'
C36H44O17
Exact Mass: 748.2578
Mol. Wt.: 748.7244
C, 57.75; H, 5.92; O, 36.33
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(1H, A of ABX, JAB 10.8, JAX 4.0, C6’HaHb), 3.58 (1H, B of ABX, JBA 10.8, JBX 2.5, C6’HaHb), 
3.81 (1H, dd, J 10.0, 3.5, H2’), 3.88 (1H, app t, J 6.5, H5”), 3.91 (1H, app dt, J 10.1, 3.1, H5’), 
4.09 (1H, A of ABX, JAB 11.3, JAX 6.5, C6”HaHb), 4.15 (1H, B of ABX, JBA 11.3, JBX 6.5, 
C6”HaHb), 4.58 (1H, d, J 8.1, H1”), 4.62 (1H, A of AB, JAB 12.2, C7’HaHb), 4.78 (1H, B of AB, 
JBA 12.2, C7’HaHb), 4.88 (1H, d, J 3.5, H1’), 4.95 (1H, dd, J 10.4, 3.4, H3”), 5.14 (1H, app t, J 
9.7, H4’), 5.19 (1H, dd, J 10.4, 8.1, H2”), 5.36 (1H, br d, J 2.8, H4”), 5.42 (1H, app t, J 9.7, 
H3’), 7.44 (1H, dd, J 8.5, 1.4, H17’), 7.46 – 7.49 (2H, stack, 2 x ArH), 7.75 (1H, s, H9’), 7.81 
– 7.84 (3H, stack, 3 x ArH); δC(125 MHz, CDCl3) 20.5 (CH3, C2”COCH3), 20.6 (2 x CH3, 
C3”COCH3, C4’COCH3), 20.6 (CH3, C4”COCH3), 20.7 (CH3, COCH3), 20.9 (CH3, COCH3), 
55.5 (CH3, OCH3), 61.4 (CH2, C6”), 67.1 (CH, C4”), 67.8 (CH2, C6’), 68.1 (CH, C5’), 68.6 
(CH, C2”), 69.2 (CH, C4’), 71.0 (2 x CH, C3”, C5”), 72.1 (CH, C3’), 73.7 (CH2, C7’), 76.9 (CH, 
C2’), 99.0 (CH, C1’), 101.9 (CH, C1”), 125.9 (CH, C17’), 126.0 (CH, Ar), 126.1 (CH, Ar), 
126.8 (CH, C9’), 127.7 (CH, Ar), 127.9 (CH, C11’), 128.2 (CH, Ar), 133.0 (quat. C, C15’), 
133.2 (quat. C, C10’), 135.1 (quat. C, C8’), 169.8 (quat. C, C2”COCH3), 169.8 (quat. C, 
C4’COCH3), 169.9 (quat. C, C3’COCH3), 170.1 (quat. C, C3”COCH3), 170.2 (quat. C, 
C4”COCH3), 170.4 (quat. C, C6”COCH3); m/z (TOF ES
+) 771.2 (100%, [M+Na]+). [HRMS m/z 
(TOF ES+) Found: [M+Na]+ 771.2466. C36H44O17Na requires 771.2476]. 
 
ENZ 17 
Lactose (0.015 g, 0.043 mmol) and 33 (0.113 g, 0.30 mmol) were suspended in the mixed 
solvent system pH 7.0 buffer/MeCN 80:20 (0.75 mL) at 30 oC.  The β-galactosidase from B. 
circulans (5.9 U, 17.6 mg, 19.6 U mmol-1 acceptor) was then added and aliquots of the 
reaction solution were taken at regular intervals for analysis by HPLC and mass 
spectrometry.  After 24 hours the reaction was stopped by denaturing the enzyme by 
heating.  The reaction mixture was then freeze-dried and the carbohydrate residues were 
acetylated to facilitate the separation (by column chromatography, 6:4 hexane/EtOAc) of 
starting material from the products which were recovered by flushing the column with 5% 
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MeOH in EtOAc.  This flushed fraction was further analysed and separated using analytical 
HPLC (H2O/MeCN gradient 00% to 100 % over 50 minutes, 1 mL min
-1) and then mass 
spectrometry was performed on the components.  Acetylated disaccharide 38 was recovered 
in 41% yield (14 mg). 
 
β-D-(-2,3,4,6-tetra-O-acetyl)-galactopyranoside-(1→2)-β-D-methyl-((2,3,4-tris-O-acetyl)- 
6-O-[2-(2-naphthylmethoxy)ethyl]glucopyranoside 38  
 
O
AcO
AcO
O
O
AcO
AcO
OAc
O
OAc
O
1'
2'
3'
4'
5'
6'
7'
8'
9'
10'
11'
12'
13'
14'
15'
16'
17'
18'
19'
1"2"3"
4" 5"
6"
OMe
C38H48O18
Exact Mass: 792.2841
Mol. Wt.: 792.7769
C, 57.57; H, 6.10; O, 36.33
 
 
 
Appearance: white powder; δH(500 MHz, CDCl3) 1.96 (3H, s, C3”COCH3), 2.00 (3H, s, 
C4’COCH3), 2.02 (3H, s, C2”COCH3), 2.06 (3H, s, C6”COCH3), 2.11 (3H, s, C2’COCH3), 
2.14 (3H, s, C4”COCH3), 3.44 (3H, s, OCH3), 3.58 (1H, A of ABX, JAB 11.6, JAX 6.9, C6’HaHb), 
3.63 – 3.71 (6H, stack, including: B of ABX, C6’HaHb, 2 x H7’, 2 x H8’, H5’), 3.86 – 3.90 (2H, 
stack, H5”, H3’), 4.17 (1H, A of ABX, JAB 11.1, JAX 6.2, C6”HaHb), 4.05 (1H, B of ABX, JBA 
11.1, JBX 7.3, C6”HaHb), 4.28 (1H, d, J 8.0, H1’), 4.54 (1H, d, J 8.0, H1”), 4.72 (2H, s, 2 x 
H9’), 4.84 (1H, app t, J 9.4, H4’), 4.92 – 4.97 (2H, stack, H3”, H2’), 5.07 (1H, dd, J 10.4, 8.0, 
H2”), 5.35 (1H, app d, J 2.8, H4”), 7.44 – 7.49 (3H, stack, H14’, H15’, H19’), 7.78 (1H, s, 
H11’), 7.81 – 7.83 (3H, stack, H13’, H16’, H18’); δC(125 MHz, CDCl3) 20.4 (CH3, C2”COCH3), 
20.5 (CH3, C3”COCH3), 20.7(CH3, C6”COCH3, C4”COCH3), 20.8 (CH3, C4’COCH3), 21.0 
(CH3, C2’COCH3), 56.6 (CH3, OCH3), 61.0 (CH2, C6”), 66.8 (CH, C4”), 68.6 (CH, C2”), 69.5 
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(2 x CH, C8’, C4’), 70.4 (CH, C5”), 70.8 (CH2, C6’), 71.1 (CH, C3”), 71.3 (CH2, C7’), 72.7 
(CH, C2’), 73.3 (CH2, C9’), 73.8 (CH, C5’), 78.6 (CH, C3’), 101.2 (CH, C1”), 101.3 (CH, C1’), 
125.7 (CH, Ar), 125.8 (CH, Ar), 126.1 (CH, Ar), 126.4 (CH, C11’), 127.7 (CH, C18’), 127.8 
(CH, C13’), 128.1 (CH, C16’), 133.0 (quat. C, C12’), 133.3 (quat. C, C17’), 135.7 (quat. C, 
C10’), 168.9 (quat. C, C2’COCH3), 169.3 (quat. C, C2”COCH3), 169.4 (quat. C, C4’COCH3), 
170.2 (quat. C, C4”COCH3), 170.2 (quat. C, C3”COCH3), 170.4 (quat. C, C6”COCH3); m/z 
(TOF ES+) 815.2 (100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 815.2761. 
C38H48O18Na requires 815.2738]. 
 
ENZ 18 
Lactose (0.011 g, 0.032 mmol) and 34 (0.096 g, 0.23 mmol) were suspended in the mixed 
solvent system pH 7.0 buffer/MeCN 80:20 (0.58 mL) at 30 oC.  The β-galactosidase from B. 
circulans (4.5 U, 13.5 mg, 19.6 U mmol-1 acceptor) was then added and aliquots of the 
reaction solution were taken at regular intervals for analysis by HPLC and mass 
spectrometry.  After 24 hours the reaction was stopped by denaturing the enzyme by 
heating.  The reaction mixture was then freeze-dried and the carbohydrate residues were 
acetylated to facilitate the separation  (by column chromatography, 6:4 hexane/EtOAc) of 
starting material from the products which were recovered by flushing the column with 5% 
MeOH in EtOAc.  This flushed fraction was further analysed and separated using analytical 
HPLC (H2O/MeCN (+ 0.05 % TFA) gradient 20% to 100 % over 40 minutes, 1 mL min
-1) and 
then mass spectrometry was performed on the components.  Acetylated disaccharide 40 was 
recovered in <1% yield (4 mg). 
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β-D-(-2,3,4,6-tetra-O-acetyl)-galactopyranoside-(1→2)-α-D-methyl-((2,3,4-tris-O-acetyl)- 
6-O-{2-[2-(2-naphthylmethoxy)ethoxy]ethyl}glucopyranoside 40 
O
AcO
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16' 17'
18'
19'
20'
21'
C40H52O19
Exact Mass: 836.3103
Mol. Wt.: 836.8295
C, 57.41; H, 6.26; O, 36.33
 
Appearance: white powder; δH(500 MHz, CDCl3) 1.96 (3H, s, COCH3), 1.99 (3H, s, 
COCH3), 2.00 (3H, s, COCH3), 2.04 (3H, s, COCH3), 2.05 (3H, s, COCH3), 2.15 (3H, s, 
COCH3), 3.37 (3H, s, OCH3), 3.54 (1H, A of ABX, JAB 11.1, JAX 4.6, C6’HaHb ), 3.58 – 3.67 
(9H, stack, C6’HaHb, C7’H2, C8’H2, C9’H2, C10’H2), 3.74 (1H, dd, J 10.1, 3.5, H2’), 3.83 (1H, 
app t, J 6.6, H5”), 3.85 – 3.89 (1H, m, H5’), 4.08 (1H, A of ABX, JAB 11.3, JAX 6.5, C6”HaHb), 
4.13 (1H, B of ABX, JBA 11.3, JBX 6.5, C6”HaHb), 4.54 (1H, d, J 8.1, H1”), 4.71 (2H, s, C11’H2), 
4.83 (1H, d, J 3.5, H1’), 4.93 (1H, dd, J 10.4, 3.4, H3”), 5.02 (1H, app t, J 9.7, H4’), 5.18 (1H, 
dd, J 10.4, 8.1, H2”), 5.35 (1H, br d, J 2.7, H4”), 5.42 (1H, app t, J 9.7, H3’), 7.47 – 7.48 (3H, 
stack), 7.78 (1H, s), 7.82 – 7.84 (3H, stack); δC(125 MHz, CDCl3) 20.5 (COCH3), 20.6 
(COCH3), 20.7 (COCH3), 20.9 (COCH3), 55.4 (CH3, OCH3), 61.4 (CH2, C6”), 67.0 (CH, C4”), 
68.2 (CH, C5’), 68.6 (CH, C2”), 69.4 (CH, C4’), 69.5 (CH2), 69.8 (CH2, C6’), 70.7 (CH2), 70.8 
(CH2), 71.0 (CH, C5”), 71.1 (CH, C3”), 71.2 (CH2, C7’), 72.0 (CH, C3’), 73.3 (CH2, C11’), 77.1 
(CH, C2’), 98.8 (CH, C1’), 101.9 (CH, C1”), 125.8 (CH, Ar), 125.9 (CH, Ar), 126.1 (CH, Ar), 
126.4 (CH, Ar), 127.7 (CH, Ar), 127.8 (CH, Ar), 128.1 (CH, Ar), 133.0 (quat. C, Ar), 133.3 
(quat. C, Ar), 135.8 (quat. C, Ar), 169.0 (quat. C, C=O), 169.8 (quat. C, C=O), 169.9 (quat. C, 
C=O), 170.1 (quat. C, C=O), 170.2 (quat. C, C=O), 170.3 (quat. C, C=O); m/z (TOF ES+) 
261 
 
859.3 (100%, [M+Na]+). [HRMS m/z (TOF ES+) Found: [M+Na]+ 859.3015. C40H52O19Na 
requires 859.3000]. 
 
5.4 Combinatorial Reactions 
 
DCC1 
Using a 12-position reaction carousel, a solution of 46 (1 mL, concentration and solvent 
shown in table below) was added to a solution of the thio-sugar 45 in MeOH (1 mL, 
concentration shown in table 4.3.1.1b below).  To this was added x equiv. of a 1 M activating 
solution of 1:1 Et3N and thiophenol.  The reaction mixtures were heated to 40 
oC and stirred 
for 72 h.  In the case of reactions i – viii, additional activating solution was added at 24 and 
48 h.   40 µL aliquots were taken from each reaction at 0, 24, 48 and 72 h.  These aliquots 
were diluted in MeOH (500 µL) and refrigerated prior to analysis by MS. 
 
Variables: 
Reaction 
number 
46 
solvent 
46 
conc m/M 
45 (MeOH) 
conc /mM 
x equiv. of 
activating solution 
Activating 
solution added: 
i CHCl3 5 5 0.3 daily 
ii CHCl3 5 5 0.6 daily 
iii CHCl3 10 10 0.3 daily 
iv CHCl3 10 10 0.6 daily 
v acetone 5 5 0.3 daily 
vi acetone 5 5 0.6 daily 
vii acetone 10 10 0.3 daily 
viii acetone 10 10 0.6 daily 
ix CHCl3 5 5 0.6 once 
x CHCl3 10 10 0.6 once 
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xi acetone 5 5 0.6 once 
xii acetone 10 10 0.6 once 
Table 4.3.1.1b 
 
DCC2 larger scale reaction conditions ix 
Two identical reaction mixtures (A and B) were prepared by adding of a solution of 46 in 
CHCl3 (4 mL, 5 mM) to a solution of the thio-sugar 45 in MeOH (4 mL, 5 mM).  0.6 equiv. of 
the activating solution of 1:1 Et3N and thiophenol (24 µL, 1 M) was then added.  The reaction 
mixtures were heated to 40 oC and stirred for 48 h.   40 µL aliquots were taken from each 
reaction at 0, 1, 2, 4, 6, 8, 24, 30 and 48 h.  These aliquots were diluted in 1000 µL of MeOH 
and refrigerated prior to analysis by MS.  At 48 h the two reaction mixtures were cooled and 
refrigerated to freeze the disulfide exchange reaction. 
 
DCC3 
 
The solvent in the pooled combinatorial libraries from DCC1 and DCC2 was removed under 
reduced pressure.  The resultant residue was then taken up in a mixture of buffer and MeCN 
(300 µL, pH 5.0 NaOAc buffer with 20% MeCN).  Gal-O-pNp (3.0 mg, 0.017 mmol) was 
added to the reaction solution which was then heated at 30 oC.  A control aliquot (5 µL) was 
taken prior to adding 2.4 U of the β-galactosidase from B. circulans (3.0 mg, 19.6 U/mmol 
acceptor).  5 µL aliquots were taken at 0, 1, 2, 3, 4, 6 and 24 h at which point the reaction 
was stopped by heating to 90 oC for 5 min.  Each aliquot was diluted in 62.5 µL of MeCN and 
submitted for mass spectrometry and HPLC [analytical HPLC, H2O/MeCN (+0.05% TFA) 
gradient 20% to 100% over 50 minutes]. Separation of the components generated from the 
enzyme reaction was done by preparative HPLC under the same conditions. 
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DCC4 
12 identical reaction mixtures were prepared by adding of a solution of 46in MeOH (16 mL, 5 
mM) to a reaction vessel containing the following solutions in CHCl3: 2-naphthyl mercaptan 
(4 mL, 5 mM), 46 (4 mL, 5 mM),  47 (4 mL, 5 mM), 48 (4 mL, 5 mM).  0.6 equiv of a solution 
of Et3N in CHCl3 (96 µL,. 1 M) was then added.  The reaction mixtures were heated to 40 
oC 
and stirred for 11 d.   500 µL aliquots were taken from each reaction at 0, 1, 2, 4, 6, 24, 48, 
72, 96 h and finally at 11 days.  These aliquots were diluted in 1000 µL of MeOH and 
refrigerated prior to analysis by MS. 
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APPENDIX 
Additional data for chapter 2 
Experimental data, UV plots for: 
Methyl-6-O-(2-naphthylmethyl)-α-D-glucopyranoside 32 
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β-Methyl-6-O-(ethoxy-2-naphthylmethyl)-D-glucopyranoside 33 
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Methyl-6-O-(7’-ethoxy-9’[ethoxy-2-naphthylmethyl])-α--D-glucopyranoside 34 
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Additional data for chapter 3 
3.3.2 
UV plot for p-nitrophenolate to determine the Molar Extinction Coeffient 
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ENZ 10 (P115) 
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ENZ 11 (P122) 
MeCN UV plots 
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ENZ12 (P127) 
Increased enzyme UV plots 
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3.3.4.1 
ENZ 14D and 14H (P142) 
ENZ 14D (pH 5.0) 
 
The first new UV-active peak observed in the HPLC monitoring of this reaction was at 30 
minutes as a shoulder on the broad peak at tr = 7.1 min which corresponds to 32 (Figure 
3.3.4.1j). 
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Figure 3.3.4.1j 
 
The reaction progressed in much the same way as reaction 18D (pH 5.0, GalOpNP), so 
much so that the results are almost identical.  The HPLC trace at 24 hours again showed the 
new peak (P1) to have become a significant part of the peak at tr = 7.1 minutes 
corresponding to 32 (Figure 3.3.4.1k). 
 
32 
New peak (P1) 
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Figure 3.3.4.1k 
 
The graph and table in Figure 3.3.4.1l show these changes over the whole 24 hour period of 
the reaction.  The amount of 32 decreased over the course of the reaction, as one would 
expect, although the UV detector does not show the processing of lactose, examination of 
the HPLC spectra using ECD shows very slow hydrolysis of lactose (tr = 3.0 min) as there is 
still a significant amount remaining at 24 hours.  
 
 
 
 
 
32 + new peak (P1) 
New peak (P2) 
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Relative area % 
Reaction time 
tr =  4.7 min 
(impurity) 
tr = 7.0 min 
(32) 
tr = 9.3min 
(P1) 
tr = 12.0 - 14.7 min 
(P2) 
0 min 0.57 99.43 
  
10 min 0.55 99.45 
  
30 min 0.59 97.05 2.37 
 
1 h 0.58 94.09 5.33 
 
2 h 0.57 91.01 8.42 
 
3 h 0.52 90.4 9.08 
 
4 h 0.47 87.56 11.48 0.48 
5 h 0.39 86.30 12.47 0.84 
6 h 0.58 83.50 15.02 0.91 
24 h 0.63 95.96 
 
 
 
Figure 3.3.4.1l 
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Looking back to experiment 18D (the HPLC results of which are shown in Figure 3.3.4.1d), 
the two reactions were virtually indistinguishable from each other even though a different 
glycosyl donor was used.  Experiment ENZ 13H  was very different to ENZ 13D, so we might 
expect the results from experiment ENZ 14H to be different to ENZ 14D.  Thus far it seems 
that pH has a bigger impact on the reaction results than the choice of glycosyl donor. 
 
ENZ 14H (pH 7.0) 
 
The first new UV-active peak appeared in the HPLC monitoring of this reaction at 10 minutes 
as a shoulder on the broad peak at tr = 7.1 min which is 32.  Under these reaction conditions 
(pH 7.0) the consumption of 32 and the increase in P1 was much faster than in 19D.   There 
were also more distinct peaks in the HPLC trace, similarly to 18H.  The trace recorded at 24 
hours had a broad peak from 7.0 – 9.7 minutes which can be split into 4 separate peaks 
(Figure 3.3.4.1m).  Again, for ease of comparison the peaks due to P1 are grouped together 
in the table and graph shown in Figure 3.3.4.1n.  These results are very similar to those in 
experiment 18H (pH 7.0, GalOpNP as glycosyl donor). 
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Figure 3.3.4.1m 
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Relative area % 
Reaction time 
tr = 4.0 - 4.7 min 
(GalOpNP + unknown) 
tr = 7.0 min 
(32) 
tr = 8.5 - 9.7 min 
(P1) 
tr = 13.2-15.6 min 
(P3) 
0 min 0.65 99.35 
  
10 min 0.52 96.76 2.72 
 
30 min 0.51 92.05 7.44 
 
1 h 0.52 84.09 14.07 1.32 
2 h 0.36 75.94 21.12 2.57 
3 h 0.73 67.95 26.43 4.89 
4 h 0.44 70.68 25.17 3.18 
5 h 0.39 68.4 28.27 2.93 
6 h 0.5 67.43 27.91 4.16 
24 h 0 44.06 52.62 3.32 
 
19H HPLC UV results 
 
 
Figure 3.3.4.1n 
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Comparison of Experiments ENZ 14D  & ENZ 14H 
 
Both reactions 14D  and 14H showed processing of 32 in the HPLC spectra.  However, in 
comparing the two experiments it was clear from the graphs in Figures 3.3.4.1l and 3.3.4.1n 
that 19H (pH 7.0) showed the the greatest amount of 32 processed and the greatest amount 
of UV-active products formed. 
 
At the end of the 24 hour reaction time the reactions were acetylated for ease of 
characterisation and separation. Mass spectrometric analysis of the crude material from both 
reactions revealed the presence of our desired disaccharide Gal-CH2NpGlcOMe 36 at m/z 
771 (Table 3.3.4.1p). 
 
Reaction MS Peak m/z RMM Assignment 
(acetylated sugars) 
comments 
19D 483 [M + Na]+ 460 XE9b Major peak 
701 [M + Na]+ 678 Gal-Gal  ~1/3 height XE9b 
771 [M + Na]+ 748 Gal-CH2NpGlcOMe 36 Minor peak 
989 [M + Na]+ 966 Gal-Gal-Gal Minor peak 
19H 483 [M + Na]+ 460 XE9b Major peak 
701 [M + Na]+ 678 Gal-Gal  ~1/2 height XE9b 
771 [M + Na]+ 748 Gal-CH2NpGlcOMe 36 Minor peak 
989 [M + Na]+ 966 Gal-Gal-Gal baseline 
 
Table 3.3.4.1p 
 
TLC analysis of the acetylated material in EtOAc/Hexane (1:1) using UV and ammonium 
molybdate to visualise the components showed a set of intense spots at Rf = 0.45 
corresponding to 32.  The remaining material was seen as UV- and ammonium molybdate-
active spots on the baseline of the plate.  The column was flushed with 5% MeOH in EtOAc 
once the other spots had eluted (32 could be recovered for use in subsequent reactions).  
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Mass spectra of the material in the flush are shown in Figure 3.3.4.1q and the analysis in 
Table 3.3.4.1r. 
 
Figure 3.3.4.1q 
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Reaction MS Peak m/z RMM 
Assignment 
(acetylated sugars) 
comments 
19D 
701 [M + Na]+ 678 Gal-Gal Major peak 
771 [M + Na]+ 748 Gal-CH2NpGlcOMe ~1/2 peak at 701 
989 [M + Na]+ 966 Gal-Gal-Gal ~1/3 peak at 701 
1059 [M + Na]+ 1036 Gal-Gal-CH2NpGlcOMe baseline 
19H 
701 [M + Na]+ 678 Gal-Gal Major peak  
771 [M + Na]+ 748 Gal-CH2NpGlcOMe ~1/2 peak at 701 
989 [M + Na]+ 966 Gal-Gal-Gal ~1/4 peak at 701 
1059 [M + Na]+ 1036 Gal-Gal-CH2NpGlcOMe baseline 
 
Table 3.3.4.1r 
 
The major components in the mass spectra of the flushed material were Gal-Gal 
disaccharide and our desired  Gal-CH2NpGlcOMe disaccharide.  A baseline peak in both 
spectra was a trisaccharide containing CH2NpGlcOMe. 
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3.3.4.3 (P153) 
HPLC traces (UV) of the 4 sugars of interest 
 
GalOpNP 
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CH2NpGlcOMe 
 
EGNpGlcOMe 
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DEGNpGlcOMe 
 
 
Combined plot of all naphthyl functionalised sugars 
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Additional Data for Chapter 4 
Section  4.3.1.2 
DCC1 
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